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SUMMARY 
 
Increasing diabetes prevalence rates (SEMDSA 1997), poor involvement of and limited 
knowledge among health care professionals in disease management, (Goodman, 1997) 
and poor implementation of guidelines (Levitt, 1996) are barriers to quality diabetes care. 
 
This thesis aimed to develop, implement and evaluate an on-site diabetes 
pharmacotherapy program for public sector pharmacists. 
Methods 
Qualitative and quantitative research methods were used in the pre- and post-intervention 
study. Current dispensing practices were identified from an observation study and a self 
administered questionnaire survey. The results indicated that practice patterns were 
suboptimal and that knowledge on diabetes management was limited.  
 
Specially designed educational materials consisting of a five-part desk folder which 
highlighted key up-to-date management principles and a pen which served as a reminder 
were provided to a purposive sample of pharmacists. A trained pharmacotherapy 
facilitator (myself) visited intervention pharmacies to implement the intervention. 
Unobtrusive unstructured interviews and structured self-administered questionnaire 
surveys were used to evaluate the acceptability of the educational program.  
Results 
Nine pharmacists received the intervention. There seems to be a pattern that indicates fair 
acceptance of the intervention amongst the pharmacists.  
 
Qualitative results indicated that all pharmacists were in favour of the outreach 
intervention. Some pharmacists (3; 33%) suggested that the educational program be 
extended to other chronic diseases, while for others (3; 33%) it served reminder when 
dispensing medication to patients. Quantitative findings indicated improvements in 
knowledge which were attributed to the educational intervention. Knowledge translation 
into routine practice was not evident.  
 
 
 
 
  2  
Conclusion 
Although the outreach visit may not have resulted in imminent practice change, it 
brought about more awareness and vigilance on good management of diabetes. 
Continual on-site educational programs are required to translate knowledge into routine 
practice. An audit of diabetes management among pharmacists is essential. Further 
studies are needed among public sector primary care facilities to evaluate the quality of 
pharmaceutical care provision in chronic disease management.                                                                          
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CHAPTER 1 
 
 
INTRODUCTION 
 
An estimated 140 million individuals worldwide have diabetes (Preston, 1998; Van 
Rooijen, 2004). Diabetes prevalence (1958 to 1989), ranged between 0.1 to 3.8% 
across the African population (McLarty, 1991) and the rates differ between urban 
(5.3 %) and rural (1.5 %) populations (Aspray, 2000). Diabetes Atlas, third edition 
shows that diabetes prevalence is rising rapidly throughout the world.  In South 
Africa, it has been estimated that there is at least more than one million known 
diabetics, and possibly an equal number undiagnosed (Bonnici, 1997) with the 
highest prevalence in the Indian population (13.5 %), (Levitt, 1993; Kalk, 1998). 
 
In South Africa diabetes accounted for up to 11.4% of the recorded 213 279 deaths 
(National Department of Health, 1994). Groenewald (2003) found that in Cape 
Town alone (2001), diabetes contributed to 5.3% of the total number of reported 
deaths (23 185). The complications associated with diabetes such as retinopathy, 
peripheral neuropathy and amputations, result in loss of personal income, which 
can impact negatively on economic well-being (Chale, 1992). This is realized in 
increased hospitalization costs and a heavy burden on health and welfare services 
especially in developing countries. Private sector healthcare is expensive, 
consequently most patients attend public sector healthcare centres (Bradley, 1999; 
Distiller, 2004). 
 
Problems associated with the management of diabetes include lack of access to 
guidelines and limited knowledge among health providers (Goodman, 1997). As a 
result patients receive limited guidance on health promotion and medication use. In 
primary care facilities, guidelines are not properly implemented (Levitt, 1996; 
Daniels, 2000) leading to inappropriate care provision. In addition, the lack of full 
participation by pharmacists in chronic disease management such as diabetes has 
serious implications in quality care provision. Patients suffering from diabetes and 
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other chronic diseases are not adequately monitored and advised appropriately by 
pharmacists.  
 
Since pharmacists are the last port of call in the health care chain, they play a 
pivotal role in identifying poorly controlled patients, ensuring the appropriate use of 
medication and reinforcing preventive care (Nau, 2000). Guideline implementation 
interventions that are multifaceted and tailored for healthcare practitioners have 
been found to be effective in the provision of guideline-based care (Avorn, 1983; 
Grol, 1995: 1999) and have resulted in positive health outcomes (Chen, 2004). 
Diabetes educational outreach interventions for pharmacists have yet to be 
implemented in South Africa.   
 
1.1 Aim 
The aim of this study is to design, implement and evaluate a diabetes educational 
outreach intervention for pharmacists working in the Metropole District Health 
Services (MDHS). 
 
The main objectives of the study were:  
• to assess current practice patterns and identify barriers encountered by  
            pharmacists with regard to care of  diabetes patients. 
 
• to design, implement  and evaluate a multifaceted educational outreach        
            intervention to address identified practice gaps in diabetes management. 
 
1.2 Chapter description   
Chapter 2 provides background on the scope of problems regarding diabetes 
management in primary care.  In addition a review of educational outreach 
programs is provided as a strategy to implement guidelines for pharmacists.  
 
Chapter 3 provides an overview of research methods and how these were applied 
in the study.  
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Chapter 4 focuses on the qualitative and quantitative assessment of pharmacists’ 
pharmacotherapeutic skills with regard to prescribed drug therapy and health 
promotion. In addition, pharmacists’ views regarding need for educational 
interventions are explored. 
 
Chapter 5 discusses the development and implementation of a guideline based 
multifaceted educational outreach intervention. The contents of the educational 
materials, the training of the educator and the implementation process are 
discussed. 
 
Chapter 6 provides the results of the implementation of the intervention. 
Pharmacists’ responses were assessed using both qualitative and quantitative 
methods which involved use of unobtrusive in-depth interviews and questionnaires 
to gain deeper insight into acceptability of the intervention. 
 
Chapter 7 discusses whether the outreach intervention was acceptable amongst the 
pharmacists. It assesses the extent to which the different intervention materials and 
methods used influenced acceptability. Further it evaluates whether improvement in 
knowledge in diabetes management principles was actually translated into practice. 
 
1.3 Use of personal pronoun 
In this thesis I use the personal pronoun, rather than “the researcher” or “the 
author” to capture my experiences to closely resemble that of the real situation.  
 
1.4 Referencing   
The bibliography follows the Vancouver style of referencing. Referencing is by 
first author and year of publication in parenthesis in the text. When a study is 
mentioned in the narrative, only the first author is cited without et al.    
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CHAPTER 2 
 
LITERATURE REVIEW 
 
This chapter provides an overview of the morbidity, prevalence and mortality rates 
for diabetes as well as its economic impact. The primary care management of 
diabetes is discussed, with emphasis on pharmaceutical practice, and the status of 
continuous professional training and development programs for pharmacists in 
South Africa. Further, the implementation of outreach programs, more especially 
those designed for pharmacists with regard to diabetes management, is reviewed.  
 
2.1 Overview of diabetes  
Diabetes is a term used to refer to a group of different diseases (heterogeneous 
syndrome) resulting from impaired insulin secretion (SEMDSA, 2003). One of the 
primary signs and symptoms of the disease is hyperglycaemia but patients may also 
exhibit other body function abnormalities, for example, dyslipidaemias. Diabetes is 
associated with serious complications (Lundstrom, 2004), including comas, sepsis, 
and microvascular disease (involving the eyes, kidneys and nerves) as well as 
macrovascular disease (concerning the coronary, cerebral and peripheral arteries).  
 
There are three main groups or classes of diabetes, namely: Type 1 also known as 
insulin-dependent diabetes mellitus (IDDM); Type 2 or non-insulin-dependent 
diabetes mellitus (NIDDM); and impaired glucose tolerance (IGT), (Knight, 1997). 
Patients with type 2 diabetes do not depend on insulin but may require it during the 
disease progression to control blood glucose. IGT signifies an ‘at-risk’ status rather 
than a disease and can only be diagnosed using an oral glucose tolerance test (ibid). 
Diagnosis depends on measuring the plasma glucose levels using tests such as 
random blood glucose (RBG), fasting blood glucose (FBG) and glycosylated 
haemoglobin (HbA1c) while serum fructosamine is recommended for screening 
elderly populations (ibid).  
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According to Greene (1993), Type 1 diabetes is genetically determined and results 
from the destruction of the islet beta-cells in the pancreas by the auto-immune 
process. Type 2 diabetes may be caused by reduced insulin secretion, relative 
insufficiency (lack of insulin secretion for the increased metabolic needs e.g. 
obesity), insulin resistance and hyperinsulinaemia. This leads to poor utilisation of 
endogenous insulin in the liver, muscle, and adipose tissue.   
 
2.2 Prevalence of diabetes   
An estimated 140 million individuals worldwide have diabetes (Preston, 1998; Van 
Rooijen, 2004). According to the World Health Organisation (1997), the rise in 
diabetes prevalence is expected to be highest in Africa, mostly due to an ageing 
population, unhealthy diets, and obesity.  
 
The diabetes prevalence rate (analysed from 1958 to 1989), ranged between 0.1 % 
to 3.8% across the African population (McLarty, 1991) and the rates differ between 
urban and rural populations. A Tanzanian study showed that diabetes was more 
prevalent in urban communities than in rural ones. Whereas prevalence rate was  
5.3% in urban communities, it was only 1.5% in rural communities (Aspray, 2000). 
In South Africa, it has been estimated that there is more than one million known 
diabetics, and possibly an equal number undiagnosed (Bonnici, 1997). Prevalence 
figures of 6.0% and 4.8% for urban and rural populations respectively, have been 
reported (Mollentze, 1995). It has also been shown that prevalence rates show 
variation within ethnic groups and across age groups (Knight, 1997). For example, 
in South Africa’s KwaZulu-Natal province, black females (5.2%) were twice more 
likely to have diabetes compared to black men (2.3%), (Omar, 1993). In the 
Western Cape province, prevalence rates vary across the population groups - Indian 
origin (13.5%), Coloured (8%), Black (6-8%) and Whites (5%), (Levitt, 1993; 
Kalk, 1998). Among the low socio-economic Coloured community, diabetes is 
common among those aged 65 years and over (8 % - 28%), (SEMDSA, 1997). 
Studies point towards a dual burden comprising an increasing prevalence of 
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diabetes and associated infections leading to serious complications amongst black 
South Africans (Levitt, 1997; Kalk, 1998).  
 
Optimal diabetes management requires concerted efforts by health care 
professionals to help reduce the morbidity and complications associated with the 
condition.  
 
2.3 Complications associated with diabetes      
Persistent high blood glucose levels could result in the glycosylation of proteins 
resulting in the irreversible damage of tiny blood vessels and nerve endings in the 
areas furthest from the heart, retina, renal glomerulus, the nerve sheath and the 
cellular membranes (Lundstrom, 2004; White, 2004). 
 
Macrovascular complications (which affect the larger blood vessels in the body), 
are common among Type 2 diabetic patients. These patients are more likely to 
suffer from coronary heart diseases including hypertension, atherosclerosis and 
thrombosis. About 75% of macrovascular diabetic mortality is due to coronary 
heart disease (CHD); the remaining 25% results from a combination of accelerated 
cerebral vascular disease, peripheral vascular disease, or both (Sowers, 2001). 
Research has shown that tight control of blood sugar levels minimizes the risk of 
complications (DCCT, 1993). 
 
2.4 Diabetes mortality in South Africa 
According to the National Department of Health (1994), diabetes accounted for up 
to 11.4% of the recorded 213 279 deaths in South Africa. Groenewald (2003) found 
that in Cape Town alone (2001), diabetes contributed to 5.3% of the total number 
of reported deaths (23 185). Kalk (1998) has estimated that amongst women, death 
from diabetes accounted for 18.2% of deaths amongst Asians, 7.1% amongst the 
Coloureds, 4.3% amongst the Blacks and 3.0% amongst the Whites. Mortality rate 
amongst Black, Coloured and White men due to diabetes ranged between 2.0 - 
 
 
 
 
  9  
2.5%, with a two-fold rate among Asians at 4.9%. Groenewald (2003) has made 
several recommendations that could be considered in an attempt to curb increasing 
mortality rate due to diabetes. These include an increase in public awareness, 
improving patient detection and an efficient management and follow-up system. 
Through these efforts, pharmacists too can play an important role in counselling 
patients about their drug therapy and in helping patients manage the disease 
optimally. However, to make an effective contribution, they must be 
knowledgeable about the pharmacotherapeutic management of diabetes. 
 
2.5 The economic impact of diabetes 
Jönsson (1998) estimated that globally, diabetes consumes 2 to 3% of the total 
country’s health care budget. Increases in diabetes incidence and prevalence, 
therefore have a significant impact on a country’s economy.  At household level, 
diabetes complications such as retinopathy, peripheral neuropathy and amputations, 
result in loss of personal income, which can impact negatively on economic well-
being (Chale, 1992). The overall effect of this is increased hospitalization costs and 
a heavy burden on health and welfare services. This is especially so in developing 
countries where health expenditure is high. 
 
In South Africa, private sector healthcare is expensive (Bradley, 1999; Distiller, 
2004). Consequently, most patients attend public sector healthcare centres. In 2002, 
the average annual cost of managing an outpatient in the hospital sector was R1050 
(Hamdulay, 1996). This average was shown to be generally higher for tertiary 
hospitals compared to the costs incurred in community health centres (CHC’s) 
(Hamdulay, 1996; van Zyl, 2002).  
 
Successful treatment of diabetes involves life-style changes for the patient [e.g 
nutrition, physical activity, self-monitoring of blood and possibly urine, and/or 
taking medication] (Steil, 1999). The goal of the diet plan for Type 1 patients is to 
build a healthy daily nutrition intake into a regimen that allows flexibility in insulin 
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therapy and home monitoring. The emphasis for Type 2 patients should be placed 
on achieving blood glucose, lipid and blood pressure goals (ibid). 
 
2.6 Management of diabetes 
Detection of diabetes is essential because complications can begin early in the 
course of the disease, even before symptoms develop (White 2004). Lipid 
disturbances, obesity and hypertension are common in Type 2 diabetes, and 
probably contribute to the high prevalence of vascular disease. Type 2 diabetes 
mellitus, is a “silent disease” that can go undetected for about 10 years and will 
often present with neuropathy and/or vascular complications. The first signs of 
diabetes may present as thirst, polyuria, nocturia, genital itchiness, tiredness and 
visual blurring (Steil, 1999). 
 
According to the Guidelines for the Management of Diabetes (2003), diabetes is 
determined from the following: 
• fasting blood glucose levels (FBG):  greater than (>) 7 mmol/L normal (4.0 to 
7.0 mmol/L) 
• random blood glucose (RBG) plasma levels: normal greater than or equal to (≥ ) 
11.1 mmol/L  
In asymptomatic patients a single random blood glucose >11.1 mmol/L and fasting 
blood glucose levels greater than > 7 mmol/L is inadequate for diagnosis. The 
abnormal value must be confirmed at least once before diabetes is diagnosed. If the 
results are uncertain the patient requires a glucose tolerance test with ingestion of 
75 grams of oral glucose after an overnight fast. The diagnosis of diabetes is 
established if the fasting blood  glucose ≥ 7.8 mmol/L and/or 2 hours post load 
blood glucose ≥ 11.1 mmol/L. 
 
There is a need for caution when interpreting blood glucose concentration because 
normal whole blood glucose values are approximately 15% lower than plasma 
glucose values. Drug treatment should be initiated at a random blood glucose level 
greater than (>) 15 mmol/L or FBG greater than or equal to (≥) 10 mmol/L. 
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Pharmacists should be able to understand and interpret blood glucose levels, so that 
they can assess and refer poorly controlled patients with diabetes.  
 
2.7 Treatment 
The therapeutic objectives are to maintain blood glucose within normal limits 
without causing dangerous hypoglycemia, to keep urine as free as possible of 
glucose and to prevent or delay the long-term complications associated with 
diabetes. 
             
Pharmacologic intervention is necessary if an appropriate diet and exercise program 
(weight reduction) does not adequately improve glycaemic control (Steil, 1999).  
Drug treatment includes hypoglycaemic agents and may include antihypertensives, 
lipid-lowering drugs, anti-clotting medication, sexual dysfunction drugs, 
antidepressants and analgesics (White, 2004). Treatment is individualised 
according to blood glucose levels, age, nutritional status, activity level and/or other 
disease conditions. Drug therapy, diet and exercise help control blood sugar levels. 
 
Dyslipidaemia and hypertension are co-morbid conditions closely associated with 
diabetes and they also require close monitoring. If a routine diabetes management 
plan including diet, weight loss, and improved glycaemic control do not 
successfully achieve these goals within three to six months, lipid-lowering drug 
therapy should be considered. Therapy must be started immediately if the patient 
has established cardiovascular disease.  Diabetes dyslipidaemia and hypertension 
are co-morbid conditions closely linked to diabetes. Type 1 patients have an 
absolute lack of insulin, so diet, exercise, self-monitoring of blood glucose, and 
insulin are necessary for proper management (Greene, 1993; Steil, 1999).  
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2.7.1 Insulin 
There are numerous types of insulin regimens, from one to two injections a day, to 
multiple daily injections or a continuous subcutaneous insulin infusion with an insulin 
pump (Yang, 2004). Insulin is a polypeptide hormone that controls the storage and 
metabolism of carbohydrates, proteins and fats. It reduces blood glucose levels and if 
found in excess, can cause life-threatening hypoglycaemia.  
 
Insulins are differentiated on their duration of activity and the route of administration of 
insulin is subcutaneous (SC). The South African Medicines Formulary, edited by Gibbon 
(2005) provides an overview about the pharmacotherapeutic and pharmacodynamic 
profiles of the different insulins and serves as a useful reference tool for pharmacists. 
Insulin is given intravenously only in emergencies and only fast/ ultra fast insulin is given 
by this route. In most cases, combination insulin therapy is recommended to achieve 
optimal control of blood sugar level. 
 
International colour codes have been used to differentiate insulin therapy of different 
duration of action (Bonnici, - personal communication-16th October, 2004). The short 
acting insulin is yellow, medium-acting green, long-acting blue, and the biphasic 
insulin is coded brown. Such colour coding enable patients to identify the type of 
insulin being used especially when combination therapy is prescribed. 
 
2.7.2 Oral hypoglycaemic agents 
The oral hypoglycaemic agents are classified into the sulphonylureas, biguanides and a 
newer group of compounds. 
i) Sulphonylureas e.g. glibenclamide (Daonil®; Clamide®), gliclazide (Diamicron®), 
glipizide (Minidiab®; Glibenese®), glimepiride (Amaryl®).                                    
These agents act by stimulating the release of endogenous insulin from β cells of the 
pancreas, and increase binding of insulin to target tissues and receptors. However they are 
not insulin sensitizers and therefore do not address the problem of insulin resistance.  
 
ii) Biguanides e.g metformin (Diabetmin®; Glucophage®; Dextrin®) 
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These agents act by decreasing hepatic glucose production and glucose absorption from 
the gastrointestinal tract. They produce beneficial changes in the lipid profile by 
decreasing triglycerides, low density lipids (LDL) cholesterol and total cholesterol but 
have no significant effect on high density lipids (HDL) cholesterol. Metformin often 
causes some welcome weight loss and is recommended in obese patients. It is best to 
avoid concurrent alcohol consumption. 
 
iii. The newer  groups of drugs include the : 
Thiazolinediones e.g Pioglitazone (Actos®)  and rosiglitazone (Avandia®).    
Meglitinides e.g Repaglinide (Novonorm®)  and nateglinide (Starlix®) 
Alpha-glucosidase inhibitors e.g acarbose(Glucobay®) and miglitol(Glyset®). 
 
2.7.3 Aspirin and heart disease                            
Aspirin is used as a secondary prevention therapy in individuals who have evidence of 
large vessel disease e.g angina or myocardial infarction (MI). It is also used in individuals 
with diabetes type1 and 2 with cardiovascular risk factors. Low dose aspirin has 
antiplatelet effects which help to reduce the risk of adverse events such as coronary artery 
disease (CAD). The adverse effects of aspirin are gastric irritation which may cause 
abdominal pain, nausea, vomiting, and hidden mucosal bleeding. 
 
2.8 Health care in the Western Cape 
The South African health system aims to provide equitable and accessible health care 
(Ntuli, 2004). The health system consists of a large public sector, which is under- 
resourced, overused, and serves 80% of the population. A smaller private sector caters for 
the remaining 20% of the population - the middle and high-income earners who belong to 
medical schemes (ibid).  Sixty percent of doctors and more than 70% of pharmacists 
work in the private sector (Padarath, 2003/4). In 2004, it was estimated that there were 
about 10 891 registered South African pharmacists of which 17% (1 855) served the 
Western Cape (Health Statistics, 2006). Attempts have been made to increase pharmacist 
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intern posts in the Western Cape public sector from 14 to 25 (M. von Zeil, e-mail 
communication 16 May, 2005).  
 
The decentralised public health system divides the province into four health regions: 
Cape Metropole, West Coast Winelands, South Cape/Karoo and Boland/Overberg which 
are further sub-divided into 25 health districts (McCoy, 1999). In the Cape Metropole, 
there are 11 health sub-districts, serviced by the Department of Health through the 
Metropole District Health Services (MDHS), the primary health care services (PHC), and 
the secondary and tertiary hospitals (Haynes, 2002). 
 
2.9 Primary health care (PHC) services and the district health system (DHS) 
Primary health care (PHC) is the foundation of the health system, which is a municipal-
based district health system (DHS), (Haynes, 2002). The two primary service providers 
consist of the City Health (Local Authority) and the Provincial Administration of the 
Western Cape (PAWC). District authorities manage primary health care clinics while 
provincial authorities control hospitals. 
 
City Health provides offers services such as immunization, nutrition, reproductive health 
(family planning), tuberculosis and sexually transmitted disease management while 
PAWC provides other services such as the regular emergency patient consultations for 
various common and minor diseases and management of chronic conditions.       
 
PHC centres provide a range of services, which include immunization, communicable 
and endemic disease prevention, maternity care, integrated management of childhood 
illnesses (IMCI) and child health care, health promotion, youth health services, 
counselling services, chronic diseases, diseases of older persons, rehabilitation, accident 
and emergency services, family planning, and oral health services (South African Year 
book, 2000/01). Many Western Cape citizens do not have health insurance (Internet 
Department of Health, 2006) therefore they rely on health care from the public sector 
MDHS facilities. 
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2.10 Metropole District Health Services (MDHS) 
MDHS facilities offer primary health care services which are managed by medical 
officers, nurses and pharmacists (Human, 1998; South African Year book, 2002/03). The 
services offer curative health care, midwife obstetric unit services (MOU), 
trauma/emergency and minor surgery (ibid). Provision of care adheres to national and 
provincial guidelines and standard treatment guidelines.  South Africa’s essential drugs 
program is aligned with the primary health care concept of universal access to cost 
effective and affordable health care for all citizens. Rational pharmacotherapy is the 
cornerstone of the public sector health service.  
  
2.11 Health services barriers to diabetes management  
According to Goodman (1997) gaps between knowledge and practice contribute to 
poor management of diabetes in primary health care facilities. The lack of full 
participation by pharmacists in chronic disease management such as diabetes is 
likely to compromise the quality of care. Nau (2000) has suggested that the 
involvement of pharmacists in diabetes care services will help to identify patients 
who are not reaching the desired therapeutic end points. Anderson (2003) found 
that pharmacists sometimes react only to patients’ questions rather than giving 
them proactive advice when counselling.  
 
Primary care management of diabetes is crucial if morbidity, mortality and the 
economic burden are to be reduced. A study by Levitt (1996) showed that up to 
50% of diabetic patients in Cape Town primary health care centres were not 
attending clinics. It was also found that between 75 to 90% did not have their 
medications changed although there were indications that their conditions were not 
well controlled by the existing treatment regime. Shankar (2001) has recommended 
the use of additional hypoglycaemic agents to maintain good control of blood 
glucose levels.  
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Diabetes is a complex disease that requires concerted efforts by all health care 
professionals especially in primary care facilities where specialist care is 
inaccessible. A team approach to diabetes management is therefore essential if 
patients are to benefit from primary care (Donnelly, 1990; Levitt, 1996; Kalk, 
2000). Some MDHS centres have diabetic clinics or “diabetic clubs” once or twice 
a week (Goodman, 1997). These clubs are staffed by doctors, primary health care 
nurses, registered nurses, staff nurses and pharmacists. Their collaborative efforts 
offer different perspectives, skills and knowledge for the benefit of the diabetic 
patient. However, very few pharmacists actively participate in these teams, 
resulting in under-utilisation of an available resource. Pharmacists 
compartmentalize their roles and see themselves only as dispensers of drugs rather 
than full participants and view health care provision to be the domain of doctors, 
nurses and dietitians (Hibbert, 2002).  
 
Poor remuneration of health professionals, inadequate space and resources, time 
constraints, lack of training and poor inter-professional communication are also 
barriers to care (Mays, 1994).  
 
2.12 Pharmacy practice in South Africa 
Pharmacists are recognized as the custodians of medicine - they guard its safety, 
quality and efficacy (Kotze, 2000). One of the guiding principles of the South 
African National Drug Policy (1996) is that pharmacists should take responsibility 
for medicine-related issues to ensure that care is effectively managed to achieve 
health gains. Pharmaceutical care underpins appropriate medication use aimed at 
improving the patient’s quality of life, one that involves a focus change for the 
pharmacy from product to patient (Management Sciences for Health (MSH) and 
WHO, 1997; van Mil, 2004). However, South African pharmacists have been slow 
in adopting the basic principles of pharmaceutical care (Futter, 1998). 
 
The Good Pharmacy Practice Manual (1997) lists some of the activities guiding the 
scope of pharmaceutical practice in South Africa as: 
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• management of the pharmaceutical services; 
• manufacture, compounding and distribution of  pharmaceuticals; 
• dispensing and ensuring the quality use of medicine; 
• providing pharmacist initiated therapy; 
• providing medicine information and education; 
• promoting public health; 
• promoting communication; and 
• conducting research and the development of new drugs. 
 
The role of the pharmacist in diabetes could assist overburdened nurses and doctors 
in identifying poorly controlled patients by monitoring therapy and counselling on 
lifestyle modification in accordance with local guideline recommendations.  
 
2.13 Role of the pharmacist in diabetes management 
In the USA and UK, there is a shift towards greater pharmacist involvement in 
patient orientated services in diabetes management (Campbell, 2002; Meece, 2003; 
Till, 2003; Simpson, 2004; Undeberg, 2005). 
 
Decker (1988) asserted that pharmacists are a greatly underutilized resource in 
diabetes management, this is despite the fact that they play a pivotal role in 
counselling and disseminating information on drug and non-drug treatment. 
Pharmacists can encourage patient self-management (Daniel, 2005) by monitoring 
therapy, in accordance with laboratory data. For example, glucose and glycosylated 
haemoglobin (HbA1c) levels, lipid profile and blood pressure measurements can be 
monitored and reviewed along with monthly prescription refills. Equally important, 
is their involvement in encouraging patients to care for their eyes and feet ( 
Anderson, 2003; Pray 2003). This requires that they have good pharmacotherapy 
skills to identify patients who have poor control and recommend appropriate 
strategies that would prevent complications and a diabetic checklist would serve as 
a useful reminder.  
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2.14 Diabetes checklist for pharmacists  
Knight (1997) has recommended the use of a time-saving checklist that could help 
pharmacists engage in a therapeutic plan for the management of diabetes. The 
checklist may include:  
• Encouraging patients’ self-monitoring of blood glucose levels through 
            random testing and recording of blood glucose levels.  
• Encouraging regular cholesterol screening; the monitoring of blood pressure 
Should be should be < 130/80 or 140/90 mmHg), eye and foot 
examinations, checking heart status and/or risk (electrocardiogram), 
dermatological and dental assessment;  
• Encouraging annual to quarterly testing and recording of glycosylated  
(glycated) haemoglobin A1c (HbA1c). Good control level is (less than)  
 ≤ 7%.   
• Taking regular urinalysis to test for microalbuminuria, proteins and ketones;  
• Maintaining ideal body weight; 
• Checking appropriateness of antidiabetic regimen and aspirin use;  
• Checking adherence to nutrition and exercise plan. 
 
Patient adherence to therapeutic plans depends on active involvement of pharmacy 
staff.  Short-term continuing education programs have resulted in improved 
knowledge and attitudes in the management of diabetes (Chen, 2004).  
 
2.15 Continued professional development programs for pharmacists  
Continuous professional development programs (CPD) in South Africa are 
endorsed by the South African Pharmacy Council (SAPC). The Pharmaceutical 
Society of South Africa (PSSA) mentors and facilitates CPD programs that are 
usually sponsored by pharmaceutical companies. However, attendance of public 
sector pharmacists at these courses is limited (Margaret von Zeil – personal 
communication, 2005). It has been seen that continuing medical education (CME)  
is not a very effective way of changing performance in practice because little 
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attention is given to overcoming specific barriers to change (Haynes, 1984; Davies, 
1995). Generally CME’s are conducted away from the workplace. This necessitates 
the use of alternative educational strategies when implementing professional 
programs. In-service tailored educational meetings may be an alternative approach 
to update pharmacists on therapeutic approaches.  
 
Pharmacists at individual institutions are encouraged to attend lectures and other 
forms of professional development at their facilities. In the Western Cape, the 
University of Cape Town (UCT) circulates course notices to MDHS pharmacies on 
behalf of the Medicine Information Centre (MIC). An independent service provider 
offers a hypertension course that is conducted off-site for health professionals such 
as pharmacists, doctors and nurses (Perkin, personal communication, 2005 and 
2006). An on-site diabetes educational program tailored for pharmacists working in 
the public sector has yet to be implemented. 
 
2.16 Educational courses for pharmacists in diabetes management 
The quality of care in some clinics and hospitals in South Africa, does not meet the 
recommendations as stated in the current diabetes guidelines (van Zyl, 2004). In the 
Western Cape, an audit of four MDHS facilities’ use of diabetes and hypertension 
guidelines showed that these were not systematically implemented (Clark, 1999; 
Levitt, 1999; van Zyl, 2004).This may mean that health care professionals might 
need educational training or support to  adhere  to guideline recommendations.  
 
Private service-providers usually offer training programs for community 
pharmacists on the management of diabetes.  Wallis (1996) in collaboration with 
Technipharm, developed a training program designed for diabetes care by 
community pharmacists in South Africa. This patient oriented program, which was 
in line with the country’s legislative requirements, has been endorsed by the SAPC. 
However, low attendance at these training programs could be attributed to the high 
course fees and the cost of traveling to the venue. Such programs are not directed to 
pharmacists working in the public sector.  
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In order to minimize travel costs and locum fees, on-site educational programs may 
be an option. Such outreach programs have been shown to improve knowledge and 
change professional practice (Soumerai, 1990; Grol, 1999; Grimshaw, 2005). The 
National Drug Policy (1996) recommends that drug products be handled by 
adequately qualified personnel who can be held responsible and accountable. It 
further supports the implementation of in-service training programs to address on-
the-job requirements of health care professionals. Educational outreach programs 
that offer patient-centred care may be considered as a viable option. Therefore, an 
educational outreach program for pharmacists could result in improvements in 
knowledge, attitude and practice patterns (Soumerai, 1990; Gerstein, 1999; Grol, 
1999; Grimshaw, 2005).  
 
2.17 Guideline implementation strategies  
The Oxford dictionary (2002) defines a guideline as a general rule, instruction, or 
piece of advice. Clinical practice guidelines describe different aspects of the 
patient’s condition and the care to be given in a convenient readily usable format 
(Eddy, 1990; Field, 1990; Grol, 1995; Hutchinson, 1999).  Guidelines can be used 
for promoting quality and rational drug use (James, 1997; Grol, 1995). However, 
the development and availability of guidelines do not guarantee good practice 
(Lomas, 1991). Implementation of guidelines is a universal problem amongst health 
care practitioners.  Factors that limit the use of guidelines include: their perceived 
usefulness; the conflict with clinical freedom; the preference to perform routine 
activities; and poor access to the guidelines (Conroy, 1995; Watt, 1999).  To 
overcome these barriers, Grol (1995) suggested the use of an intervention package 
consisting of educational reminders on the latest therapeutic approaches and whose 
content is peer reviewed.  
 
For the effective implementation of guidelines, Baker (1999) and Watt (1999) have 
suggested several strategies. These include: audit and feedback; educational 
outreach; academic detailing; use of opinion leaders; and sharing clinical guidelines 
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with patients. Their success, however, depend on behaviour change by the relevant 
health care professional. Positive attitudes and perceptions of the health providers 
towards the guidelines are critical for successful implementation (James, 1997; 
Mohammed, 2001). Successful implementation of guidelines is also dependent on 
what they are used for and how they were developed (Grimshaw, 1995; Grol, 
1995). In South Africa some hospital staff do not follow clinical guidelines in the 
management of chronic lifestyle diseases (Clark, 1999; Levitt, 1999; Kalk, 2000; 
Mohammed, 2001; van Zyl, 2004). Face-to-face education with individual 
instruction, computer reminder systems and peer review with practice visiting, has 
been shown to work well in changing professional practice (Conroy, 1995; 
Grimshaw, 2005). 
 
Since people with diabetes encounter pharmacists more than any other health care 
provider (Taylor, 2003) for prescription refills, it is important for the pharmacists to 
know how to interpret monitoring parameters (Brown, 2002). They can then 
counsel and guide patients on how to self-monitor blood glucose (SMBG). 
Therefore, providing educational programs that would help them understand and 
interpret blood glucose levels, increase their awareness, and equip pharmacists with 
the skills to encourage self-management among patients. Educational outreach 
programs that address these needs could change professional practice. 
 
2.18 Educational outreach programs 
Educational outreach is a program in which a trained health care professional 
conducts brief face-to-face meetings with health care providers in their practice 
settings, with the aim of changing their clinical performance (Avorn, 1983). In this 
approach, emphasis is placed on providing health care professionals with relevant, 
localized, up-to-date information on therapeutic approaches.          
 
Generally, educational outreach programs have been shown to be successful in 
developed countries. For example, in a study by Fedder (1988), pharmacists 
demonstrated improvement in professional practice after an intervention that helped 
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them to systematically follow-up and monitor hypertensive patients. In Chen’s 
study (2004), pre- and post-intervention measurement tests showed improvement in 
pharmacists’ attitudes and an increase in knowledge of the management of diabetes. 
There have been improvements in knowledge, attitude and self-reported practice 
patterns among physicians who participated in educational outreach programs 
(Gerstein, 1999). Such programs can also be adapted in resource-poor countries, to 
enable pharmacists to fulfill their professional roles. 
 
Educational outreach programs have been conducted for conditions such as asthma 
(Bheekie, 2001), malaria (Tavrow, 2003), tuberculosis (Fairall, 2005) and for upper 
respiratory tract infections (Meyer, 2001). These studies underpin the effectiveness 
of outreach programs in improving practices among health care professionals. 
Meyer (2001) used the Guide to Good Prescribing manual (World Health 
Organisation, 1995), as a guideline for the design of the training programs which 
led to improved prescribing practices amongst the nurses. Outreach educational 
programs also include a problem-based learning approach (PBL) as part of the 
guideline implementation strategy (De Vries, 1995). 
 
2.19 Problem-based learning 
Problem based learning (PBL)  is described as learner-centred, it involves choosing 
a relevant problem that mimics a real-life situation and developing appropriate 
knowledge and skills (Hmelo, 1998) to solve it.  PBL strategies include the use of 
learning cases, small group discussion and cooperative activities (ibid).   
 
Some studies have demonstrated successful outcomes with the problem-based 
approach during pharmacotherapy training, (De Vries, 1995; Akici, 2003). These 
include knowledge retention and the ability to apply their newly acquired skills (the 
transfer effect). Problem-based training in pharmacotherapy is one of the several 
activities that have proved very useful and effective in promoting rational drug use 
(Laing, 2001).   
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Undergraduate modules employ the PBL technique to prepare students for their on-
site pharmacotherapy / clinical programmes (UWC, School of Pharmacy course 
outline, 2005). The objective and structured clinical examination (OSCE) is used to 
assess student performance under controlled conditions on campus. This 
assessment tool has been modified to assess their pharmacotherapeutic skills during 
service-learning. Such a tool could also be used to monitor or assess the 
pharmacist’s pharmacotherapy skills at the pharmacy outpatient counter. This 
would enable pharmacists to become aware of potential deficiencies in the practice 
pattern, especially in chronic disease management where therapeutic monitoring is 
essential.  
 
2.20 Education of the patient 
Diabetes is a lifelong disorder which always requires adherence to a specialized 
diet and often needs compliance with various pharmacological interventions 
(Knight, 1997). Patients will not, on their own, be able to manage their condition 
without being given the appropriate knowledge and understanding as to why they 
have to do things differently (Naidoo and Willis, 2000). To encourage patient 
adherence to treatment (pharmacological or non-pharmacological), they must be 
informed about the disease and its consequences to minimize the onset of 
complications (Roberts, 2004). 
 
Pharmacists are in the ideal position to teach patients the importance of complying 
with their drug treatment to achieve glycaemic control which is within 
recommended levels (DCCT, 1993; UKPDS, 33; 34; 35 1998) and good blood 
pressure control (UKPDS, 38; 39 1998; Hypertension Optimal Treatment (HOT) 
trial, 1998). Such monitoring has been found to minimize the progression of 
diabetes and reduce the risk for developing complications. 
 
Doctors and pharmacists seem to explain too little about the use of medicines. Even 
though pharmacists have the knowledge, they are not very eager to share their 
knowledge with the patients to assist them to better manage their condition, 
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including diabetes (Hexheimer, 1993). It seems this unwillingness may be 
entrenched in past practice habits. Also, lack of enough knowledge prevented them 
from proactively sharing the information while counselling patients. Pharmacists 
should ensure that both the patients and their caregivers understand the factors that 
may lead to poor control of diabetes. 
 
Pretorious (2003) explained that it is the duty of the pharmacists to warn patients 
about harmful side effects. The SAPC regards this duty as sufficiently important to 
reproduce it as an ethical rule. There is a need for educational programs that can 
encourage pharmacists to proactively share drug information (Anderson, 2003). 
Concerns about being “intrusive” in offering potentially unwelcome health advice 
predisposes one to a reactive stance (ibid).  
 
2.21 Conclusion 
Diabetes incurs substantial morbidity in South Africa. It places a huge burden on 
the public sector health services where adherence to guideline recommendations is 
limited. Primary care diabetes management requires the concerted efforts of all 
health care professionals, especially the pharmacist. The implementation of a 
diabetes educational outreach program could improve the knowledge and 
subsequently change current practice patterns.  
 
A review of the research methods to design, implement and evaluate an outreach 
program for pharmacists would be useful. 
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CHAPTER   3 
 
 
RESEARCH METHODS USED IN STUDY 
 
I provide an overview of research methods (Section A), and describe how these were 
applied in the study (Section B). In this exploratory study, both qualitative and 
quantitative methods were used. The study was directed at pharmacists working in 
purposively selected community health centres of the Metropole District Health 
Services (MDHS) in the Western Cape province.   A pre- and post-test design was 
used to assess receptivity of the diabetes educational outreach intervention (Bless, 
1995). 
 
3.1 Section A: Review of research methods 
Qualitative and quantitative research methods are commonly used in health service 
research.    
3.1.1 Qualitative research and triangulation  
Qualitative research explores people’s subjective understandings of their everyday 
lives. Its methods include direct observation, interviews, the analysis of texts or 
documents, recorded speech or behaviour, and audio/video tapes (Neuman, 2000; 
Pope, 2000). Qualitative research involves giving a thick description of events. 
Patton (1990) argues that sufficient description and direct quotations should be 
included so that the reader can enter into the situation and thoughts of the people. 
This involves detailed portrayals of participants’ experiences, uncovering feelings 
and interpreting the meaning of their actions (Holloway, 1996; Merriam, 1998).  
 
Several qualitative methodologies can be used concurrently to bring about better 
understanding of the research topic. The use of more than one method to understand 
the topic under investigation is called triangulation (Creswell, 2004). Triangulation 
embraces multiple data sources and methods. For example, data can be obtained by 
using both a questionnaire and interviews. This has the advantage of producing 
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insight and understanding in ways that one method alone cannot achieve (Bernard, 
1994).  
3.1.2 Quantitative research methods 
Quantitative research methods involve the collection of facts to study their 
relationship to each other. The methods use techniques that are likely to produce 
quantified and, if possible generalisable conclusions (Bell, 1993). Data is converted 
into numbers which are analysed statistically to test hypotheses (Armstrong, 1990).  
Table 3.1 below summarizes some of the fundamental attributes of qualitative and 
quantitative methodologies. 
Table 3.1:  Summary of Qualitative and Quantitative research attributes (Cook, 
1979) 
Qualitative research Quantitative research 
Concerned with understanding human 
behaviour from the actor’s own frame of 
reference. 
Valid; “real,” “rich,” and “deep” data that 
shows  “insider” perspective. 
Assumes a dynamic reality. 
 
Seeks the facts or causes of social 
phenomenon with little regard to the 
subjective states of individuals.  
Reliable; “hard,” and replicable data 
that shows  “outsider” perspective. 
Assumes a stable reality. 
 
 
3.1.3 Mixing of research methods                                  
Many researchers combine both qualitative and quantitative methodologies to bring 
together complementary information in order to best understand the research topic. 
Mixing different methods of investigation involves the integration of quantitative and 
qualitative data collection and analysis into a single study. The two approaches can 
be combined in several ways. There are four ways that quantitative and qualitative 
methods might be integrated (Steckler, 1992). Firstly, qualitative methods can be 
used to help develop quantitative measures and instruments. For example, the results 
of an interview survey can be used to help formulate a questionnaire. Secondly, 
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qualitative methods can be used to help explain quantitative findings. Thirdly, 
quantitative methods can be used to enhance the results of a primarily qualitative 
study. Lastly, qualitative and quantitative methods can be used equally and parallel 
to each other. Depending on the nature of the problem under investigation, one 
method might be given more weight than the other or they might be used in balance. 
Data is integrated, related, or mixed at some stage of the research process, yielding a 
more complete analysis (Creswell, 2004).  
 
3.2 The research design  
Research design has two meanings. It can be understood as the planning of any scientific 
research from the first to the last step or a set of guidelines and instructions to be 
followed in addressing the research problem (Mouton, 1996). It enables the researcher to 
anticipate what appropriate research decisions should be made. There are various types of 
data recording and collection instruments used in quantitative and qualitative research.  
3.3 Data collection instruments 
In quantitative research, survey instruments consist of interviews, self-administered 
questionnaires, structured record reviews, and structured observation (Fink, 1995).    
3.3.1 Interviews 
The interview is the most commonly used qualitative technique in healthcare settings 
(Pope, 2000). Interviewing involves direct contact with persons who are capable of 
providing information. The researcher must establish a good working relationship 
with the informant (DePoy, 1994; Denzin, 1998; Merriam, 1998; Neuman, 2000; 
Babbie, 2001).  
 
An interview has the advantage of flexibility (Darling, 1986). For example if an 
interviewees misinterprets a question the interviewer can clarify it and make sure that 
the (s)he  understands. Many people are more willing to take part in an interview 
than to sit down on their own and complete a questionnaire (Darling, 1986). Personal 
reaction between interviewer and interviewee may be positive or negative due to 
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voice projection, the way questions are read or phrased and appearance, dress or 
accent (ibid). 
 
Interviews can be expensive in time and travel if the study is on a wide geographical 
basis (Darling, 1986). The analysis of interviews can be time consuming for example 
if notes are made during the interview some comments may be missed and the notes 
have to be read and analysed (ibid).     
Table 3.2 below summarizes the advantages and disadvantages of interviews 
Table 3.2: Summary of the advantages and disadvantages of interviews (Darling, 
1986)     
Advantages Disadvantages 
In-depth  information can be obtained 
 
Can explore unexpected and interesting 
topics and is flexible 
Personal rapport build up  
High response rate 
Analysis of open ended responses to 
questions is lengthy 
Transcription of information can be costly 
  
Possible interviewer bias 
Time consuming to conduct                                 
 
 
There are four types of interviews; unstructured, structured, semi-structured and in-
depth. A structured interview entails the preparation and use of the same questions to 
interview a number of people (Bernard, 1994; Morse, 1994). For in-depth interviews 
the questions are based on what the interviewee says and one or two issues are 
covered in great detail (Pope, 2000).  
 
Unstructured and semi-structured interviews are characterized by a minimum of 
control over the interviewee’s responses (Bernard, 1994). The idea is to get people to 
open up and let them express themselves in their own terms, and at their own pace. 
In an unstructured interview, the researcher introduces a theme or topic. The 
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interviewee develops his or her ideas. Both semi-structured and unstructured 
interviews allow interviewees to use their own words and develop their own 
thoughts. Sometimes the interviewing style is curious rather than investigative and 
encourages the interviewee to do most of the talking (Rollnick, 1999).  
 
Unstructured interviews are used primarily in naturalistic research and exploratory 
type studies (DePoy, 1994). The researcher initially presents the topic of the 
interview to a respondent and then uses probing questions to obtain information. The 
interview begins with an explanation of the study purpose. For example, if the aim is 
to identify practice experiences, the researcher may start by asking an open-ended 
question such as, “could you please describe your daily experiences as a care giver?” 
Other probing questions emerge as a consequence of the information provided by 
this initial query (DePoy, 1994).  
 
3.3. 2 Questionnaires 
Questionnaires are one of the most widely used social research techniques. They can 
be mailed, administered telephonically or face-to-face with the respondent. Another 
method is the drop-and-collect technique. A self-administered questionnaire is left 
with the respondent and collected later (Bernard, 1994).  
The type of questions and the layout of the questionnaire are important parameters when 
conducting a survey study.  
A self-administered questionnaire contains the sender’s details and focused questions. 
The questions can either be closed or open (Armstrong, 1990). Closed questions can be 
answered with yes-no or true-false responses, or by selecting an answer from a list of 
suggested responses. The respondent places his or her answer within a given range of 
choices (Armstrong, 1990; Harding, 1990). Some exploring questions to measure change 
in practice use response alternatives such as: all the time, about 1 out of every 10 patients, 
about 1 out of every 30 patients, about 1 out of every 50 patients and never. Some 
questions are based on the Likert type rating scale and may comprise four response 
alternatives such as strongly agree/ agree/ disagree/strongly disagree (Singleton, 1993).  
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The layout of the questionnaire must appear neat, clear and attractive. Linking 
phrases are necessary to ensure a smooth link-up between sections. Finally, the 
questionnaire must be tested in a pilot study which helps to remove any ambiguities 
(Armstrong, 1990). 
 
Strategies to improve response to questionnaires include telephone reminders, 
offering respondents monetary incentives and enhancing the colour of the 
questionnaire paper (Bernard, 1994).   
 
The advantages are that all respondents receive the same questions thereby 
eliminating interview bias. Further, self-administered questionnaires use more 
complex questions than in an interview. Study participants find it easier to report 
socially undesirable behaviours and traits when completing questionnaires (Bernard, 
1994). 
 
The disadvantage of a questionnaire is that there is no control over how people 
interpret questions: for example, in a self-administered questionnaire, a respondent 
can read subsequent questions before hand thereby influencing the response 
(Bernard, 1994).  
 
 
In qualitative research focus groups and participant observations are commonly used 
methods of enquiry. 
 
3.4 Focus groups  
 
The focus group is an interview style designed for small groups (Berg, 2001). It 
relies on interaction within the group based on the topics that are supplied by the 
researcher who typically takes the role of a moderator. The distinctive feature of a  
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focus group is the explicit use of group interaction to produce data and insights that 
would be less accessible without the interaction found in a group (Morgan, 1998).  
 
3.5 Participant observation 
Fieldwork can involve two quite different roles, where the researcher is a 
participating observer and/or an observing participant (Bernard, 1994). There are two 
common types of observations; simple observation and participant observation 
(Pope, 2000). The former involves the unobtrusive and systematic observation of the 
phenomenon of interest while the latter requires that the researcher joins the group of 
people who are being studied in order to observe interactions and better understand 
their behaviour, feelings, attitudes or beliefs (Stein, 1980; Bless, 1995; Pope, 2000). 
Most studies are based on the former, but in some studies, researchers who start as 
participating observers, find that they are completely drawn into the participants’ 
lives and thus become observing participants.  
Field notes consist of any written account of the observation, which are analogous to the 
interview transcript (Merriam, 1998). It is a technique for remembering and recording the 
specifics of an observation. Denzin (1998) states that field notes are constructed 
representations of experience. During participant observation interviews, field notes, 
check-lists and questionnaires can be used in data collection.  
3.6 Validity and Reliability  
Validity refers to the degree to which a survey instrument assesses what it purports to 
measure, whereas reliability refers to whether or not you achieve the same answer by 
using an instrument to measure something more than once (Bernard, 1994).   
 
3.7 Sampling                                                                                        
Sampling is the process of selecting a number of individuals for a study in such a 
way that the individuals represent a larger group from which they were selected (the 
study population), (Bernard, 1994). The two basic types of sampling are probability 
and non-probability sampling. Simple random sampling is based on the principles of 
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probability theory (Bernard, 1994). It is a method used for assigning cases randomly 
to groups for the purpose of making comparisons (Neuman, 2000). There are four 
basic types of non-probability convenience sampling: purposive or judgement 
sampling, snowball sampling and quota sampling (Bernard, 1994; DePoy, 1994). The 
disadvantage of non-probability, non-random purposive sampling is that such studies 
have very low external validity and generalizability is limited to the sample 
(Bernard, 1994). However, when backed up by ethnographic data, studies based on 
these sampling methods are frequently highly credible (ibid).  
3.8 Matching 
Matching is an alternative to random assignment. In matching one forms pairs of 
members having identical characteristics considered as relevant for the research 
(DePoy, 1994; Bless, 1995). Some researchers match cases in groups according to 
certain characteristics, such as age and sex (Neuman, 2000).   
 
3.9 Section B: Research methods used in the study 
 
The hypothesis of this study is that implementation of the diabetes educational 
outreach intervention should result in an improvement in knowledge and practice 
pattern of pharmacists.   
 
The study design and research methods are outlined in Table 3.3. For this pre- and 
post-intervention study qualitative and quantitative research methods were 
employed. Qualitative research methods were selected to generate rich, detailed data 
that is imbedded in context. Data was collected by means of unstructured depth 
interviews, field notes and questionnaires. During implementation of the outreach 
intervention the researcher recorded participants’ actions and responses as part of the 
field notes to evaluate pharmacists’ receptivity.  
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Table 3.3: Outline of study design and research methods used 
 
Stage one: Pre-intervention / Baseline study                                            (Chapter 4) 
Aim:  Identify and assess current practice patterns 
Research methods 
• Qualitative – observation using a checklist to assess current dispensing 
pattern (Appendix A) 
• Quantitative – self-administered questionnaire survey to obtain views of an   
educational programme (Appendix B) 
                              - self-administered questionnaire to assess  pharmacists’ 
knowledge of diabetes management ( Appendix C)    
 
Results from this study were used to design and develop the diabetes 
pharmacotherapy educational outreach intervention 
 
                                                                        
 
Stage two: Intervention:  Implementation of diabetes educational outreach  
(Chapter 5 )        
 
Trained outreach educator used specially designed folder (Appendix D) to highlight 
key diabetes management principles with pharmacy staff  
 
                                                                          
 
Stage three:  Post-intervention study                                                        (Chapter 6) 
Aim:   To assess pharmacists’ receptivity of the outreach intervention 
 Research methods 
• Qualitative – unobtrusive observations. Researcher took mental notes of 
actions, responses and / or attitudes towards educator and folder during 
first and second pharmacy visits  
• Quantitative – self-administered questionnaire to assess knowledge and 
change in practice pattern in diabetes management   (Appendix J)  
 
 
The self-administered questionnaire surveys (pre- and post-intervention) provided 
quantitative data, which, after analysis, produced generalisable patterns that were used 
to test the hypothesis. The questionnaires assessed pharmacists’ knowledge, attitudes 
and application of diabetes principles in providing patient-centred care. 
 
 
 
 
 
  34  
3.10 Sampling 
For the baseline study ten MDHS pharmacies were selected from a total of forty-five in 
Cape Town. Nineteen (n = 19) pharmacists who worked in these MDHS pharmacies 
constituted the study sample. Non-probability, purposeful sampling (Bernard, 1994) was 
used to identify five MDHS pharmacies described in the present study as intervention 
pharmacies where the diabetes outreach was to be implemented.  These pharmacies are 
established pharmacotherapy learning sites for the final year pharmacy students’ service-
learning program and are in close proximity to the university.  Nine pharmacists worked 
in these pharmacies.  The same five pharmacies were included in the post-intervention 
study.  
3.10.1 Matching 
Five pharmacies where routine dispensing activities were carried out were matched 
and referred to as non-intervention pharmacies (Sinclair, 1999) since the 
pharmacotherapy training program was not implemented there. Ten pharmacists 
worked in these pharmacies.  
   
The criteria used for matching was based on the number of pharmacists and the 
number of patients served at the pharmacy (the patient load per pharmacist). The 
pharmacies served on average 6 000 patients per month. Sites with equivalent 
numbers were paired. We assumed that a month is 28 days or 4 weeks. Pharmacies in 
these facilities operate a five-day week, and are closed on weekends. For example,  
if a pharmacy served 6 200 patients a month, and it employed two pharmacists, it 
therefore serviced 1550 patients per week (6200/4 weeks); 310 patients per day (or 
1550/5 days in a week).  Each pharmacist served (310/2) 155 patients per day. All 
this can be reduced to: 
  6200         = 155 patients per day 
4 x 5 x 2  
 
The MDHS staffing level and patient attendance data (2002 - 2003) were used to 
match the facilities and these are summarized in table 3.4.  
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Table 3.4: Matching profile of intervention and non-intervention pharmacies 
Intervention 
sites (n = 5) 
Number 
of patients 
Number 
 of  
pharmacists 
Number 
 of 
patients  
/day  
Non-
intervention 
sites (n = 5) 
Number 
 of 
patients 
Number 
of pharmacists 
Number 
of 
patients 
/day 
Delft 6814 2 170 Heideveld 6850 2 171 
Parow 3923 1 196 Belhar 3900 1 195 
Bishop 
Lavis 
6778 2 169 Hanover 6800 2 170 
Vanguard 6800 2 170 Retreat 6780 2 169 
Athlone 6701 2 167 Elsies 
River 
6720 2 168 
 N.B figures in the table are based on averages.  
 
An MDHS pharmacy located in Bellville, which is of close proximity to the 
University of the Western Cape, was used to pilot the questionnaires and the 
intervention.  
3.11 Baseline study 
Nineteen pharmacists participated in the baseline study. It comprised non-participant 
observation (Bernard, 1994) and the administration of two survey questionnaires.  
 
The aim of this observation study was to assess pharmacists’ dispensing patterns. A 
modified objective structured dispensing examination (OSDE) check list was used 
(see Appendix A) as the observation schedule. It was designed to assess pharmacists’ 
therapeutic counselling skills applied during dispensing. These include appropriate 
use of the prescribed drug(s); alerting patients to side effects and how to deal with 
them; warning patients not to share their medicines; keeping medicines out of reach 
of children; and general handling of medicines.  
 
When observing the pharmacist at the dispensing window, I stood about one and a 
half metres on either the left or right side. This was done to minimise disrupting and 
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influencing the pharmacists interaction with the patients The observation was 
followed by the administration of two questionnaire surveys. 
3.12 Questionnaire survey 
The aim of the first survey was to obtain pharmacists’ views and perceptions of their 
working environment (Appendix B). This questionnaire had both closed (yes/no) and 
Likert-type questions. Data obtained from the first questionnaire was used to 
structure questions for the second survey.  
 
The aim of the second survey was to assess pharmacists’ knowledge of diabetes 
management. The questions were similar in format to those in the first questionnaire. 
The closed questions sought to assess the pharmacists’ knowledge and required them 
to respond by ticking yes-no or true-false in the appropriate spaces provided. The 
Likert-type scale questions ranged from strongly agree, agree, disagree to strongly 
disagree. 
 
The questionnaires were administered sequentially with a month’s interval between 
the administrations. 
 
3.13 Post-intervention questionnaire survey 
The aim of the post-intervention questionnaire (Appendix J) was to assess 
pharmacists’ receptivity of the outreach intervention. It was similar in format to the 
previous two questionnaires and contained additional questions that were meant to 
assess if there was some change in practice resulting from acceptance of the 
intervention by pharmacists. The questions contained alternatives such as; all the 
time, about 1 out of every 10 patients, about 1 out of every 30 patients, about 1 out of 
every 50 patients and never.  
             
All the questionnaires used in the pre- and post-intervention study were checked for 
content and construct validity by two experienced researchers who were 
knowledgeable about pharmacy practice patterns in the Western Cape. Discussions 
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with these researchers allowed further modification and rephrasing of items before 
the questionnaires could be used.  
 
3.13.1 Administration of the questionnaires    
In view of the busy workload of pharmacists, I hand-delivered the questionnaires to 
the participants at the pharmacies to secure their delivery and completion. The 
questionnaires were self-administered. On average, pharmacists took 30 minutes to 
complete the two baseline questionnaires and for the post-intervention questionnaire 
it took about forty minutes. 
 
Response rates for the post-intervention questionnaire were initially low (33 %). 
Other pharmacists agreed to complete the questionnaire upon receipt of certificates 
of acknowledgement for participation in the study (Appendix I).  
  
3.14 Unobtrusive Interviews  
Interviews were conducted unobtrusively during and immediately after 
implementation of the diabetes educational outreach intervention as part of the 
evaluation process. These unstructured interviews were conducted with pharmacists 
at the intervention sites to obtain in-depth perceptions and views of receptivity of the 
intervention.  Unstructured interviews would help minimize intrusion on the practice 
pattern and provide an authentic account of receptivity of the intervention.     
3.15 Data presentation and analysis 
Qualitative analysis 
For the qualitative analysis, responses were categorized into positive and negative 
responses. This helped to identify significant patterns and themes.  
 
Quantitative analysis 
Questionnaire responses were collated as either positive or negative feedback. 
Questions marked strongly agree, agree or yes were identified as positive feedback, 
while those responses with strongly disagree, disagree or no were identified and 
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collated as a negative feedback. Recurring patterns to the responses were identified 
and presented as general observations. Data from the questionnaires were coded and 
entered into a Statistical Package for Social Sciences (SPSS), version 12.0 and 
frequency counts were obtained. 
 
Results obtained from a questionnaire survey were compared with those from 
interviews. In some instances the results complemented each other (Creswell, 2004). 
 
3.16 Ethics  
The Senate Ethics Research Committee of the University of the Western Cape 
authorized the proposed study. A letter of permission to conduct the study was 
obtained from Cape MDHS (see Appendix K).  
 
3.17 Conclusion 
In this chapter research methods were reviewed and the study design was discussed. I 
demonstrated how qualitative and quantitative research methods were used in the pre- 
and post-intervention study. Findings obtained from the baseline study were used to 
design the diabetes educational outreach intervention.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  39  
CHAPTER   4 
 
 
BASELINE   STUDY 
  
The first aim of the baseline study was to identify current practice patterns of 
pharmacists working in the public sector Metropole District Health Services 
(MDHS) facilities. The focus was to assess their pharmacotherapeutic skills in 
monitoring prescribed drug therapy and in counselling patients on health promotion. 
The second aim of the baseline study was to explore pharmacists’ views on 
implementing an educational program and to assess their knowledge of diabetes 
management.  
 
4.1 Methods 
During the qualitative observation study a checklist was used (Appendix A). This 
was followed by two self-administered questionnaire surveys (Appendix B and C).  
The study was conducted over a three month period, from May 2004 to July 2004. It 
involved the selection of MDHS pharmacies using convenience sampling. An 
approval letter to conduct the study was obtained from the Metropole District Health 
Service (MDHS) management (see Appendix K). Participation in the study was 
completely voluntary and data obtained from the study was coded and kept 
confidential. 
  
4.2 Selection of pharmacies 
Five community health centre pharmacies located in the suburbs of Parow, Bishop 
Lavis, Vanguard, Delft, and Athlone were selected as intervention sites (see Table 
3.4). These were matched with other five pharmacies located in the suburbs of 
Belhar, Elsies River, Heideveld, Hanover and Retreat and identified as non-
intervention sites.  
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4.3 Participants in the baseline study  
Nineteen (n = 19) pharmacists who worked in ten MDHS pharmacies constituted the 
study sample. They participated in both the observation study and the two 
questionnaire surveys.   
 
4.4 Part A: Observation study to assess current practice patterns  
 
I used a checklist to assess pharmacists’ pharmacotherapeutic skills. The checklist 
consisted of an objective structured dispensing examination,OSDE, (Frieslaar, 2004) 
modified from the Objective Structured Clinical Examination (OSCE) which is a tool 
used to assess a learner’s ability  to solve a clinical problem (Harden 1975). The 
checklist comprised three main sections (see Appendix A):  
i) Establishing contact with the patient or care giver 
ii) Dispensing: giving information, instructions and warnings about the 
medicines 
iii) Communication style 
All the sections of the checklist were weighted equally, where each observed 
parameter was graded subjectively. A score of one was assigned whenever a relevant 
counselling point as described in the checklist, was communicated. For example, 
when a pharmacist greeted the patient I allocated one (1) mark whereas if he/she did 
not greet the patient, zero (0) was allocated. I regarded this as a sign that they failed 
to establish contact. Percentages were calculated for each parameter that was 
observed from OSDE checklist.  
   
4.5 Data analysis     
The score allocated to each pharmacist was coded and fed into SPSS, (package 
version 12.0), in order to obtain frequencies.  
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4.6 Results 
All pharmacists (19; 100%) agreed to be observed while dispensing.  
 
Staff distribution across the intervention and non-intervention pharmacies was 
similar. The intervention facilities consisted of nine pharmacists (5 male and 4 
female) and fifteen pharmacist’s assistants (3 male and 12 female). Staff distribution 
in the non-intervention facilities consisted of ten pharmacists (5 male and 5 female) 
and fourteen pharmacist’s assistants (3 male and11 female).  
 
Table 4.1: Profile of pharmacists in the observation study (n = 19) 
Gender Number of 
pharmacists 
Percentage Age range 
(years) 
Male 10 (53%) 25-67 
Female 9 (47%) 25-50 
 
 
Table 4.2: Results of pharmacists (n = 19) current dispensing patterns  
                   
 
 
Scores allocated for 
each parameter 
(n=19) 
 
Percentage
(%) 
Pharmacists who established contact with the patient 
or care giver such as…  
  
             1.     Greeting (establishing language used)          19 100 
             2.     Verifying folder number                               19 100 
             3.     Verifying name of patient 18 95 
             4.     Verifying for whom medicine is issued        18 95 
             5.     Getting attention of patient 18 95 
Pharmacists who gave patients information on:    
             1.     clinical indication                                          19 100 
             2.     generic name 6 32 
             3.     strengths 2 11 
             4.     administrative form 2 11 
             5.     instruction (when to take and dosage) 19 100 
             6.     total amount/special instructions  14 74 
 
 
 
 
  42  
Pharmacists who advised patients on drug effects 
which include the following…      
  
            1.     side effects (described what to do)                 6 32 
            2.     duration of therapy (onset) 0 0 
            3.     storage/ safety   2 11 
            4.     adverse effects /warnings/ cautions  2 11 
Pharmacists who informed patients about the 
suitability of their medications in terms of …  
 
           1.     contra-indications                                            0 0 
           2.     drug interactions 0 0 
           3.     convenience                                                    0 0 
Pharmacists who informed patients about their follow 
up dates for…  
 
           1.        the next appointment                                    12 63 
           2.        when to return earlier  2 11 
Pharmacists whose communication…    
          1.     was clear (i.e. audible, pronounced  
                  properly and understandable)                         
19 100 
          2.     was structured logically                      19 100 
          3.     allowed patients to express themselves 6 32 
4.   ensured that patients understand and even  
         asked them to repeat drug information.          
3 16 
 Pharmacists who counseled patients about non-drug 
measures  
 
          1.  described the rationale for non-drug treatment 3 16 
          2.   gave instructions and warnings for example,  
                about the importance of stopping smoking   
4 21 
 
 
All nineteen pharmacists (100%) had structured the conversation logically and 
communicated clearly during counselling. They greeted and verified the patients’ 
folder number and informed patients of the dosage frequency and the condition being 
treated. Two-thirds (12; 63%) had informed patients of their follow-up appointment.  
 
Some pharmacists seemed not to inform patients about drug details. One third of the 
pharmacists (6; 32%) mentioned the generic names of drugs and side-effects, while 
only two (11%) of the pharmacists mentioned strengths, administrative form, storage 
and safety, as well as adverse effects/warnings/cautions.  
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A third (6; 32%) of the pharmacists allowed patients to express themselves, but only 
two (11%) had asked them to return if problems arose after they had taken their 
medicines. Advice on health promotion was limited. One-fifth of the pharmacists (4; 
21%) offered advice on health promotion (e.g. stopping smoking). Few pharmacists 
(3; 16%) had mentioned non-drug measures such as adherence to a diet, or alcohol 
avoidance when taking prescribed medication. 
 
All the pharmacists (100 %) seemed not to counsel patients on contraindications, 
drug interactions and onset of action of drug therapy. 
 
4.7   Discussion 
 
The aim of the baseline observation study was to gain insight into pharmacists’ 
current dispensing patterns. In this study pharmacists seemed proficient in 
mechanical dispensing, namely informing patients about the dosing frequency and 
the condition being treated. However, as custodians of medicines, their 
pharmacotherapy skills seemed sub-optimal.  
 
Limited counselling on side effects, warnings and safety was evident, and this finding 
concurs with that found elsewhere. Bissell (1997) similarly found that pharmacists 
provided limited counselling to patients on drug therapy. Patients should receive adequate 
counselling, especially with regard to potential unwanted effects which could lead to non-
adherence to therapy. Roberts (2004) suggested that pharmacists should properly counsel 
patients so that patients can manage their condition and minimize the effects of the 
disease on their lifestyle. Limited counselling on side effects impacts negatively on 
patients who take medication long-term. Shuster (2005) emphasised that adherence to 
drug treatment is crucial in chronic care. Research has shown that the longer the patient 
takes a complex combination of medicines, the poorer the adherence (Anderson, 2003).  
For a chronic condition like diabetes, adherence to prescribed medication is crucial to 
control blood glucose levels. Therefore patients need to be consistently counselled by 
pharmacists as they are usually the last link in care provision at public sector facilities.  
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Overall, pharmacists’ dispensing practice seemed sub-optimal when assessed with the 
OSDE criteria. The high patient load and understaffing at pharmacies result in 
pharmacists working under enormous pressure at the out-patient counter. As a result very 
little time is available to monitor and counsel patients fully. Other studies have shown 
that due to lack of time, pharmacists and physicians have not provided enough 
counselling to patients (Shabbir, 1999). 
 
Airaksinen (1998) found that pharmacists dispensing patterns were unsatisfactory, but 
that their counselling improved after an intervention, which in turn encouraged patients to 
ask questions about their medicines.  
 
The small sample size limits generalisability of this study’s findings. While this study 
attempted to assess current practice patterns, a study to investigate patients’ views and 
perspectives about the counselling they receive from pharmacists, would be equally 
useful. The practice pattern evident in this study may well imply that pharmacists in the 
public sector require educational programs to improve their pharmacotherapy skills in 
chronic disease management. 
 
The second aim of the baseline study was to obtain pharmacists’ views on implementing 
an educational program (Part B) and to assess their knowledge on diabetes management 
(Part C) using self-administered questionnaire surveys respectively. 
 
4.8 Part B: Questionnaire survey to obtain views for an educational program   
 
The second part of the baseline study used a questionnaire survey to obtain pharmacists’ 
views of an educational program. 
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4.9 Methods 
The survey was conducted with the same sample selected for the observation study. I 
made appointments with each pharmacist telephonically to arrange for a suitable time to 
administer the questionnaire. However, due to time constraints experienced with some 
pharmacists, I followed the drop-and-collect technique, with fifteen out of the nineteen 
pharmacists, as only 4 pharmacists could complete the questionnaire while I waited. The 
methods used to design the questionnaire have been described in Chapter 3, section 3.7. 
Data from the questionnaires was coded and entered into a Statistical Package for Social 
Sciences (SPSS), version 12.0.  
 
4.10 Results 
 
The profile of the pharmacists was the same as that of the observation study (n = 19) 
nineteen.Table 4.3 below shows the results of the pharmacist’s views concerning the 
need for an educational program.  
 
Table 4.3:  Results of pharmacists’ views about an educational program (n = 19)                              
 
 Score allocated for 
each parameter  
(n=19) 
 
Percentage 
(%) 
1) Pharmacists who estimated daily average of 
the number of patients receiving medicines at the 
facility was…  
                     <100 
                     100-199 
                     200-299 
                     300-399 
                     400-499 
 
 
 
0 
0 
2 
17 
0 
 
 
 
0 
0 
11 
89 
2) Pharmacists who perceived that the dispensing 
window was… 
                      too small 
                      there is no privacy  
  
 
 
13 
19 
 
 
68 
100 
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3)Pharmacists who perceived that external sources 
of interference when counselling patients were... 
                    noise 
                    constant patient queries                           
                    angry patients 
                    telephone calls 
 
 
15 
19 
17 
15 
 
 
79 
100 
89 
79 
  
4) Pharmacists who felt that patients preferred a 
private counseling area when collecting 
medication 
                    Yes 
                    No 
                    Up to half of the patients 
 
 
 
 
6 
2 
11 
 
 
 
 
32 
11 
58 
  
Barriers when dispensing and counselling 
5) Pharmacists who noted that barriers to good 
dispensing are… 
                      Shortage of staff 
                      Heavy work load 
                      No privacy 
                      Patients are impatient 
                      
                      Language and communication 
                      problems    
                      Lack of space 
                      Lack of proper equipment 
                      Friends and family members collect  
                      medicines for patients who are at  
                      home/work 
                      Other 
 
 
 
 
17 
17 
15 
17 
 
11 
 
11 
0 
 
19 
 
6 
 
 
 
 
89 
89 
79 
89 
 
58 
 
58 
 0 
 
100 
 
32 
  
6) Pharmacists who felt the following about 
rational drug use… 
                     that they are familiar with the concept  
                     that they have been trained in it 
                     that they have tangible results 
                     proving application of concept      
 
 
 
19 
8 
2 
 
 
100 
42 
11 
  
7)  Pharmacists who felt that… 
    -based on their experience there was a need for 
    patients to have more information about their  
    medicines  
     -there is a need to improve the quality of  
    dispensing information 
 
 
 
19 
 
8 
 
 
 
100 
 
42 
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 Pharmacists who felt a pharmacotherapy-training 
program at the pharmacy would enable them to 
improve…  
           
          dispensing skills 
          knowledge about side–effects of drugs 
          alertness to identification of drug 
          interactions and contra-indications    
          alertness to correct drug dosages 
 
 
 17 
15 
17 
17 
17 
 
 
 
 
 
89 
79 
89 
89 
89 
 
  
8) Pharmacists who felt that the pharmacotherapy 
training should be part of a continuing education 
program. 
  
 
 
19 
 
 
 
 
100 
 
 
9) Pharmacists who felt they need 
pharmacotherapy training in the following areas… 
              antiretroviral therapy (ARV)  
              central nervous system (CNS)  
              antidiabetic drugs  
              drugs acting on cardiovasular system 
              antiasthmatic drugs & antituberculosis  
              drugs       
 
 
15 
11 
9 
9 
 
7 
 
79 
58 
47 
47 
 
37 
 
 
A high response rate (100%) was obtained as a result of several follow-up telephonic 
reminders to ensure completion of the questionnaires. All except two pharmacists (in 
Parow and Belhar), estimated that they served an average of 300-400 patients per 
day, indicative of a high patient load. 
 
Pharmacists identified that external sources of interference were: angry patients (17; 
89%); noise (15; 79%); telephone calls (15; 79%); and constant patient queries (19; 
100%).  
 
All nineteen pharmacists (100%) reported that friends and family members collect 
medicines for patients who are either at home or at work. Most pharmacists (17; 
89%) said they have experienced a high workload and limited time for counselling. 
Fifteen pharmacists (79%) believed that there was lack of privacy. More than four-
fifths (17; 89%) believed that patients preferred a private counselling area and 
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slightly more than half (11; 58%) felt that language and communication problems 
hindered pharmaceutical care provision.  
 
Over one third (7; 37%) of the pharmacists were of the view that patients seemed not 
to understand the drug information that they are given and that pharmacies lack 
access to a direct telephone line to offer follow-up care.  
 
All nineteen pharmacists (100%) seemed familiar with the concept of rational drug 
use (RDU) but less than half of them (8; 42%) claimed to have received such 
training. However, only two (11%) felt that they have tangible results that could 
prove the application of RDU.   
 
Most pharmacists (17; 89%) agreed that a pharmacotherapy training program at the 
pharmacy would enable them to improve their dispensing skills, alert them to 
identify drug interactions/contraindications and enable them to give correct drug 
dosages. Most pharmacists (15; 79%) also believed the program could help enhance 
their knowledge of side-effects. Pharmacists felt that they need pharmacotherapy 
training in antiretrovirals (15; 79%); central nervous system (11; 58%); antidiabetic 
and cardiovascular (9; 47%); antimycobacterial/antituberculosis (TB) and 
antiasthmatic (7; 37%) drugs. All (19; 100%) pharmacists felt that such training 
should form part of a continuing education program. 
 
4.11 Discussion  
 
All pharmacists (19; 100%) agreed that constant patient queries are a common 
external source of interference that resulted in poor adherence to good pharmacy 
practice. Tietze (1997) has pointed out that pharmacists must have good 
interpersonal relationships to be able to address constant patient queries and the 
needs of angry patients. 
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Only a few pharmacists (2; 11%) claimed to use the rational drugs concept which is  
one of the fundamental goals of the South African National Drug Policy. Levitt 
(1996) established that diabetes care in public sector health facilities was not given 
the attention it deserves as care givers did not systematically adhere to guidelines. 
Patients were only treated for specific complaints and that there was evidence of 
polypharmacy. Laing (2001) has recommended the use of pharmacotherapy as an 
approach for promoting the effective rational use of drugs.  
 
All the pharmacists (19; 100%) expressed the need for a pharmacotherapy training 
program to increase their awareness of drug interactions/contraindications, side-
effects and correct drug dosages. This may imply their willingness to receive an 
educational intervention that would enable them to improve professional practice.  
 
All the pharmacists (19; 100%) believed that there is a need for pharmacotherapy 
training programs for the management of common conditions and three-quarters of 
the pharmacists (15; 79%) opted for training in ARV’s. During the time of this study 
(2004) this was not possible since the South African government did not offer drug 
therapy to treat human immunodeficiency virus/acquired immune deficiency 
syndrome (HIV/AIDS) patients in MDHS facilities. Over half of the pharmacists (11; 
58%) opted for training in CNS pharmacotherapy. This pharmacological group could 
not be considered since it consists of varied drug classes and would have involved an 
extensive educational program beyond the time frame of this study. Almost half of 
the pharmacists (9; 47%) stated their preference for a diabetes educational 
programme. Consequently, a diabetes pharmacotherapy program was considered, 
because it is a common chronic disease in South Africa, which places a severe 
burden on the health services, and incurs substantial morbidity (Bradshaw, 2006). It 
was also perceived as a manageable intervention for this study’s time frame.  
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4.12 Part C: Questionnaire survey to assess pharmacists’ knowledge of diabetes 
management  
 
Appointments were made with the pharmacists telephonically to arrange for a 
suitable time to administer the questionnaire. I used similar methods to those 
described in section 4.9 of Part B in this chapter.  
 
Data presentation and analysis were done as described in section 4.9. 
 
4.13 Results  
Findings from the questionnaire are summarized and tabulated (refer to Table 4.4). 
The table contains an additional column (2) where the number of pharmacists who 
did not respond to specific questionnaire items are noted.  
 
The profile of pharmacists who completed the questionnaire survey is the same as that 
noted in the observation study (refer to section 4.6 table 4.1). 
 
Table 4.4: Results of pharmacists’  knowledge of diabetes management (n = 19)     
 3 2 1 
  
  
  
  
  
  
  
  
Strongly 
agree, 
agree, 
or 
yes 
(%) 
 
# of 
subjects 
(%) 
who did 
not 
respond 
 
Strongly 
disagree, 
disagree, 
or 
no 
(%) 
 
1) Pharmacists who were familiar with the national 
diabetes guidelines for adults and children  
8(42)  11(58) 
  
2) Pharmacists who were of the opinion that …    
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 Thirst and weight loss are the 2 most common  
symptoms that diabetes patients 
present with in hypoglycaemia        
2 (11) 13 (68) 4(21) 
      
 Thirst and weight loss are the 2 most 
common symptoms that diabetes patients 
present with in hyperglycaemia  
4 (21) 13(68) 2(11) 
     
3) Pharmacists who identified the recommended 
fasting blood glucose level range to be… 
   
              4 (≤) and less than or equal to  7 mmol/L        17(89) 2 (11) 
            16 (≤) and less than or equal to 20 mmol/L  0 
            22 (≤) and less than or equal to 25 mmol/L  0  
     
4) Pharmacists who believed that hypoglycaemia 
can be due to drug effects 
15(79) 4 (21)  
     
5) Pharmacists who believed that some side effects 
of bezafibrate are muscle wasting and abdominal 
pain 
11(58)  8(42) 
     
6)  Those pharmacists who felt that they advised 
patients on… 
   
          a)  foot care    2(11) 2 15(79) 
          b)  eye care     4(21)  15(79) 
     
7) Pharmacists who felt that they should reduce the 
dose by 50% when introducing bedtime insulin for a 
patient on the maximum dose of sulphonylurea 
11(58) 4 (21) 4(21) 
     
8) Pharmacists who reported that their responses to 
glycosylated hemoglobin (Hb A1c) level above 12% 
   
           a) to let it pass 4(21)  
           b) do not have time to look at it closely  11(58) 
           c) refer the patient to the doctor 4(21)  
    
9) Pharmacists who perceived that the ideal lipid 
profile of a diabetic is …   
               i)  total cholesterol  < 5 mmol/L                     15(79)  4(21) 
               ii) triglyceride  < 1.5 mmol/L            11(58) 8(42) 
    
10) Pharmacists who felt that a diabetes 
management  program should include: 
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             a) counselling patients on how to control  
                  blood sugar levels                                    
19(100)  
             b) monitoring blood sugar levels 19(100)  
             c) monitoring long-term blood sugar control 
                 levels (HbA1c) 
15(79) 4(21) 
             d) monitoring side effects of insulin  
                 treatment 
17(89) 2(11) 
             e) monitoring side effects of oral  
                  hypoglycaemic agents   
17(89) 2(11) 
    
    
11) Pharmacists who advised patients on weight 
control measures 
11(58)  8(42) 
  
     
 
  
Less than half of the pharmacists (8; 42%) were familiar with the national diabetes 
guidelines for adults and children (2003).  
   
Pharmacists’ ability to differentiate between the signs and symptoms of 
hypoglycaemia and hyperglycaemia seemed limited. Only one fifth (4; 21%) of them 
believed that thirst and weight loss were some of the most common symptoms 
associated with hyperglycaemia. The same number said they were familiar with the 
use of glycosylated hemoglobin (HbA1c) as a monitoring parameter and seemed to 
be aware of the appropriate action to be taken if a patient has HbA1c level above 
12%.       
 
Over half (11; 58%) of the pharmacists knew that: the maximum dose of 
sulphonylureas must be reduced by half when introducing bed time insulin;  
hypertension accelerates the development of diabetic retinopathy; and muscle 
wasting and abdominal pains are some of the side effects of bezafibrate and that  the 
ideal lipid profile for triglycerides is 1.5 mmol/L or less.  
 
All pharmacists (19; 100%) felt that a diabetes management program should include 
information on how to monitor and control blood sugar and counselling. More than 
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three quarters of the pharmacists (15; 79%) believed it is important to include 
information on HbA1c, side effects of insulin and oral hypoglycaemic agents (17; 
89%). 
4.14 Discussion 
This section is a discussion of the findings from assessing pharmacists’ knowledge on 
diabetes. The few local studies available have been used to improve the discussion.  
 
Of concern in this study is that less than half of the pharmacists (8; 42%) were 
familiar with the national diabetes guidelines for adults and children. Possible 
reasons are that these guidelines may not be easily available to the MDHS or that 
pharmacists may not be able to understand or apply key recommendations in 
practice. A study by Kalk (2000) found that among nine community and secondary 
hospitals only five used guidelines for the four chronic disease conditions which they 
managed. This is in line with Steyn, (1999) who found that guidelines were not 
systematically implemented in four community health centres in the Western Cape. 
Lack of use of guidelines by pharmacists may be a contributing factor to both the 
low awareness and knowledge of diabetes. Implementation of a diabetes educational 
program tailored to the needs of pharmacists could help to address this practice gap.  
 
Only four pharmacists (21%) responded appropriately to knowledge-based questions. 
The rest of the pharmacists could not clearly differentiate between symptoms of 
hypoglycaemia or hyperglycaemia and the use of HbA1c to monitor patient care. 
This suggests a limited understanding of diabetes management amongst the 
pharmacists working in MDHS pharmacies. This finding is similar to Goodman’s 
(1997) study which found that MDHS staff involved in diabetes management did not 
know the pathophysiology including the signs and symptoms of diabetic 
emergencies. HbA1c evaluation is an accepted standard of care for assessing diabetes 
control (Sicard, 2005). Ensuring that it is always within recommended levels is vital 
to the prevention and reduction of diabetes-associated complications (DCCT, 1993; 
UKPDS, 1998). 
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4.15 Conclusion 
The data collection instruments used in the baseline study provided insight into 
pharmacists practice patterns, their educational needs and knowledge on diabetes 
management. The observation checklist provided insight into the pharmacotherapeutic 
skills of pharmacists. An additional parameter that could be included in the checklist is 
the monitoring of drug therapy with clinical data, especially for the management of 
chronic diseases. Focus group discussions may have been an alternative method in view 
of the concerted efforts that were required to ensure completion of the self-administered 
questionnaires.  
 
Pharmacists’ knowledge of diabetes management seems to be sub-optimal. They 
seemed to lack familiarity with important monitoring parameters such as HbA1c, and 
they lacked the ability to differentiate between the signs and symptoms of 
hypoglycaemia and hyperglycaemia.  
 
Educational programs that can encourage pharmacists to become proactive in 
pharmaceutical care provision are needed. Specially designed pharmacotherapy 
educational programs can help enhance pharmacists’ knowledge and skills to engage with 
diabetic patients in controlling blood glucose and preventing complications (Anderson, 
2003; Pray, 2003).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  55  
 
CHAPTER   5 
 
DESIGN AND IMPLEMENTATION OF AN EDUCATIONAL 
OUTREACH INTERVENTION FOR DIABETES MANAGEMENT 
 
This chapter provides the rationale that underpins the development of a diabetes 
educational outreach intervention. Findings from the baseline studies that identified 
knowledge deficiencies which could be addressed through an outreach intervention, were 
primarily considered. The contents of the educational materials, the training of the 
educator and the implementation process are discussed. Structural, regulatory and social 
factors could not be addressed in this intervention even though they influence practice 
patterns (Grol, 1995). 
 
5.1 Summary of findings from the baseline studies 
Data obtained from the baseline studies indicated that pharmacists had knowledge 
deficiencies and perceived numerous barriers in the management of diabetes, 
especially when dispensing. 
 
Findings from the observation study indicated that pharmacists seemed not to have 
enough knowledge on how to articulate drug details. Few pharmacists (2; 11%) 
mentioned the strengths, administrative form, storage and safety, and adverse 
effects/warnings/cautions of drugs to patients. None of the pharmacists seemed to 
inform patients about, contraindications (0), drug interactions (0) and onset of action 
of drugs (0). Pretorious (2003) and Lamb (2005) explained that it is the duty of the 
pharmacists to warn patients about harmful side effects. 
 
 
Only a third (6; 32%) of the pharmacists allowed patients to express themselves during 
counselling, an indication that active patient involvement was limited.  Provision of 
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advice on health promotion was limited. Only a few pharmacists (3; 16%) described 
non-drug measures (diet, alcohol use) and gave instructions about health promotion 
e.g. the cessation of smoking (4; 21%). Disease management through lifestyle 
modification seemed to be given little priority among pharmacists.  
 
Educational programs that can encourage pharmacists to proactively share drug 
information, and enable them to monitor therapeutic outcomes, could help improve 
pharmacists’ pharmacotherapy knowledge and skills. 
 
5.2 Pharmacist’s views on the need for an educational program 
Findings from the survey showed that less than half of the pharmacists (8; 42 %) had 
received training and were familiar with the concept of rational drug use. Further, all 
pharmacists (19; 100%) sought a pharmacotherapy training program to update their 
knowledge and also expressed the need for a training program to increase their 
awareness concerning important counselling points such as drug 
interactions/contraindications, side-effects and correct drug dosages. This indicates 
that an educational program that will sensitize pharmacists on how to apply 
pharmacotherapeutic principles was deemed necessary.  
 
5.3 Pharmacist’s knowledge of diabetes management  
Less than half of the pharmacists (8; 42%) were familiar with the national diabetes 
guidelines for adults and children which may indicate either poor implementation of 
the guidelines or that guidelines have not been adapted for use at MDHS pharmacies. 
Pharmacists seemed to make little differentiation between symptoms of 
hypoglycaemia or hyperglycaemia because only one-fifth of the pharmacists (21%) 
responded appropriately when identifying common symptoms associated with 
hyperglycaemia. Further, about half of the pharmacists (9; 47%) knew that the 
maximum dose of sulphonylureas must be reduced by half when introducing bedtime 
insulin  
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Pharmacists are expected to familiarize themselves with monitoring parameters so that 
therapy can be optimized. Findings from baseline study indicated that pharmacists 
seemed unaware of the importance of reading and interpreting glycosylated 
haemoglobin levels (HbA1c). Few pharmacists (4; 21%) could relate to the referral 
criteria for patients with glycosylated hemoglobin (HbA1c) levels which were out of 
range. Similarly, about half of the pharmacists (58%) knew the recommended level 
values for triglycerides (TG) and total cholesterol levels. A few pharmacists seemed to 
advise patients about preventative care for the feet (2; 11%), eye (4; 21%) and slightly 
over a half (11; 58%) of the pharmacists claimed to counsel patients on the importance 
of lifestyle management such as weight control. 
   
The monitoring aspect of the pharmaceutical role seems limited possibly because of 
the lack of regular on-site educational programs to keep them abreast of guideline 
based pharmacotherapeutic principles of diabetes. 
 
All pharmacists (19; 100%) expressed the need for a diabetes management program. 
Almost all of the pharmacists (17; 89%) wanted a program that will cover the side 
effects of insulin and oral hypoglycemic agents. Furthermore, most pharmacists (15; 
79%) wanted a program that will alert them to the importance of measures used to 
monitor blood sugar levels such as glycosylated hemoglobin( HbA1c). Pharmacists’ 
willingness to participate in an educational program clearly demonstrates that gaps in 
knowledge and practice require attention. Locally adapted guideline recommendations 
may provide pharmacists with the knowledge and skills needed to improve 
professional practice. 
 
5.4 Summary of contextual factors which modified the intervention 
In view of the knowledge barriers and the skills deficiency which prevent good 
dispensing, the use of a single intervention would have been unlikely to achieve a 
meaningful outcome for pharmaceutical care provision. A multifaceted approach 
seemed most appropriate to address the identified barriers using an outreach 
intervention (Sharp, 2004).  Structural, social and regulatory constraints were beyond 
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the scope of this study. The indirect effects of contextual issues were taken into 
account as modifying factors (Bheekie, 2001). For example time constraints, and the 
perceived high patient load, were considered. The perceived high patient load also 
influenced the choice for an on-site educational outreach intervention. Researchers 
have obtained positive health outcomes from multifaceted educational outreach 
programs (Fedder, 1988; Hendryx, 1998; Fairall, 2005). 
 
Pharmacists usually receive updated clinical and drug information from 
pharmaceutical drug representatives. However, such information may be biased 
towards product promotion and may lack salient information about undesirable effects 
(Grimshaw, 2005).   
 
To address the knowledge gap an intervention that provides up-to-date, unbiased, and 
practical therapeutic recommendations was deemed appropriate.    An intervention that 
enables pharmacists to recognize potential signs and symptoms of diabetes provides 
advice on the treatment of hypoglycaemia and hyperglycaemia and emergency care, 
interpret monitoring parameters such as HbA1c to control blood glucose, being alert to 
blood pressure and cholesterol levels, prevent the onset of complications and provide 
advice on drug therapy and preventative care would be useful to practice. 
  
5.5 Development of the intervention materials 
As a practicing pharmacist from Botswana, I had to familiarize myself with diabetes 
care in South Africa. I consulted with local medical experts and familiarized myself 
with hospital pharmacy practice in the Western Cape. I consulted with a locally 
renowned diabetes expert, Professor F Bonnici. I also attended a diabetes workshop on 
24 August, 2004 which he facilitated entitled “An update on diabetes management and 
the role of the pharmacists in patient care”. During the workshop he highlighted the 
need for pharmacists to be closely involved in monitoring diabetic patients and 
intervening appropriately in order to prevent the development of complications, 
emphasising the pharmaceutical care role of pharmacists. He reiterated that 
pharmacists could educate and support people to prevent complications associated 
 
 
 
 
  59  
with diabetes.   I also observed another diabetes expert Dr A Philotheou. She was 
consulting and monitoring diabetic children at Red Cross Children’s hospital on the 
15th September 2004. Further, I interacted with diabetes educators at Red Cross and 
Groote Schuur Hospitals to obtain insight into their teaching approaches. I worked for 
two days at Groote Schuur and Red Cross Children’s hospital pharmacies filling in 
prescription folders for diabetic patients to obtain insight into local practice patterns. 
In addition, I facilitated pharmacotherapy practicals for final year pharmacy students 
for three months at a service-learning site in Parow. I visited the Diabetes Society of 
South Africa Western Cape branch in Cape Town where I learnt about its functions, 
and the importance of education and support groups for the management of diabetes. 
 
5.6 Printed and support materials for the outreach intervention 
The intervention materials consisted of an accordion folder, practice scenarios and a 
pen. I used these as teaching aids during my meetings with pharmacists. Information 
in the accordion folder (Appendix D) was obtained from the guidelines for the 
management of diabetes type one in children less than 18 years and the guidelines for 
the management of diabetes type one and two in adults (2003), the standard treatment 
guidelines and essential drugs list for primary health care (2003), the South African 
medicines formulary (6th edition) and consultations with a diabetes medical expert. 
Information from the national guidelines and standard treatment guidelines was 
systematically reviewed (Eccles, 1999) to arrive at a format suitable for use by 
practising pharmacists. It was intended to serve for use as a reminder at the outpatient 
counter. 
 
5.7 Design of the folder and illustrations 
The presentation style of the folder aimed to draw pharmacists’ attention to key 
management principles. Illustrations were used to depict symptoms of hyperglycaemia 
and hypoglycaemia as well as adverse effects observed with insulin and the use of oral 
hypoglycaemic agents.  
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The layout was designed in consultation with a graphic artist to achieve a professional 
appearance and to compete with pharmaceutical sales promotional materials that are 
provided for pharmacies. The Coreldraw graphics program was used when designing 
the folder which was made of an ivory coloured smooth thick card, laminated on both 
sides and folded in an accordion style. The panels were colour-coded to attract the 
pharmacists’ attention and enhance recall. In designing the printed support material we 
considered the fact that it must be catchy to the eye, easy to handle, durable, conserve 
space, be able to support itself on top of the desk and above all contain enough 
information that could be used to influence change in practice. The best design was to 
make it an accordion style folder. Bheekie (2001) used a 3-part folder and poster as 
printed and support materials for an asthma outreach intervention.   
 
The content was comprehensive and was approved by a diabetes medical expert .The 
aim was to colour-code salient counselling points for quick reference. For example, 
red messages highlighted the problem of hypoglycaemia, yellow was used to indicate 
hyperglycaemia, turquoise was used to indicate adverse effects observed with oral 
antidiabetic tablets and light green indicated drug interactions resulting from oral 
antidiabetic tablets. An illustration outlining a human figure shows the site of action of 
antidiabetic agents.  
 
The five-part accordion folder contained information on diabetes, the co-morbidity of 
dyslipidaemia, the hypertension associated with it, the diagnosis based on symptoms 
and biochemical tests, the importance of monitoring parameters, the influence of drugs 
on diabetes, drug treatment and associated pharmacotherapy factors, emergency care 
and additional antidiabetic agents. The information was printed on an ivory coloured 
smooth thick card. The outreach educators’s name and the University of the Western 
Cape (UWC) logo were printed on the last panel of the folder to indicate association 
with a neutral academic institution 
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5.8   Contents of the different pages of the folder 
A pictogram of people in a team pulling simultaneously on a rope, signified the 
importance of teamwork in addressing the problem of diabetes (page one). 
Explanations covering the aetiology, causes, the diagnosis, the diagnostic criteria and 
the diagnostic stages of diabetes, were also highlighted. 
 
Colourful eye-catching illustrations were used to enhance recall of symptoms, namely, 
hyperglycaemia (yellow) and hypoglycaemia (red) which appeared on page two. An 
adverse effect such as hypoglycaemia, which is associated with insulin therapy, was 
coloured red, while that observed with oral hypoglycaemic drugs was coloured 
turquoise. Drug interactions were highlighted in blue. These colour codes linked 
identical and sometimes similar concepts and were repeated in different sections 
throughout the folder.  
 
The glycosylated haemoglobin (HbA1c) test which is used as a parameter for blood 
glucose levels was outlined and interpreted in tabular form on page three. Insulin 
resistance and some risk factors appeared on a purple background and aimed to 
highlight the importance of the concept in the development of diabetes.  
 
The acute and late signs and symptoms of hyperglycaemia (yellow background) and 
hypoglycaemia (red background), the co-morbidity of dyslipidaemia and hypertension 
associated with diabetes, are highlighted on page four.  
 
A table on page five referred to cholesterol levels in adults. Poorly controlled blood 
sugar levels also tend to cause the blood levels of fatty substances to rise, resulting in 
accelerated atherosclerosis, the build up of plaque in blood vessels, (Berkow, 1997). 
The same page contains information describing the damage to blood vessels, nerves, 
tissues and organs resulting from hyperglycaemia, and a description of the damage and 
a review of medications that interfere with diabetes control. Further, the antiplatelet 
role of aspirin in heart disease, was included.  
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The therapeutic objectives, treatment and the different types of insulin therapy are 
tabulated for easy reference on page six. The adverse effects of insulin which are 
usually associated with hypoglycaemia, appear on a red background. The international 
colour codes used for insulin therapy with different duration of action, was followed: 
short-acting was indicated in yellow, medium-acting in green, long-acting in blue, and 
biphasic in brown.  
 
The sulphonylureas were tabulated on page seven and the biguanides on page eight. A 
different colour code was used to represent the adverse effects (turquoise) and drug 
interactions (light green). Adverse effects and drug interactions affect diabetic control. 
Throughout the folder the key therapeutic reminders were linked using the designated 
colour-coding. 
 
A reminder to encourage pharmacists to offer patients advice about the use of oral 
hypoglycemic agents was shown on page eight. In addition, a pharmacist’s checklist to 
aid approaches to emergency care, was added.  
 
The common complications of diabetes, hyperglycaemic and hypoglycaemic 
emergencies and their management, which were linked through colour codes to other 
parts of the folder, also appeared on page nine.  
  
The newer anti-diabetic agents were outlined on page ten. These are medicines that are 
used for the treatment of diabetes in the private sector and internationally as opposed 
to the limited list prescribed for the public sector.  A pictogram of an attentive listener 
was followed by a counselling reminder for the pharmacist and was phrased thus: 
“Have you provided the following information to your patients?” This included the 
name of the medicine, drug effects (effects of the medicine on the body), instructions 
on how to use the medicines, adverse effects/ warnings/ cautions. Further, the 
pharmacist was prompted to enquire about the patient’s understanding of the 
instructions. Pharmacists were encouraged to counsel patients by emphasising a 
message which read as follows:  
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“even though you work as a team, do not assume other team members 
have done appropriate counselling on your behalf. Play your part, 
discuss drug use and preventive care e.g. the importance of stopping 
smoking, reducing alcohol use and encouraging exercise”.  
The message further asks,  
“have you talked to your patient about the importance of stopping 
smoking and the fact that there is an increased chance of amputation if 
you are a smoker?  
 
Have you given them leaflets on tips to stop smoking”?  
These reminders served to prompt the pharmacist to initiate discussions with the 
patient. 
 
To encourage pharmacists to engage with patients about controlling their glucose and 
blood pressure levels, ensuring a cholesterol check, maintaining a healthy diet, 
exercising regularly and advising on low-dose aspirin, the following statement was 
included in the folder: 
 “Make it your habit to talk about all of the above with your patients” 
 
Having realized from the pilot study that one of the pharmacists was interested in 
taking the folder home to read, I photocopied the folder into the form of a booklet. I 
gave the booklets to the pharmacists at the end of the meetings to enable them to 
internalize the key concepts and use it as a reference tool when working on the 
practice scenarios and to also encourage them to read on their own. 
 
5.9 Implementation of educational outreach intervention 
The educational outreach intervention favoured a multifaceted approach because no 
single approach fits all prospects (Soumerai, 1990; Hutchinson, 1999). It consisted of 
a trained outreach educator (myself) using a social marketing technique to highlight 
key management principles on diabetes. Four matters deserve a final check by the 
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salesperson as part of the approach: physical appearance, mental attitude, equipment, 
and a plan for how the activity would be carried out (Kirkpatrick, 1981). 
 
5.10 The outreach educator     
Successful implementation of an educational outreach intervention depends on the 
educator’s knowledge, skills and attitude. I was to be the outreach educator, a black 
male pharmacist from Botswana. I have extensive (20 years) practical experience as a 
hospital pharmacist in the public sector with background training in Essential Drug 
Management and Rational Drug Use (1992). Part of the training included teaching 
methods and how to present a lecture under time constraints. A trained pharmacist 
(myself) conducted outreach visits to the pharmacies.   This would be in contrast to the 
intrinsic suspicion of a non-health care professional, whose information might be more 
likely to be distrusted and ascribed to a purely commercial motive (Bheekie, 2001). 
 
I dressed in professional attire and carried the printed materials in a brochure holder 
during the visits to the MDHS pharmacies. I recorded my appointments with the 
pharmacists and captured detailed accounts of each visit in my diary. During the visits 
to the pharmacies, I wore a UWC identity badge which indicated the organization I 
represented. 
 
In response to the time constraints experienced among public sector health care 
facilities, the use of educational reminders consisting of an accordion folder and a 
pen, formed part of the diabetes outreach package. 
 
5.11 Access to pharmacies 
Gaining access to a study site involves a style which explicitly minimizes the 
disruption which the researcher might cause to routine activities (Bernard, 1994; 
Baker, 1999). Appointments were made with pharmacy staff telephonically to secure a 
meeting time. I adopted a flexible approach by negotiating meeting times with the 
participants, and was sensitive to the time constraints, patient overload and 
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understaffing at the pharmacies. Visiting pharmacists at the work setting was 
interpreted as a mark of respect for their work, and the scarcity of their time.  
Implementation of the intervention aimed to minimally disrupt the pharmacists daily 
work schedule. 
 
5.12 Implementation of the diabetes pharmacotherapy educational outreach 
program using the IDEALS approach  
Implementation was done at the five intervention pharmacies using a social 
marketing technique commonly used by drug company representatives (Soumerai, 
1990; Baker, 1999). I used the IDEALS approach during the educational meeting. 
IDEALS is an acronym for: introduction, discover, explain, ask, leave and seek. In 
practice this worked as follows: 
I→      Introduction: I introduced the purpose of my meeting with staff      
D→  Discover: I explored their experiences with diabetes management.  
E→      Explain: I explained information contained in the diabetes educational  
            program – an accordion folder and a pen.  
A→     Ask: I asked the pharmacists if they had any concerns about diabetes  
            management and engaged them with the information contained in the folder.             
L→    Leave: I placed the folder in a plastic sleeve which was subsequently mounted  
           on the wall next to the dispensing window so that pharmacy staff could easily  
           retrieve it when dispensing. 
S→   Seek: I finally asked for a commitment from the pharmacists to use the 
            folder as a reference tool when engaging with diabetic patients.                          
 
5.13 Interviews  
Unstructured interviews were conducted with pharmacists at the intervention sites as 
part of the assessment. This was done during and immediately after implementation 
of the intervention process in order to minimize intrusion into their routine practice 
pattern, and to obtain in-depth perceptions and views about the receptivity of the 
program.  
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I gave a brief outline of the purpose of my visit and explained various elements of 
the accordion folder. Furthermore, I guided pharmacists on how information in the 
folder could be applied to solve three practice scenarios. Each pharmacist 
subsequently received a photocopied booklet of the folder to assist with solving the 
scenarios and to enable them to work at their own pace. 
 
I describe the framework of my three visits to the pharmacies.  
 
5.14  First visit      
The first visit was planned to last thirty minutes, and was aimed at introducing and 
explaining the various elements of the folder. At the end of the discussion I handed three 
practice scenarios which mimicked real-life diabetic conditions to the pharmacists to 
assess their knowledge and application of the pharmacotherapeutic principles. The 
scenarios were an application of a problem-based learning (PBL) approach (De Vries, 
1995; Akici, 2003). The aim of the scenarios was to help pharmacists gain familiarity 
with the use of the folder in order to manage diabetes. Solutions to the practice scenarios 
were to be discussed during the second visit. Towards the end of the visit, I enquired 
about my role as an educator using the probing question, “What are your views about my 
presentation style”? I concluded the first visit by seeking approval for a second visit. 
   
5.15 Second visit   
The aim of this visit was to reinforce and maintain the adoption and application of 
information on diabetes management. Further, the aim was to discuss the three 
practice scenarios (Appendices F, G and H) that would provide an indication of the 
pharmacists’ engagement with the folder. 
 
I arranged for a second visit, three to four weeks after the first one. Appointments 
were made with the pharmacist telephonically. Responses to practice scenarios were 
not graded, instead I read through them to deduce if pharmacists used the folder to 
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arrive at the solutions. Although the questions were easy, they were structured in 
such a way that one had to refer to the folder to identify the answers. In this way the 
folder was used as a reference guide.  
 
To assess the visit, I used unobtrusive depth interviews, observations, and made 
notes. This was done to obtain realistic responses, and to avoid the Hawthorne effect 
(Pope, 2000).  Pharmacists were asked about their experiences with the use of 
educational materials and I also probed them about what they had attempted to do 
differently when engaging with diabetic patients.  
 
5.16  Third visit 
The third visit aimed to quantitatively evaluate receptivity of the program among the 
pharmacists. As was done with the second visit, appointments were made 
telephonically. Pharmacists were asked to complete the structured, self-administered 
post-intervention questionnaire containing 38 questions. The questionnaire aimed to 
assess knowledge, attitudes and the pharmacists’ application of key diabetes 
concepts and explored their ability to make changes in practice (Appendix J). For 
example the perceived frequency of occurrence was indicative of potential change 
when a particular behaviour was explored:  How frequently do you advise diabetic 
patients to stop smoking ?  
one out of every ten patients  
one out of every thirty patients 
To assess acceptance or resistance towards solving the practice scenarios, 
unstructured in-depth interviews were used. 
5.17 Pen                                                                                                                                
A flat translucent pen with a blue top, connected with a clip to a jelly bean plastic 
lanyard(chain) that could be used around the neck (See annex E), served as a gift 
incentive (Grol, 1995). It was given to each pharmacist for participating in the 
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intervention. A blue inscription on the pen: “I am a diabetes educator” served as a 
reminder and an inspirational message. This reminder was linked to information 
appearing on the bottom part of the last page of the accordion folder, to emphasise 
the important role which the pharmacist could play as a diabetes educator. 
5.18  Practice scenarios 
The scenarios were structured to enable pharmacists to apply and reinforce adoption of 
the information that was discussed during the visits. It served to ease them with key 
diabetes concepts that could be applicable in practice. Responses to the questions were 
not graded, instead I reviewed them to deduce if pharmacists had actually engaged 
with the folder. 
 
5.18.1 Practice scenario 1 (see Appendix F) 
The aim of the scenario was to raise pharmacists’ awareness of signs and symptoms of 
diabetes and for them to be able to differentiate between symptoms showing 
hypoglycaemia and those for hyperglycaemia. In the scenario, the sugar levels are below 
the recommended goal (between 4 – 7mmol/L) thus suggesting hypoglycaemia, which 
may manifest as irritability in the patient. Furthermore, using the folder, pharmacists had 
to identify common dosing schedules. Lack of proper monitoring of dosages such as 
giving glibenclamide three times a day instead of a maximum of two times a day can 
result in hypoglycaemia, as is the case in the scenario. Therefore the close monitoring of 
treatment is critical. 
 
5.18.2 Practice scenario 2 (see Appendix G) 
The aim of this scenario was to encourage pharmacists to identify the classic symptoms 
of hyperglycaemia and identify appropriate treatment options. Furthermore the aim was 
to alert pharmacists to counsel patients on the side effects of oral hypoglycaemic drugs 
(e.g. gastrointestinal disturbances and nausea) and insulin (e.g. hypoglycaemia, 
lipodystrophy or hypertrophy). 
 
5.18.3 Practice scenario 3 (see Appendix H) 
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The aim of this scenario was to alert pharmacists to engage with patients about the proper 
use of their medicines, and to check contraindications and drug interactions which are 
factors that influence therapeutic outcomes. The scenario also aimed to alert pharmacists 
to apply the HbA1c monitoring parameter of blood sugar level and to  avoid developing 
diabetic complications (e.g. a rash from the sugary urine). Another aim of the scenario 
was to sensitize pharmacists to the risk factors which complicate diabetes such as lipids 
and cholesterol levels which are above the recommended goals. Outlining the lipid 
monitoring parameters was meant to encourage pharmacists to advise patients about the 
importance of lifestyle modification (e.g. exercise and following a diet plan).  
 
Pharmacists readiness in responding to the scenarios as well as their experiences 
captured during the interviews, during the two visits was assessed qualitatively to 
determine the receptivity of the intervention (Rollnick, 1999).   
   
5.19 Summary  
Findings from the baseline study contributed to the design and development of the 
multifaceted educational outreach intervention. The intervention was designed to fit 
into the pharmacists’ routine duties and was to be conducted in a professional manner 
to address knowledge and skill deficiencies. The intervention aimed to be non-
threatening and allowed pharmacists the opportunity to engage with the outreach 
educator on diabetes care. A flexible approach was considered in order to respond to 
the different educational needs required among the pharmacists. A problem-based 
learning approach and the use of pictograms (Dowse, 2003) aimed to reinforce the 
adoption of key management principles for diabetes care.  
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CHAPTER 6 
 
RESULTS 
 
PHARMACISTS RECEPTIVITY OF THE DIABETES 
EDUCATIONAL OUTREACH INTERVENTION PROGRAM 
 
In this chapter the qualitative (Part A) and the quantitative (Part B) assessments of 
pharmacists acceptability of the educational outreach intervention are discussed.     
Part A: Qualitative assessment of outreach visits 
For the qualitative assessment I discuss my meetings with pharmacists during the first 
and second visits to the five intervention pharmacies.  
6.1 Visit 1 
The aims of the first visit to the pharmacies were to: 
• introduce the outreach intervention 
• explain the various elements of the accordion folder  
• assess the pharmacists’ responses to the outreach educator (myself) and the 
printed material and 
• obtain responses to the question: 
 “What did the intervention mean to the pharmacists”?  
 
6.2  Scheduling of appointments to meet with pharmacy staff 
Telephonic access to the pharmacy was possible when the switchboard was 
informed that I was calling from the University of the Western Cape. My 
telephonic conversation to initiate the first meeting was as follows: 
E:  Is that the responsible pharmacist? 
Ph1: Yes, what can I help you with? 
E:  I am Emmanuel Molosiwa from the University of the Western 
Cape, School of Pharmacy. Last year I visited your facility to 
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complete a questionnaire. As a result I have developed an 
educational program which I would like to discuss with the 
pharmacy staff. Can you spare some time for me any day this week 
when you and one of the pharmacist’s assistants may attend a 
meeting at which I discuss diabetes management. It will take about 
30 minutes. 
Ph1: We are always busy but let me talk to some of the staff members 
first. Do you mind holding on or do you prefer to call later?  
 
Usually I preferred to hold on for a minute or two. Some pharmacists asked me to 
call back 15-30 minutes later to confirm the appointment. 
 E: What time would be suitable? 
Most pharmacists arranged to meet in the afternoon usually between 2:30 p.m and 
3:30 p.m. because of a decrease in patient load. It was necessary to include 
pharmacist assistant (PAs) in the meeting as they are key support personnel for 
pharmacists and to avoid a sense of discrimination among pharmacy staff. 
However, PAs were not the focus of this study. 
 
6.3  Length of waiting times at pharmacies  
The waiting times ranged from 10 minutes to about 3 hours. Pharmacists who failed 
to meet me at the appointed time, apologised and arranged for another meeting. The 
longest wait was 3 hours due to the fact that pharmacist (Ph7) had not 
communicated my intended visit to the rest of the pharmacy staff, and the meeting 
was rescheduled. 
 
The venue for our meetings ranged from the staff tearoom, the pharmacist’s office, 
the central floor space in the dispensary or a small quiet back room in the 
pharmacy. Participants occupied their seats randomly at the start of the 
presentation. 
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6.4 Number of pharmacists per facility  
Nine pharmacists, of whom four were females and five males, received the 
intervention. 
The number of pharmacists in each pharmacy location is outline in Table 6.1.  
 
Table 6.1 Number of pharmacists per facility 
Location of facility Number of pharmacists 
Bishop Lavis 2 
Delft 2 
Parow 1 
Athlone 2 
Vanguard 2 
 
Variables such as age of the pharmacists and number of years of experience were 
obtained from analysis of the questionnaires and are reported in part B of the results. 
 
Even though some of the community health centres (CHC’s) offer services seven 
days a week, pharmacies involved in this study did not operate on Saturdays and 
Sundays. 
 
I used the IDEALS approach (Chapter 5, section 5.12) to introduce the diabetes 
program. I explained the use of the folder and how these could be used with the case 
scenarios to obtain relevant key information. At each site, the outreach intervention 
was implemented at the same time for both the pharmacists and the pharmacists’ 
assistants since they work as a team.  
 
Even though the educational intervention was aimed at pharmacists, pharmacist’s 
assistants were invited to attend as they are an integral part of the pharmaceutical 
service. Therefore it was important to ensure that my discussion was pitched at a 
level that would be meaningful to pharmacist’s assistants as well.  
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6.5  Assessment of Visit 1 
Key for meeting with pharmacy staff 
Ph:  represents a pharmacist 
Ph1:  represents the first pharmacist I had met 
Ph2:  represents the second pharmacist I had met. This consecutive  
order is followed for all the subsequent pharmacists with  whom I    
interacted.  
E:  represents Emmanuel Molosiwa (myself) 
 
The first visit to the intervention sites i.e. MDHS pharmacies, took place over a 
four week period from 6th April 2005 to 3rd May 2005.  
 
6.6  Pharmacists’ responses 
The three main themes identified from the first visit were pharmacists who 
responded positively, those who had negative perceptions and those that seemed 
confused. 
 
Almost all the pharmacists were fairly comfortable and relaxed throughout the 
meeting. The social marketing approach generated hospitality and friendliness 
amongst almost all the participants and a comfortable learning environment was 
created through rapport-building and interactive discussions. 
 
6.7  Positive responses to the outreach intervention 
Pharmacists (Ph1; Ph4; Ph5 and Ph7) responded positively and perceived the visit 
as worthwhile. They responded positively to the folder and seemed enthusiastic 
about the adoption of key diabetes concepts. Further they felt there was a need for 
more of these interventions.  
 
Ph7: I wanted something like this and you have definitely provided it. 
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 E: (smiling)…I appreciate it that some of you like the program and 
realise its value.   
 
When discussing some of the risk factors associated with diabetes, I explained that, 
“about 30% of women with gestational diabetes will develop permanent type two 
diabetes in later life and that pancreatic diabetes is due to chronic alcohol 
damage”.  One pharmacist responded as follows: 
 P1: mmhhh, mmmhh, Yeah, Yeah, ehe! [acknowledging understanding] 
 
One pharmacist was impressed by the layout of the folder and expressed interest to 
in purchasing it.  
 Ph4: Where can I buy such material [referring to the folder in my hands] 
because I do not mind spending on it? 
E: (Smiling)…I am going to leave this folder in the pharmacy so that you 
can always refer to it. Moreover, I have the folder photocopied into a 
booklet form so that you can read it whenever you feel like it. 
 
Pharmacists who agreed with and displayed keenness towards the educator’s role 
were very friendly and enjoyed a humorous and relaxed atmosphere throughout the 
meeting. One pharmacist’s (Ph7) enthusiasm implied that (s)he did not need a lot of 
encouragement to accomplish tasks despite the constraints under which he/she had 
to work. Furthermore, some pharmacists (Ph3; Ph5; Ph8) tried to minimize 
interruptions by checking the urgency of the queries so as to retain their focus on 
the meeting. 
 
6.7.1 Pharmacists who wanted the outreach intervention to be extended to other 
health professionals 
Some pharmacists (Ph1; Ph4) perceived the importance of the educational meeting 
and indicated that it should be extended to nurses, doctors and community 
pharmacists.  
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 Ph4: Why not arrange for a mixed audience which includes nurses so that 
they could appreciate the reasons behind what they are doing daily 
to diabetic patients?  
 E: For now I am intending to only work with pharmacists. However 
pharmacists’ assistants have been allowed in our meetings but they 
are not the focus of my study. 
 Ph1: Why don’t you take this educational program to the community 
pharmacies as well? 
 E: Currently I have planned to work with public sector pharmacists 
only. 
 
6.7.2  Pharmacists who requested the extension of the outreach intervention to 
other chronic diseases 
Some pharmacists were very complimentary and further expressed their need for 
educational material such as the folder for the management of other chronic 
diseases. 
        Ph1; Ph2; Ph5:    It would be useful if you had this type of folder for the 
management of hypertension and other chronic diseases.  
                    Ph1: What is the next program that you will educate us on? 
E: We want to see how much the current program is accepted 
first, and then the decision will be based on what you 
expressed as your needs during the baseline study. 
                    Ph1: I have definitely improved, in fact all of us. 
  E: Smiling…a small improvement is good enough, even 1%! 
 
The positive responses towards the educational program were also reflected in the 
findings from the questionnaire survey where all pharmacists (9; 100%) were of the 
opinion that the short and educative programs on diabetes should be extended to the 
management of other chronic conditions. 
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Pharmacists who enjoyed the session supported the need for more educational 
sessions.  
  Ph4: Services should encourage educational sessions. These  
 should be considered and allowed during working hours.  
 
Some pharmacists used this opportunity to enquire and to further clarify 
pharmacotherapeutic principles on diabetes management.  
 Ph1: We see that some diabetics are put on carbamazepine 
treatment, do you have an idea on this? 
 E: This could have possibly been indicated for some neuralgia 
that possibly results from the complications of diabetes.  
                                                                                                         
6.7.3  Pharmacists who agree but were passive 
Some pharmacists (Ph2; Ph3; Ph5; Ph8) seemed to agree with the information in 
principle but their commitment patterns seemed to be limited.  
 
One pharmacist (Ph2) felt that the diabetes club provided patients with information 
on the management of the disease, while others (Ph3; Ph5) feared that information 
overload might be deemed disadvantageous to the patients.  
 E: Have you ever thought about giving patients more 
information on the management of diabetes disease? 
          Ph2: I do not have time and do not think it’s necessary because 
patients will get that information from the diabetes club. 
    Ph3; Ph5: I do not want to scare patients away from taking their 
medicines by giving them too much information 
 
One pharmacist (Ph8) felt that extensive counselling of patients was time- 
consuming. 
 Ph8: If you tell patients about control of sugar and cholesterol, 
foot care, the importance of stopping smoking, then you will 
be in the pharmacy until past midnight or even up to 1:00 
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a.m. Further, (s)he said, “Intellectuals don’t live in the real 
world, sometimes I think you are looking for a perfect 
world”. 
        E: Our aim is to work together even though we know very well 
there are many barriers and situational constraints. 
 
Another pharmacist (Ph 4) felt that their undergraduate training could not be 
applied easily in practice due to lack of staff. 
       P4: What we do in practice is different from what we were 
taught or what we know to be good practice. When you come 
out to real life practice, you realise the aim is to give patients 
their medications as quickly as you can. Patients are 
impatient, and they do not have time to listen when you try 
to counsel them.  
 
While patient overload, understaffing and time constraints remain a challenge to 
public sector health facilities, passivity among pharmacists could further hinder 
optimal care provision. 
 
6.8  Negative responses to the outreach intervention 
Even though pharmacists had welcomed me, some either seemed reluctant to spend 
their time in our meeting or were deliberately non-participatory. 
 
One locum pharmacist (with 40 years service experience) presumed that my visit 
was to have the pharmacy staff complete questionnaires, and commented 
negatively:   
Locum Pharmacist: Honestly, the last time you made us fill in your 
questionnaires, the moment you left, I and the other 
two pharmacists discussed what you did with us. 
Although we filled in the questionnaires we thought it 
was silly! 
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                          E: At least you filled in the questionnaire, for which I 
am grateful. 
The locum pharmacists’ negative comments could have subsequently  
influenced the other pharmacists interactions with me.  Chen (2004) confirmed 
that pharmacists’ knowledge and attitudes towards a diabetes program 
significantly influenced patient outcomes. This may well mean that negative 
perceptions could easily translate into passivity, where pharmacists are viewed 
as ‘mechanical dispensers’, where they lack active involvement in monitoring 
patient health outcomes.    
 
Pharmacist (Ph6) made several excuses, in that (s)he had a tendency to 
continuously and deliberately avoid our scheduled meeting. He/she excused 
him/herself because of the perceived outpatient load and arranged personal medical 
appointments that coincided with our pre-arranged meeting time. 
Ph6: There are many patients as you can see there is no way I can 
meet with you. 
E: Yes, I see let’s appoint for a different time.  
We agreed to fix the appointment for Tuesday at 2:00 p.m. I came in for the 
appointment as scheduled but this time I was given a different excuse. 
Ph6: I have got no time. I have an appointment with the doctor, at 
half past two, serious! 
 I have got no time! [Whispering as he/she goes out of the 
pharmacy]. 
 Subtle avoidance was evident as this pharmacist (Ph6) seemed to adopt situational 
constraints to disregard our meeting at the pre-arranged time.  
 
One pharmacist (P3) looked interested at the beginning of the presentation but soon 
seemed to have lost interest in the discussions. (S)he looked too tired and dozed off 
intermittently. This left me wondering whether (s)he listened better when (s)he 
occasionally closed his/her eyes, was too tired in the afternoon or that the 
discussions were boring.  
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Despite confirming a pre-arranged time, some pharmacists were not keen to meet 
with me. Three pharmacists (Ph3; Ph6; Ph8) felt that the educational session did not 
warrant their undivided attention. Pharmacist (Ph8) felt that I should discuss the 
educational material while (s)he was dispensing at the outpatient counter.  
Ph8: How do you think we can do this? Other than my normal duty of 
dispensing, I have a lot of other duties to carry out this morning that 
will prevent me from listening to the presentation. Talk to me while 
I am dispensing to patients at the same time. 
E: It will not work, I explained. 
 
Pharmacist (Ph6) listened to me for some minutes then attended to patient queries.  
Ph6: As long as you don’t ask me to do anything like answering questions 
and filling in questionnaires its fine you can talk to me. 
I started explaining the various elements of the desk folder. When I was just about 
to finish the discussion, a patient appeared at the outpatient counter of the 
dispensary window. (S)he immediately excused himself/herself out of the meeting 
to attend the patient. When she came back I acknowledged there was a problem.  
 E: Well, there is a problem. I had more information I wanted to share 
with you, but it does not seem to work.  
We agreed and postponed the meeting.     
 
Another pharmacist (Ph3), who worked in the same pharmacy with (Ph6), seemed 
to be always busy, either, placing an “emergency” order, balancing the narcotic 
drugs register or processing leave forms that made it impossible for us to meet at 
the scheduled time. 
   E:  Good afternoon Mr/Mrs ___________.  
Ph3: Emmanuel as you can see I am very busy now I can’t meet with   
you today? 
    E: Yes sir/madam, I can see that. I will talk to you over the telephone to 
arrange when to come again.      
I realized that the pharmacist would not make time to meet me on that day. 
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6.9 Interruptions during implementation of the outreach intervention  
Interruptions to some extent contributed to negative receptivity. Disruptions ranged 
from ringing cell phones, landline calls and attending to patients’ or nurses’ 
queries. Telephonic interruptions resulted in some pharmacy staff (Ph8; PA11) 
missing salient points during the discussions. 
 
Some pharmacists had to leave urgently in the middle of our discussions. One pharmacist 
(Ph1) had to rush out of the meeting because the locum pharmacist had to leave around 3: 
30 p.m therefore he/she had to immediately resume dispensing at the outpatient counter, 
which was a priority.   
Ph1:  I am sorry I have to leave  
E: Please take the three practice scenarios to help you apply the 
information on diabetes that appears in this folder [referring to a 
photocopy of the folder which I handed to the pharmacist]. I will 
discuss them with you on my next visit.         
  Ph1:   Okay 
As I was about to leave the pharmacy, pharmacist (Ph1) re-assured me that (s)he 
would assist the pharmacists’ assistants and patients by applying the diabetes 
management principles we had discussed.  
 
Findings from the questionnaire survey also indicated that the majority of pharmacists 
acknowledged that interruptions were barriers to the intervention (see Part B, figure 
6.1). 
 
Poor planning, lack of communication among staff and the inability to coordinate 
activities at the pharmacies, hindered the implementation of the on-site educational 
program. It may mean that public sector pharmacists are not accustomed to 
receiving on-site educational programs within working hours or may not want to 
view it a necessary part of their professional development. Lack of a dedicated 
room to conduct educational visits, could hinder implementation of outreach 
educational programs at public sector health facilities. 
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6.10 Confusion about my role as the outreach educator 
Some pharmacists’ initial responses to my role as an outreach educator was 
perceived with some confusion, although this was usually quickly and easily 
clarified. The confusion took one of two forms. Some pharmacists seemed to view 
me either as a representative from either a drug company or from the Department of 
Health. 
Ph4: Which company are you representing? 
E: None (smiling)…I am from the University of the Western Cape, 
School of Pharmacy. I am a postgraduate student.  
Ph4: In fact you are more than halfway to becoming a company 
representative. They are training you very well then to be a company 
representative! 
 E: Is that so! (Smiling)   
 
In other instances some pharmacists (Ph1 and Ph7) perceived my role to be that of 
a public servant working as a representative for the Department of Health’s 
pharmaceutical services.  
     Ph1; Ph7: Is it the department of health that sent you to do this with us? 
    E: No (smiling)…I am from the University of the Western Cape, 
School of Pharmacy. I am a postgraduate student.  
 
In view of the social marketing technique used in this study it was inevitable that 
staff perceived the outreach educator to be a drug company representative, and that 
may have resulted in some pharmacists (Ph1; Ph4; Ph 7) feeling uncertain about my 
role. 
 
One locum pharmacist adopted a defensive attitude about his/her practice upon my 
entry as an outreach educator.  
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Locum Pharmacist: Do you think you can teach me anything when I have 
been practising this long without anybody 
complaining about my standard of practice? 
                           E: I did not reply 
 
Although many pharmacists agreed with key principles of the diabetes outreach 
intervention, their commitment to actually apply these in practice may be 
questionable. It seems that contextual factors in the work environment limit their 
ability to provide a better dispensing service to diabetics. Until structural barriers, 
lack of planning, time constraints due to high patient load and understaffing are 
addressed, adherence towards good pharmacy practice and guideline based care 
remains a challenge to public sector pharmacists.   
 
6.11 Conclusion 
Despite situational constraints, there seemed to be fair acceptance among 
pharmacists of the intervention. Pharmacists who received the educator openly, 
held favourable views that the educational program provided practical information 
on key management principles of diabetes. Further, the folder and the social 
marketing approach seemed to obtain pharmacists’ approval. 
  
Findings from this qualitative study indicate that public sector pharmacists may be 
willing to participate in educational interventions. 
 
6.12 Visit 2 
 I discuss pharmacists’ responses to my second visit. Visits were assessed 
qualitatively to explore pharmacists’ perceptions and acceptance of the diabetes 
educational program. Common themes were identified from the field notes and I 
conclude the discussion with my perceptions as an educator. 
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I concluded the first visit by handing out practice scenarios at each pharmacy and 
requested pharmacists to use the folder to answer them. Even though all 
pharmacists had agreed to apply the information in the folder, comprising the key 
pharmacotherapeutic principles of diabetes management when solving the practice 
scenarios and when counselling patients, only a few fulfilled this commitment. 
 
The aim of the second visit was to reinforce the management principles of diabetes 
using the accordion folder (Appendix D), and assist them in solving three practice 
scenarios (Appendices F, G and H). The visit was also meant to assess pharmacists’ 
responses and experiences with the application of the information contained in the 
folder, which formed part of the assessment of the receptivity of the program. 
 
The second visit took place over a six week period from 16th May 2005 to 24th June 
2005. 
6.13  Scheduling of appointments to meet pharmacy staff 
I followed a similar procedure to that in visit one by scheduling appointments with 
the pharmacists and introducing the purpose of my visit.Meetings with pharmacists 
at the community health centre pharmacies were scheduled telephonically. Some 
pharmacists postponed appointments, as they explained that they “were short-
staffed” because one or two staff members were either “off-sick” or “off-duty”. 
6.13.1  Telephone conversation to initiate meetings 
I used the same conversation structure as in visit one, but requested 15 minutes of 
their time rather than 30 minutes. 
 
Most pharmacists except three (Ph4; Ph7; Ph9) responded with an apology during 
our telephone conversation to arrange for a meeting, as they had not been able to 
work on the scenarios.  
Ph1; Ph2; Ph3; Ph5; Ph6; Ph8: I am sorry I did not have time to do the problems. I 
do not know if the other pharmacist has solved the problems. Since 
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you are going to discuss approaches to solve practice scenarios you 
can come. 
            E: Should I come in the morning or in the afternoon? 
All pharmacists preferred an afternoon visit. 
Ph2:       As you witnessed during your previous visit, we are ever busy, but  
  you can come any day in the afternoon. 
Ph3; Ph4; Ph5; Ph7; Ph8:   You can come in the afternoon, anytime from 2:00 p.m. 
E: Thank you 
 
6.14  Length of waiting times at pharmacies during visit 2 
As in the first visit, meeting times depended largely on the availability of 
pharmacists with regard to their dispensing duty. Most visits were conducted from 
Mondays to Fridays. Meetings usually lasted for up to 15-20 minutes. 
 
At some pharmacies the scheduled meetings were delayed because the pharmacist 
was busy, resulting in prolonged waiting times ranging from ten minutes to about 
one hour. Pharmacists who failed to meet at the appointed time, apologized and 
subsequently arranged for another meeting.  
6.15  Implementation of the intervention  
In my second visit  met with the same sample of pharmacists as for the first visit 
and used the IDEALS approach. I reinforced aspects of diabetes care and 
subsequently guided pharmacists on how to apply key concepts when solving the 
practice scenarios using the folder (Appendix D). The intention was that the 
practice scenarios would enable the pharmacists to familiarise themselves with the 
folder so that it would be relatively easy for them to refer to the folder when 
dispensing to patients with diabetes.  
 
I concluded the visit by referring to inscription on the pen, “I am a diabetes 
educator” which served as a reminder for pharmacists that they are recognized as 
diabetes educators.  
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The key used in visit one which identifies responses to various aspects of the 
intervention, also applies for visit two. 
 
6.16  Pharmacists responses   
Pharmacists responses to the second visit were categorized into two main themes, 
those that showed interest or attempted to use the information contained in the 
folder (positive responses), and those who showed no interest to do so (negative 
responses).  
 
6.17  Positive responses 
Themes that describe pharmacists who agreed, were enthusiastic and had 
completed the practice scenarios are discussed below. 
 
Three pharmacists (Ph4; Ph7; Ph9) showed confidence in solving the practice 
scenarios questions as they could apply the information gleaned from the folder.  
          Ph7: I am done with the practice scenarios.     
  Ph4: I browsed through the folder once or twice and quickly went 
through the practice scenarios and solved them. 
        Ph9: Solving the problems was a really good exercise 
          E:          I would like to know your experiences with the use of  
           any of these materials and information? 
Ph7:    Yes, it was beneficial the first couple of days, some of the 
details we forget with time, man! 
   E:       Tell patients the information all the time when you counsel 
them, doing so will assist you to retain the information in 
your memory for long periods of time. 
Ph7: Mmm..h I will try that 
   E:          Thank you    
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Despite contextual constraints, responses from some pharmacists were positive.  
One pharmacist (Ph9) responded positively about the folder but patients absence  
limits optimal care provision.  
E: Since the first visit during which we discussed information 
on diabetes management principles, please tell me about 
your experiences. 
Ph9: I like using the folder because every time I have a question I 
just quickly refer to it. The locum pharmacist and I use it to 
quickly check information that we need on diabetes. It is 
very good indeed. 
   E:          That’s good! Do you counsel diabetic patients?  
Ph9: Yes, since the educational program, I talk to patients more 
about diabetes management. The problem is that the diabetic 
patients do not come themselves to collect their drugs, they 
just send “collectors”. However, the few that come to the 
pharmacy to collect their medicines, I talk to them about 
their medicines. I really try to make a difference. 
 
One of the barriers when dispensing to a collector (a person who collects 
medication on behalf of a patient) is that salient drug information for patients may 
not be conveyed to patients (Tietze, 1997).   
 
Another pharmacist explained that (s)he only provides additional information when 
the patient actually asks for it. 
                   Ph4: I only tell patients more information about diabetes 
management if they want to know more. 
                    E: The purpose of the diabetes educational session at the 
pharmacy was to enable you to initiate appropriate 
counselling for diabetic patients. 
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Pharmacists should not only respond to patients’ questions, but they should also be 
proactive (Anderson, 2003) in engaging with patients about their therapeutic needs 
and encourage self management (Roberts, 2004).   
 
One pharmacist expressed difficulty in translating technical pharmaceutical 
information into lay-persons’ terms to enable patients to make informed decisions 
about their health.      
Ph4: Most patients’ queries are not in-depth related. They will not 
talk about metformin drug plasma levels, or the interactions 
between aspirin and metformin. In varsity we were taught 
that there is an interaction and you can’t use the two.  
E: In practice we have to closely monitor the blood glucose 
levels of the patient and advise the patient or refer as deemed 
appropriate. 
 
Pharmacists often find that it is difficult to avoid the use of technical terms (Tietze 
1997). However, such translation into lay-terms is essential, for adherence to 
treatment. A further problem arises when friends or family collect medicines on 
behalf of patients. This hinders patient centred care. 
 
Despite time constraints, the intervention was viewed favourably.  
Ph2: We would have liked to fully talk to you and do more work 
with you, now it’s a pity we could not afford that. However, 
even with the little time we had together, we benefited. 
               E:       Thank you    
   
6.17.1  Perceptions of pharmacists who agreed and were enthusiastic but had not 
solved the practice scenarios  
This category included pharmacists that had positive intentions but who had not 
attempted to solve the practice scenarios. 
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In the accordion folder it is explained that the most useful drugs for the 
management of diabetic dyslipidaemia are the statins (simvastatin) and the fibrates 
(bezafibrate). Consequently practice scenarios one and three aimed to sensitise 
pharmacists to the importance of monitoring triglycerides and cholesterol in the 
management of diabetes.  One pharmacist enquired as follows:  
Ph8: Which are the best drugs for the control of cholesterol? 
E: For triglycerides, bezafibrate is the best considering what is 
available in the formulary or drug list. It is one of the broad-
spectrum lipid controlling agents in that although its main 
action is to decrease serum triglycerides, it also tends to 
reduce low density lipids (LDL-cholesterol) and raise high 
density lipids (HDL-cholesterol). Whereas simvaststin is 
good for cholesterol reduction, it acts by competitively 
inhibiting 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-
CoA) reductase, the enzyme that catalyzes the rate-limiting 
step in cholesterol biosynthesis.   
 
Some pharmacists (Ph5;Ph8), although positive about the information we discussed 
as outlined in the folder, still expressed negative responses when I asked them 
about their experiences concerning the application of the information in the 
educational materials when dispensing. 
E: What were your experiences with the use of any of the 
educational materials since our last meeting - especially 
when you were dispensing.   
Ph8: It definitely made a difference, but I didn’t change my 
practice. 
         Ph5: I did not change my practice.  
 
Even though pharmacists (Ph8; Ph 5) agreed that their knowledge of diabetes care 
had improved as a result of the intervention, pharmacist Ph8 did not apply key 
concepts in practice. Efforts to change practice behaviour indicate the need for 
regular support or reinforcement visits (Grol, 1995). When comparing the two 
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pharmacist (Ph8 and (Ph5) in terms of translating knowledge into practice, 
pharmacist Ph5 became more aware of the need to provide better care. (S)he 
seemed proactive to the extent that (s)he even pantomimed the activity when 
counselling patients on how to rotate injection sites when administering insulin. 
This pharmacist may be identified as one who could be at the stage of 
contemplating practice change (Rollnick, 1999).  
 
Although pharmacist (Ph5) had not answered the practice scenarios, she seemed to 
have grasped the importance of rotating insulin injection sites. 
Ph5: Since the educational program I have realized that some 
patients are not sure about the practice of rotating sites when 
injecting insulin. When I advise them about rotating injection 
sites, I make them follow a pattern. I simply ask them to 
place their hand over an injection area and use the spaces 
between the fingers as the next injection sites. This is 
practical and it helps them rotate injection sites.  
 
 E: (Smiling)…I appreciate it that some of you apply the 
information we shared for the benefit of patients. 
 
Even though the outreach visit may not have resulted in imminent practice change, 
it seemed to have instilled more awareness and vigilance of good management of  
diabetes. 
 
Pharmacists’ active involvement in advising patients about the importance of 
rotating injection sites and probing into patients’ knowledge and understanding 
(Tietze, 1997) of diabetes could contribute to better self-control.   
 
One pharmacist (Ph5) expressed concern about the poor monitoring of information 
when patients are transferred from tertiary to primary care facilities, resulting in 
lack of continuity of care.  
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 Ph5: Concerning the glycosylated haemoglobin (HbA1c) values, 
that information is not readily available in patients’ folders. 
When a patient is referred from tertiary centres, we only 
receive a referral letter at the community health centres. 
 E: Okay, that is one area that needs to be explored with the 
relevant authorities. I believe the information is important in 
order that better care can be provided to patients. 
 
During the process of the transfer of care (Grimshaw, 2005) from a tertiary to a 
primary care facility, sometimes there is a lack of relevant clinical data, and this 
may result in the provision of sub-optimal care.  
 
Pharmacist (Ph2) commented positively about the intervention, suggesting that 
(s)he realized the level of engagement expected of pharmacists in diabetes care. 
Ph2: The program is interesting and helpful but the problem is 
lack of time. The good thing about the program is that it 
somehow forces you to concentrate on your work.  It draws 
your attention and reminds you to do things that you will not 
normally do when you dispense to diabetic patients. In fact it 
encourages you to talk more with the diabetic patients.                          
E:  (Smiling) that’s a good experience. 
 
Other pharmacists (Ph7; Ph8) were positive about the educational program and 
shared their experiences after using the accordion folder.     
  Ph8: At least we have valuable information in the form of a folder 
that we can refer to. 
 Ph7: It’s good information. 
 
Since trained post-basic pharmacist’s assistants will be allowed to dispense under 
the supervision of pharmacists (Pharmacy Act of 1997), the pharmacist’s skill in 
critical analysis of prescriptions is crucial. During implementation of the outreach 
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intervention, a positive interaction with one of the pharmacists (Ph5) was as 
follows: 
E: I understand post-basic pharmacist’s assistants (PA’s) will 
soon be dispensing and counselling patients for some of the 
medicines up to schedule six at the beginning of July 2005. I 
guess pharmacists could be involved more with patient care. 
I suppose they will concentrate more on reading the folder, 
interpreting and analyzing prescriptions and advising more 
once they identify any anomaly with prescriptions. 
Ph5 Pharmacists better check prescriptions, and monitor 
adherence on other conditions such as hypertension and not 
just diabetes. They need groundwork on how to go about 
putting up say a diabetes clinic in place. It is best that 
pharmacists check prescriptions and identify those patients 
not well-controlled say on diabetes. In fact what you are 
doing with the current diabetes educational program is a step 
in the right direction.  
E: I am happy with your observations.     
Ph5: You know Emmanuel, we always make recommendations 
and we do not put workable solutions in place, thus they 
remain recommendations and will remain idealistic. 
 
By reviewing prescriptions and identifying patients with diabetes who are poorly 
controlled, pharmacists can refer patients for more appropriate therapy. Further 
reviewing response to therapy from clinical data  will enable better control (Tietze, 
1997). Observations from this study suggest that pharmacists dispensing overall, 
remains mechanical.  
 
One pharmacist (Ph9) expressed his/her appreciation of the colour-coded folder that 
was used to highlight key information on diabetes management.   
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Ph9: I appreciate the manner in which you linked the different 
colours to emphasise the important information that we have 
to know. How did you do that? 
E: Information highlighting the same message is colour-linked 
to specify the same topic. For example, all the messages 
emphasising hypoglycaemia (low blood sugar levels), appear 
in a red background and those emphasising hyperglycaemia 
(high blood sugar levels), appear in a yellow background. 
Drug interactions appear in a light green background. The 
side effects of drugs appear in a light blue background.  
 
6.18  Pharmacists who were negative in their responses 
Some pharmacists openly admitted they not only forgot to use the folder to solve 
the practice-based scenarios, but also that they did not have the time to do so. 
 
These pharmacists did not show interest and were cynical in their approach towards 
the intervention. Even though I may have established a rapport with the 
pharmacists since my first visit, their non-cooperation towards the practice 
scenarios, was attributed to the numerous practice barriers. 
 
Time constraint was identified as the main limitation. Some pharmacists  were on 
sick leave, while others had forgotten to familiarise  themselves with the folder.  
E: What are your experiences with the use of the folder that I 
discussed with you during my last visit?  I’d also like to 
know if you were able to solve some practice scenarios.  
Ph3: I do not know where I left the practice scenarios. Let me 
check in my drawer. I haven’t used the folder, I have been 
sick for five weekdays and now I have “stuff” (referring to 
his/her office work) to catch up with.  
         Ph3; Ph6; Ph8: I did not have time. 
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One pharmacist (Ph3), was not able to work on the practice scenarios because (s)he 
was moving house, and was too tired to do any extra work.  
        Ph3: I have not yet had time to attend to the practice scenarios [I 
had been told this explanation six times before]. You know I 
am moving house and I just don’t have time! I just can’t help 
you. I am in a bad situation. You know Emmanuel there 
comes a point in your life when you just can’t put an hour 
together. 
            E: Yes, I do understand. Working on the scenarios would help 
you to apply the key principles.  
       Ph3: Well I do not know, check me Thursday afternoon. Please 
call me first but I am not promising anything. 
 
Situational constraints, seem to influence the overall preparedness or willingness of 
pharmacists to engage fully in the educational program.   
 
Other pharmacists claimed that solving practice scenarios was perceived to add to 
their intense workload.   
                Ph8: I cannot do your practice scenarios now, I am busy! You 
better come for guiding and solving the scenarios, Thursday 
or Friday. Be aware that what you want us to do increases 
our workload. 
                     E: Yes I can see it. 
                       Ph8: Look at my desk, I have lots of work to do! I never have time 
to sit in this office and do my work! 
                       Ph6: Do you think we ever have free time here?  
  Look [showing me the dispensary area full of patients] this is 
how busy we are from morning to evening everyday.  
 
Some pharmacists added humour to their negative responses.   
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Ph6: Emmanuel see what you are doing to us. You are chasing us 
around! This pharmacist walked out of the pharmacy for an 
errand and returned shortly after five minutes. 
 
Another pharmacist highlighted the problem of lack of time as a joke:  
Ph1:      My supervisor does not give me time to look at the practice 
scenarios [Indeed joking!] 
E: it’s you, [________ calling the name of the pharmacist] who 
is not keen to solve the practice scenarios. 
 
Underlying the relaxed atmosphere and humor expressed as laughter, 
[ha..ha..ha..ha, e..e..e..e], it was apparent that lack of time was identified as a main 
barrier for most pharmacists. Further, reluctance to work on the scenarios was not 
because they were difficult but mainly that they simply did not find it necessary to 
solve them as they were viewed as an additional load to their already overstretched 
practice duties. Time limitations have also been noted in other studies (Mays, 
1994). 
6.19  Attempts to retrieve the completed practice scenarios  
On average I made nine visits to each of the four sites to retrieve the completed 
practice scenarios, but my efforts were not successful. While the care of patients 
takes priority over other activities at health facilities, pharmacists may have used 
this as leverage. Consequently, an incentive was offered as a strategy to improve 
the response rate. The offer of a certificate for recognizing their participation in the 
educational program and the return of solved scenarios and completed 
questionnaires, subsequently resulted in 100 % response rate and a change in 
attitude was also evident.  
 
Pharmacists (Ph1; Ph3; Ph5; Ph6; Ph8) were initially reluctant to cooperate but 
changed their attitude once they realised that certificates for the acknowledgement 
of their participation would be offered. Attitude and planning are factors that are 
likely to influence practice behaviour.   
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One pharmacist (Ph6) who habitually found some excuse not to fully participate in 
the educational program, adopted a more positive approach once (s)he realized that 
certificates would be offered. However, (s)he asked me, whether I would do a 
similar study again under the same constraints, after realizing how busy they were 
and how little time they had to accommodate any educational programs.  
E: Good afternoon __________ (name of pharmacist) 
Ph6: Hello Emmanuel 
E: I am here to collect the solutions to the practice scenarios as 
agreed.  
Ph6: Are you ever going to do a similar study under the same 
constraints, where you follow people at practice sites?  
E: Yes, we want to see how best we can share knowledge with 
pharmacists while they are on duty under the constraints and 
barriers you currently experience. Maybe from this study we 
may begin to know better, what it is that would encourage 
you to implement guidelines in practice. 
Ph6: But you can see it is not working. The best way is to invite 
some pharmacists to a common venue and educate them. I 
believe you will get better concentration from the staff and 
also better results. 
E: I would have preferred to do that but I do not have the 
authority to give you time off from work. Remember that I 
do not work for government. 
6.20  Perceptions of the educator 
My role as an outreach educator who is not resident in South Africa did not 
significantly influence the practice behaviour of pharmacists. However, knowledge 
of local languages (Xhosa and Afrikaans) would have enabled me to identify   some 
perceptions, prejudices and attitudes unfamiliar to a non-South African. One fifth 
(2; 22%) of the pharmacists spoke Xhosa, while the rest were Afrikaans-speaking. 
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The social marketing technique commonly used by the pharmaceutical industry 
(Soumerai, 1990) seemed acceptable.  The aim was to influence pharmacists’ 
practice patterns towards patient-centred diabetes care. It enabled pharmacists to 
share the barriers they encountered and what motivated them as well as what 
inhibited them from  applying key concepts when  providing care.  
 
A number of barriers have been identified during the implementation of this 
intervention. One of these is the high patient load which limits the involvement of 
pharmacists in devoting time in professional development programs. 
 
6.21  Conclusions 
There were some attempts made to engage with the scenarios which indicated that 
some effort was evident.  
 
Most pharmacists seemed to agree with the implementation of the on-site diabetes 
pharmacotherapy educational outreach program. Their commitment to actually 
apply the key concepts in practice was limited. 
 
In this study the qualitative methods using unobtrusive depth interviews and 
covertly making notes about the meetings, were appropriate. Views, perceptions 
and attitudes towards the educational intervention, provide indepth insight into the 
reality of pharmaceutical care provision in public sector health facilities. Overall 
findings indicate that the outreach intervention was found to be fairly acceptable 
among the pharmacists despite the contextual constraints.  
6.22  Part B: Quantitative results: Post-intervention questionnaire 
survey   
 
The questionnaire survey was used to assess pharmacists’ receptivity of the outreach 
intervention. The main objective was to assess if the intervention could improve 
pharmacists’ knowledge on diabetes management and if it influenced their practice 
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pattern. I present the results of the post-intervention questionnaire survey in Tables 6.2 
and 6.3.  
 
6.23  Overview of the contents of the post-intervention questionnaire   
The post-intervention questionnaire (Appendix J) inquired about the pharmacists’ 
background, their views and perceptions concerning diabetes care, their management 
principles, and their monitoring and lifestyle management skills. Furthermore, other 
questions assessed pharmaceutical practice, training and the educational program.  
 
Expressions that indicated frequency of ratio e.g. 1 out of every 10 patients, were used 
to measure change in practice.  
 
6. 24  Profile of pharmacists who completed the questionnaire 
The gender profile of pharmacists who completed the questionnaire is shown below.   
 
Table 6.2: Gender profile of pharmacists (n = 9) 
 n (Percentage) Age 
range 
(years) 
 
Gender:    Male  
                Female  
5 (56%) 30 - 60 
4 (44%) 20 - 50 
 
All pharmacists were registered with the South African Pharmacy Council and most 
were males (5; 56%). The duration of employment amongst the pharmacists varied 
between one and forty years. 
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Table 6.3: Results of post-intervention questionnaire survey 
 
  1 2 3 
 Strongly
agree, 
agree, 
or 
yes 
(%) 
 
# of 
subjects 
(%) 
who did 
not 
respond 
 
Strongly 
disagree,
disagree,
or 
no 
(%) 
 
    
    
Pharmacy practice barriers    
1a) Pharmacists who felt that the hatch or dispensing 
window is too small 
6(67)  3(33) 
1b) Pharmacists who felt that there is n 
o privacy at the hatch or dispensing window 9(100) 
  
     
     
2) Pharmacists who perceived that the external 
sources of interference commonly experienced when 
counselling are…  
  
      noise       7(78)   
      constant patient queries 9(100)   
      angry patients 8(89)   
      telephone calls 7(78)   
    
     
3) Pharmacists who felt patients prefer a private 
counselling area when collecting medication  
 
 
    
      yes 3(33)   
      no   1(11) 
      up to half of the patients 5(56)   
     
     
Barriers to dispensing and counselling    
4)  Pharmacists who noted that barriers to good 
dispensing are…. 
   
      shortage of staff 8(89)   
      too much workload 8(89)   
      no privacy 7(78)   
      patients are impatient 8(89)   
      language and communication problems 5(56)   
      lack of space 5(56)   
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      friends and family members collect medicines for 
      patients who are at home/work     
9(100)   
      other 3(33)   
     
 Pharmacotherapy educational programs for 
pharmacists  
 
 
5)  Pharmacists who felt there is a need to improve 
the quality of dispensing information 
9(100)   
     
     
6 Pharmacists who felt the program helped them to 
improve their: 
a) dispensing skills in terms of diabetes management  
 
 
9(100) 
  
     
b) knowledge of side effects of drugs used in diabetes 9(100)   
     
c) ability to identify drug interactions and 
contraindications 
9(100)   
     
d) alertness to correct drug dosages  8(89)   
     
     
Diabetes care    
7) Pharmacists identified the recommended fasting 
blood glucose level range to be… 
   
          4 (≤) and less than or equal to 7 mmol/L         9(100)   
         16 (≤) and less than or equal to 20 mmol/L   0 
         22 (≤) and less than or equal to 25 mmol/L   0 
     
     
8) Pharmacists who believed that hypoglycaemia can 
be due to drug effects 
9(100)   
     
     
9) Pharmacists who believed hypertension accelerates 
development of complications such as...  
             a) diabetic nephropathy 
 
 
9(100) 
  
             b) diabetic retinopathy 9(100)   
     
    
 10 After implementation of the program pharmacists 
who…  
   
a   i)  agreed to advise patients on foot care                    6(67)   
    ii)  claimed they do not have time to advise 
          patients on foot care    
3(33)   
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b   i)  agreed to advise patients on eye care after the 
         program  
7(78)   
     ii) claimed they do not have time to advise 
          patients on eye care   2(22) 
  
c   i)  agreed to advise patients on HbA1c levels  5(56)  2(22) 
     ii) claimed they do not have time to advise  
          patients on HbA1c levels 
2(22)   
d   i)  agreed to advise patients on the importance of  
          well-controlled blood glucose levels 
6(67)   
    ii)  claimed they do not have time to advise  
         patients on the importance of well controlled 
         blood glucose levels 3(33) 
  
     
     
11 a) Pharmacists who would advise the following 
proportions of patients on foot care  
 
 
             1 out of every 2 diabetes patients 0   
             1 out of every 10 diabetes patients 4(45)   
             1 out of every 20 diabetes patients 3(33)   
             all diabetes patients 0   
             none of the diabetes patients  1(11)   
             missing  1(11)  
    
11 b) Pharmacists who would advise the following 
proportions of patients on eye care  
 
 
              1 out of every 2 diabetes patients 1(11)   
              1 out of every 10 diabetes patients 2(22)   
              1 out of every 20 diabetes patients  4(45)   
              all diabetes patients 0   
              none of the diabetes patients 1(11)   
              missing  1(11)  
     
     
12  Pharmacists who spent more time counselling the 
following types of patients after the program  
 
 
              newly diagnosed diabetics only 7(78)  2(22) 
              chronic diabetic patients only 3(33)  5(56) 
              all newly diagnosed and chronic diabetic 
              patients              5(56) 
 
3(33) 
              missing  1(11)  
     
     
13) Pharmacists who after the program    
              changed their work routine to spend more  
              time on caring for diabetes patients                  4(44) 
 
5(56) 
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              did not change their work routine at all 3(33)  5(56) 
              missing  1(11)  
     
     
Monitoring of diabetes    
14) Those pharmacists whose response to a recorded 
HbA1c level 12 was…  
 
 
           let it pass 0   
           I do not have time to look at it closely 1(11)   
           I advise the patient to make enquiries at the 
           doctor     8(89) 
 
 
     
    
15) Those pharmacists who would check FBG levels 
to monitor treatment in the following proportions of 
patient’s folders   
 
 
               In about 1 out of every 10 diabetes  
               folders/charts   3(33) 
 
 
               In about 1 out of every 30 diabetes 
               folders/charts 0 
 
 
               In about 1 out of every 50 diabetes 
               folders/charts 2(23) 
 
 
               all the time 1(11)   
               never 3(33)   
    
     
16) Those pharmacists who intend referring to FBG, 
RBG, HbA1c, and TG…   
 
 
              when analyzing patients’ prescriptions 9(100)   
              when analyzing patients’ prescriptions  
              although it’s time consuming 9(100) 
 
 
     
     
17) Pharmacists who correctly identified the ideal 
lipid range to be the following…  
 
 
               total cholesterol less than 5 mmol/L 9(100)   
               triglycerides less than 1.5 mmol/L   8(89)  1(11) 
     
18) Pharmacists who were of the opinion that the 
drug of choice for a patient with 
hypertriglyceridaemia is bezafibrate 9(100) 
 
 
     
19) Pharmacists who were of the opinion that 
bezafibrate should be used with extreme caution in 
patients with impaired kidney function 9(100) 
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20) Pharmacists who were of the opinion that some 
side effects of bezafibrate are muscle wasting and 
abdominal pain 9(100) 
 
 
     
Lifestyle management    
21) Those pharmacists who found that after the 
program they tended to advise the following 
proportions of patients represented as patients’ 
folders on the importance of stopping smoking…    
 
 
            all the time 3(33)   
            In about 1 out of every 10 diabetes 
            folders/charts 4(45) 
 
 
            In about 1 out of every 30 diabetes  
            folders/charts 1(11) 
 
 
            In about 1 out of every 50 diabetes 
            folders/charts 1(11) 
 
 
            never    
     
     
22) Those pharmacists who found that after the 
program they tended to advise the following 
proportions of patients represented as patients’ 
folders on the importance of exercise and weight 
control…  
 
 
            all the time 3(33)   
            In about 1 out of every 10 diabetes  
            folders/charts 4(45) 
 
 
            In about 1 out of every 30 diabetes  
            folders/charts 2(22) 
 
 
            In about 1 out of every 50 diabetes  
            folders/charts  
 
 
            never    
     
     
Comments about the pharmacotherapy 
educational program   
 
 
23) Pharmacists who found that the pharmacotherapy 
educational program makes dispensing…  
 
 
            highly interesting 9(100)   
            less interesting    
            boring    
            It does not make a difference    
     
 Educational program    
24) Pharmacists who perceived that the    
 
 
 
 
  103  
pharmacotherapy educational program… 
            increases the work load 4(44)  5(56 
            although it increases workload, it’s worth 
            doing    8(89) 
 
1(11) 
            good knowledge for use during practice 9(100)   
            information needed if you teach in a  
            university  
 
 
     
     
25) Pharmacists who were of the opinion that the 
following materials increased awareness of diabetes 
when dispensing….  
 
 
            folder only 4(44)   
            pen only    
            both pen and folder 5(56)   
            none of them    
     
26 Pharmacists who were of the opinion that the desk 
folder…  
 
 
             is easy to understand 9(100)   
            is difficult to understand   9(100) 
            is a good reference source 9(100)   
            is too full of ‘information’ (cluttered)   9(100) 
            is a good reminder 9(100)   
            helped improve knowledge of diabetes   
            management 9(100) 
 
 
            takes too much space   9(100) 
            improved my confidence in diabetes 
            management  9(100) 
 
 
            is accessible because it is mounted on the wall  8(89)  1(11) 
        
    
           
27) Pharmacists who are of the opinion that 
illustrations in desk folder helped improve their  
understanding and clarity with regard to diabetes 9(100) 
 
 
     
    
     
28) Pharmacists who asserted that some of the 
information in the folder they do not agree with 
because …  
 
 
            it is wrong 1(11)  7(78) 
            they are not sure if it is wrong or right  1(11)  
            they did not use the folder    
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29) Pharmacists who found that the pen serves as a 
useful reminder  6(67) 
 
3(33) 
     
     
Students    
30) Pharmacists who were of the opinion that an 
educational program will definitely help them 
facilitate students learning at the site 9(100) 
 
 
     
     
Opinion of educator    
31) Pharmacists who were of the opinion that the 
educator…  
 
 
               was knowledgeable about the principles of  
               diabetes management 9(100) 
 
 
     
               clarified and reinforced their understanding  
               of diabetes management principles 9(100) 
 
 
     
     
Educator and the educational material    
32) Pharmacists who found that the following 
components of the program could have contributed to 
improving their understanding of diabetes…  
 
 
            educator and material 9(100)   
            folder and pen 1(11)  8(89) 
            only the educator 1(11)  8(89) 
            none of the above (educator, folder or pen)   9(100) 
     
     
Overall view of the educational program    
33)  Pharmacists who were of the opinion that visits 
during routine working hours were….  
 
 
            useful 9(100)   
            did not make a difference    
            were not useful    
     
     
Perceptions/feelings about the presentation style 
of the educational session  
 
 
34) Those pharmacists who perceived the following 
about the presentation style….  
 
 
            free to pose questions or ideas 9(100)   
 
 
 
 
  105  
            were guided on important concepts 9(100)   
            were encouraged to counsel patients more 9(100)   
            were dictated to as to how they should act  
            when dispensing    1(11) 
 
8(89) 
     
     
 Experiences with the use of information in the 
desk folder  
 
 
35) Those pharmacists who experienced the 
following with the use of the information in the desk 
folder…  
 
 
            did not use the folder 2(22)  7(78) 
            know most of the contents and will apply the 
            knowledge    8(89) 
 
1(11) 
            do not know what is in the folder 9(100)   
            haven't had time to apply the information in 
            the folder  2(22) 
 
7(78) 
            are satisfied with their usual style of  
            dispensing 3(33) 
 
6(67) 
           will use the folder from now onwards    9(100)   
     
     
Attendance preference for educational session    
36) Pharmacists who were of the opinion that a 
combined session for pharmacists and pharmacists’ 
assistants was …  
 
 
            fine 9(100)   
            not fine    
            it did not make a difference     
     
Recognition for participation in an educational 
program  
 
 
37) Pharmacists who were of the opinion that….     
they need a certificate for participating  in the 
program                    8(89) 
 
1(11) 
It did not make a difference    
                       
38) Pharmacists who were of the opinion that the 
short and educative programs on diabetes must be 
continued for the management of other chronic 
conditions 9(100) 
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6.25 Response rate 
The initial response rate was low (3; 33%) but it increased after pharmacists were 
informed that a certificate would be offered to pharmacists who completed all facets of 
the program. This resulted in a 100% response rate.   
6.26  Results 
Two thirds of the pharmacists (6; 67%) were of the opinion that the outpatient 
dispensing window was too small, and all of them (9; 100%) felt that there was no 
privacy.   
 
In identifying external sources of interference all pharmacists (9; 100%) felt that 
constant patient queries were most prevalent. The majority of them (8; 89%) found that 
patients became angry as they waited for a long time for their medications. Over three 
quarters of the pharmacists (7; 78%) believed that both noise and telephone calls were 
equally disturbing because patients strain to listen to instructions thereby limiting 
comprehension (Moody, 1998).  
 
The majority (8; 89%) of the pharmacists felt that most patients prefer a private 
counselling area when collecting their medications. Pharmacies without designated  
counselling rooms, leads to dispensing being done in an overburdened environment 
form noise and overcrowding of patients. This could have a high potential for poor 
adherence (Grimshaw, 2005).  
 
Pharmacists identified a range of barriers to good dispensing (Figure 6.1). Most of them 
identified, shortage of staff, high work-load and long periods of waiting (8; 89%), no 
privacy (7; 78%), language and communication problems (5; 56%), lack of work space 
(5; 56%), lack of direct patient contact as friends and family members collect medicines 
when patients are at home/work (9;100%), lack of understanding and no direct phone 
line to contact patients (3; 33%).   
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          Figure 6.1 Summary of pharmacists’ barriers to good dispensing (n=9) 
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All pharmacists (9; 100%) believed that there is a need to improve the quality of 
dispensing information on diabetes management. The perceived high work-load and 
impatient patients due to long waiting periods (8; 89%) added to suboptimal service 
provision. Stress and burn-out affect service delivery. All pharmacists (9; 100%) found 
that since friends and family members collect medicines on behalf of patients, this 
impact negatively on information transfer.  
6.27  Lack of time     
One third (3; 33%) of the pharmacists claimed they do not have time to advise patients 
on the importance of well-controlled blood glucose levels. This finding was also 
supported by statements expressed during unobtrusive interviews. A number of studies 
have shown that lack of time for the promotion of health was a major barrier (Keene, 
1994; Mottram, 1995; Moore, 1996; Anderson, 1998).  
 
Although all pharmacists mentioned the problem of lack of time as a factor that hinders 
them from providing quality counselling, qualified post-basic pharmacists’ assistants  
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(PA’s) may be utilized optimally to provide counselling. Currently pharmacist’s 
assistants have undergone post-basic training to improve their skills in not only reading 
prescriptions, but counselling patients too.  This means that pharmacists should invest 
their time in providing patient-centred care (Armstrong, 1990).  
 
More than half (5; 56%) of the pharmacists perceived language difficulties when 
counselling patients. As language is central to understanding, some Afrikaans-speaking 
patients may not fully comprehend counselling that is conducted in English. 
Multilingualism will be an advantage for pharmacists working in this environment 
because it enables them to assess the patient’s level of understanding when providing 
information (Moody, 1998). 
 
6.28 Pharmacists’ knowledge of diabetes care and monitoring 
Knowledge questions from the pre-intervention questionnaire were used in the post-
intervention. They are based on the national diabetes guidelines and are focussed on 
care and monitoring. The post-intervention questionnaire survey was conducted one 
year after the pre-intervention study. I compared the number of pharmacists who gave 
correct responses to the same questions. An increase in the number of pharmacists 
responding correctly indicated that there had been some increase in general knowledge 
(see bar graph Figure 6.2).  
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Table 6.4 Results of the pharmacist’ responses to the pre-intervention and 
post-intervention diabetes knowledge survey (n = 9) 
The percentages (%) for the number of pharmacists who responded correctly are placed 
in brackets. 
 
Description of question  
(The abbreviated question appears in brackets)  
Number of 
pharmacists 
who 
responded  
correctly 
(Pre-
intervention) 
(%) 
Number of 
pharmacists 
who 
responded  
correctly 
(Post-
intervention) 
(%) 
Hypertension accelerates diabetic nephropathy 
(Hypertension  & kidney) 
7 (79) 9 (100) 
Hypertension accelerates diabetic retinopathy 
(Hypertension & eye) 
5 (57) 9 (100) 
Hypoglycaemia can be due to drug effects (Drugs & 
hypoglycaemia) 
7 (79) 9 (100) 
Fasting blood glucose (FBG) level is between 4 - 7 
mmol/L (Fasting blood glucose FBG levels 4-7) 
8 (93) 9 (100) 
I will refer patient to the doctor instead of filling in 
the prescription when glycosylated haemoglobin A1c 
(HbA1c) level is 12 (Glycosylated haemoglobin A1c 
(HbA1c) at 12) 
1 (11) 9 (100) 
The ideal lipid profile of a diabetic should be less 
than 5 mmol/L (Cholesterol levels at 5 mmol/L) 
6 (64) 9 (100) 
The ideal lipid profile of a diabetic should be a 
triglycerides level less than 1.5 mmol/L 
(Triglycerides level at 1.5 mmol/L)          
5 (57) 8 (89) 
The drug of choice for a patient with 
hypertriglyceridaemia is bezafibrate  (Bezafibrate for 
hypertriglyceridaemia)           
5 (57) 9 (100) 
Some side effects of bezafibrate include muscle 
wasting and abdominal pain (Side effects of 
bezafibrate)  
6 (64) 9 (100) 
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Figure 6.2 Pre- and post-intervention knowledge surveys 
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6.29 Diabetes monitoring 
All pharmacists (9; 100%) correctly identified the recommended fasting blood glucose 
level range and knew that hypoglycaemia may be associated with drug use. They also 
believed that hypertension accelerates the development of complications such as 
diabetic nephropathy and retinopathy and that the ideal lipid profile level range for 
diabetics should be total cholesterol less than 5 mmol/L. Further they could identify that 
the drug of choice for a patient with hypertriglyceridaemia is bezafibrate and that some 
side effects of bezafibrate are muscle wasting and abdominal pain. Most pharmacists (8; 
89%) correctly identified that triglycerides levels for diabetics should be less than 1.5 
mmol/L.  
              (N = 9) 
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6.30  Pharmacotherapy educational program  
 After participating in the educational program, all pharmacists (100%) believed that 
their dispensing skills and knowledge of the side-effects of drugs had improved and that 
they were more alert to identifying drug interactions and contraindications in diabetes 
management. The majority (8; 89%) felt that the program helped them to identify 
correct drug dosages. Almost all (8; 89%) of the pharmacists mentioned that the 
educational program was worth doing even though it increased their workload.  
 
During the baseline observation study, pharmacists performed poorly when counselling 
patients about side-effects, adverse effects, warnings and cautions. Lack of sufficient 
information by pharmacists and other health care professionals such as doctors, has 
been noted in some reviews (Herxheimer, 1993).  During the visit, specific efforts were 
made through the use of illustrations to highlight information about these effects.   
  
6.31  Experiences with the accordion folder 
 
All pharmacists (9; 100%) believed that the folder helped improve their knowledge of 
and confidence in diabetes management, and served as a good reference source and 
reminder that was easy to understand. 
 
After implementation of the intervention, all pharmacists (9; 100%) believed that they 
would continue to use the folder. The majority (8; 89%) of them felt that they knew the 
contents of the folder and would apply the knowledge and that the accordion folder was 
accessible to them because it was mounted on the wall. 
  
All pharmacists (9; 100%) were of the opinion that illustrations in the desk folder 
helped improve their understanding and clarity about diabetes. The colourful 
illustrations aimed to stimulate a more focused behavior change in the pharmacists 
(Avorn, 1983). Other studies have shown that incorporating visual or pictorial aids such 
as pictograms in medicine labels and leaflets to complement written text, improved 
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comprehension of information (Dowse, 2003).  However, their successful use depended 
on their use as an aid to, rather than the sole means of communication (ibid).  
 
Each component of the intervention promoted greater awareness and aimed to reinforce 
the adoption of optimal diabetes care. Printed educational materials are rarely read or 
applied in practice but other forms of multifaceted interventions, especially those that 
catch the attention of the user, have been found to influence positive behaviour  (Avorn, 
1983).  
 
6.32  Pharmacists’ views on the pen  
One third (6; 67%) identified the pen as a useful reminder. Reminders have consistently 
been found to be effective in contributing positively towards improving professional 
practice (Grimshaw, 2005).  
 
6.33 Effect of the educational program on students facilitation 
All pharmacists (9; 100%) believed that the educational program will definitely help 
them facilitate students who learn at site. Pharmacists who are involved in facilitating 
students’ learning should have easy access to evidence-based information and easy-to-
understand guidelines are essential. 
  
Based on the above observations, it appears that pharmacists need support to consistently 
advise patients on drugs, treatment and complications associated with diabetes.      
 
6.34  Monitoring      
Glycosylated haemoglobin (HbA1c) evaluation is an accepted standard of care for 
assessing diabetes control (Sicard, 2005).  
 
One of the inquiries into assessing change in practice amongst the pharmacists was their 
ability to evaluate if treatment was appropriate by referring to FBG levels. One third (3; 
33%) of the pharmacists stated that they do not refer to them. However an equal number 
 
 
 
 
  113  
(3; 33%) claimed that they checked if treatment was appropriate in one out of every ten 
diabetic folders which they dispensed. A fifth (2; 22%) of the pharmacists mentioned 
that they checked if treatment was appropriate in one out of every fifty diabetic folders. 
This suggests that pharmacists seem to infrequently monitor [fasting blood glucose 
(FBG), random blood glucose (RBG), glycosylated haemoglobin levels (HbA1c), 
triglycerides (TG) and total cholesterol levels)], for diabetes control even though they 
have every intention to do so.  Close monitoring was perceived to be time-consuming, 
and not easy to implement. In other studies patients have benefited considerably in 
programs where the pharmacists were involved in medication profile review and proper 
counselling (Pray, 2003; Britton, 1991). 
 
More than three-quarters (7; 78%) of the pharmacists mentioned that they have used the 
folder as a reference tool. 
   
6.35  Provision of advice on lifestyle management  
Pharmacists provision of advice on the importance of smoking cessation and weight 
control is crucial in diabetes management. One third (3; 33%) of the pharmacists stated 
that they advised all patients, while a higher proportion (4; 45%) claimed to advise one 
out of every ten patients. One pharmacist (1; 11%) mentioned that (s)he advised one out 
of  every thirty patients and another pharmacist (1; 11%) claimed (s)he advised one out 
of  every fifty patients.  
 
An inquiry into whether pharmacists advised patients on the importance of exercise and 
weight control was explored. Only one fifth (2; 22%) of the pharmacists claimed that 
they advised one out of every thirty diabetic patients. This may imply that diabetic 
patients may not be appropriately advised on lifestyle modification. In other words, 
although the outreach intervention was well accepted, it had little effect in influencing 
pharmacists’ counselling styles. Good educational programs include the use of 
reminders (Grimshaw, 2005). A systematic review of the effectiveness and efficiency of 
guideline dissemination and implementation strategies published in 2004, estimated the 
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effectiveness of some interventions such as educational materials, reminders, audit and 
feedback. Reminders were consistently observed to be effective (ibid).   
 
Results from the post-intervention questionnaire and unobtrusive interviews showed 
that, although pharmacists believed that their dispensing had improved as a result of the 
intervention, this was however, not reflected in actual practice. During my unobtrusive 
observation, I paid special attention to pharmacists dispensing to diabetes patients and 
found that they had adhered to their usual counselling and dispensing styles. Past 
behaviour seemed to directly affect intentions and subsequent behaviour (Szeinbach, 
1998).  Perceived change towards practice improvements is a slow process that requires 
continual support.  Even if care providers are well informed about what they should be 
doing, they often do not perform in accordance with their knowledge and skills      
(Sanazaro, 1983; Kosecoff, 1987). 
 
6.36  The accordion folder and standards of practice 
Two-thirds of the pharmacists (6; 67%) mentioned that they were not satisfied with their 
usual style of dispensing and all of them (9; 100%) felt the need to improve the quality 
of counselling information which they provided. This may suggest that they were aware 
that they do not meet the recommended standard operating procedures (SOP’s) 
stipulated by the MDHS pharmaceutical department, and the Guide to Good Pharmacy 
Practice manual (1997). Even though two-thirds of the pharmacists were aware of their 
practice deficiencies, they were not necessarily receptive to the desired behaviour 
change. 
 
Rollnick (1999) explains that the stages of change model is an attempt to describe 
readiness and how people move towards making decisions and behaviour change in 
their everyday lives. In this study only a third (3; 33%) of the pharmacists seemed to 
demonstrate behaviour change in terms of accepting and readily applying the 
information in the folder in order to improve their counselling of patients. They were 
willing and showed a positive attitude (Fedder, 1988) during the implementation of the 
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intervention process. However, most pharmacists (6; 67%) were slow to change. This 
could mean that these pharmacists are pre-contemplators, who required additional 
support to influence their behaviour resulting in improved practice.  
 
6.37  Opinion about the educator  
All pharmacists (9; 100%) believed that the educator was knowledgeable and has 
helped to clarify and reinforce their understanding of diabetes management.  
Further they agreed that the educator and educational materials, folder, pen and practice 
scenarios contributed towards improving their understanding of diabetes management. 
In addition they felt that they were free to interact concerning concepts and were 
encouraged to counsel patients more about the management of the disease.  
Some studies have demonstrated positive results in behaviour change in physicians that 
had face-to-face education in addition to studying illustrated and visually appealing 
bulletins as an intervention (Avorn, 1983). Interventions that used only printed materials 
to bring about change in behaviour were found to be unsuccessful (ibid).  
 
6.38  Attendance preference for the educational session 
All pharmacists (9; 100%) supported a combined meeting between pharmacists and 
pharmacist’s assistants during implementation of the outreach intervention. All 
pharmacists (9; 100%) were of the opinion that the short but educative programs on 
diabetes should be introduced for the management of other chronic disease conditions. 
Educational programs should also focus on improving the pharmacotherapy knowledge 
of pharmacist’s assistants in service provision in public sector facilities. 
 
6.39  Recognition for participation in an educational program 
The majority of the pharmacists (8; 89%) responded positively to provision of a 
certificate to endorse their participation in the program. In this study certificates were 
awarded as an incentive to improve the response rates for the completion of practice 
scenarios and questionnaires. Some researchers have offered monetary incentives to 
improve response and participation rates (Wong, 2004; Edwards, 2005). 
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6.40  Conclusion 
The results of the current study suggest that when pharmacists are supported by an 
educational program, positive changes in knowledge and attitudes are imminent.  
 
Overall the results of this educational intervention suggest that it was fairly acceptable 
to the pharmacists. Improvements in knowledge and positive attitude indicate that 
educational interventions are needed for pharmacists to remain up-dated on guideline 
recommendations in chronic disease management.   
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CHAPTER   7 
 
DISCUSSION 
 
The aim of this study was to design, implement and assess pharmacists’ receptivity of an 
outreach intervention. In addition the study aimed to determine if their knowledge on 
diabetes management had improved and if this could be subsequently translated into 
practice.  
 
Diabetes is a multifactorial disease requiring concerted efforts by all health care 
professionals who bring in different perspectives, skills and knowledge to optimize care 
provision. Results from the pre-intervention study showed that the involvement of 
pharmacists is limited. Other studies also indicate that their role in monitoring drug 
therapy is limited (Decker, 1988; Younis, 2001).  
 
It is reasonable to suggest that if pharmacists are updated and guided about the key 
principles of diabetes management, they are likely to better counsel patients on self- 
management of the disease. Research has shown that short-term continuing education 
programs can improve pharmacists’ knowledge (Leemans, 1998) and attitudes towards 
the management of diabetes (Chen, 2004). The current study partially supports this. 
Overall, the results of this study show that the intervention was fairly well accepted and 
that it had enhanced pharmacists’ knowledge and awareness on optimal diabetes 
management, but this was not translated into practice.   
7.1 Acceptability of the intervention 
Results obtained from the qualitative interviews and field notes, indicated that 
pharmacists were generally in favour of the outreach intervention. For two pharmacists 
the folder served as a quick reference tool at the out-patient counter. 
 “I like using the folder because every time I have a question I just quickly 
refer to it”. 
One had further suggested that the educational program be extended to other chronic 
diseases. 
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“It would be useful if you had this (folder) [referring to the diabetes folder] 
for the management of hypertension and other chronic diseases”. 
One pharmacist summed up appreciation of the intervention:  
“It draws your attention and reminds you to do things that you will not 
normally do when you dispense to diabetic patients. In fact it encourages you 
to talk more with the diabetic patients”. 
This conclusion is also supported by the results from the quantitative post-
intervention questionnaire where all pharmacists (9; 100%) believed the educator 
and educational materials contributed to a clearer understanding of diabetes. All 
pharmacists (9, 100 %) believed they will continue to use the folder, and the 
majority (8; 89%) of them felt that they knew the contents of the folder and had 
hoped to use the knowledge in routine practice. Furthermore, all nine pharmacists 
believed after receiving the educational program, their dispensing skills and 
knowledge about the side-effects of drugs improved and that they were more alert 
to identifying drug interactions and contraindications in diabetes management. 
Before the intervention two thirds of the pharmacists responded correctly to the 
knowledge questions whereas after the intervention all pharmacists responded 
correctly suggesting that there was increase in knowledge of diabetes management 
principles. Thus integrating and mixing of research methods, provided insight into 
pharmacists’ acceptance of the intervention (Creswell, 2004).  
 
7.2 Factors that contributed towards acceptability of the intervention 
One plausible explanation for acceptance of the intervention was that a personal 
face-to-face informal discussion, in the pharmacist’s own setting enabled them to 
openly share their individual concerns and experiences. This collegial interaction 
fitted well into their routine dispensing activity and provided pharmacists with an 
empathic and interested listener who encouraged them to share their unique 
experiences openly and without the fear of criticism. They seemed uninhibited to 
enquire about key concepts during the discussions. This resulted in an authentic 
account of their views on the use of the intervention in line with other studies 
(Stålsby, 1999) where there was a positive behaviour change and improvement in 
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knowledge for the management of urinary tract infections among physicians. A 
study, which involved testing of four educational methods dealing with transferring 
information on cough medicines was also well accepted (Leemans, 1998).  
 
7.2.1 The educator 
All pharmacists believed that the educator was knowledgeable and had clarified and 
reinforced their understanding on the key principles of diabetes management. 
Behavioural science literature indicates that several important principles derived from 
adult learning and persuasive communication theories support pharmacists’ 
interventions to improve the quality of healthcare delivery (Soumerai 1990). These 
theories suggest that behaviour change is likely to occur when the agent of change has 
credibility as an expert consultant (Grol, 1995) who can present both sides of a 
controversial issue. There are a number of studies that have shown positive results 
where a pharmacist was involved in providing services with the clinical health care 
team (Sczupak, 1977; Hendryx, 1998; Sinclar, 1999; Simpson, 2004) or provided 
outreach services (Fedder, 1987; Coenen, 2004). Therefore, an outreach role in chronic 
disease management may seem a possible alternative role for South African pharmacists 
to explore. 
 
7.2.2 The educational materials 
The educational materials included the folder and practice scenarios (Sodha, 2002), may 
have also contributed to improving pharmacists understanding of diabetes management.  
 
The practice scenarios served as a vehicle to quantitatively evaluate how pharmacists 
could internalize key concepts and then apply them within their scope of practice. 
Those pharmacists who participated in solving the scenarios felt that they could 
engage more freely with patients as their understanding of the disease had improved. 
While this might be viewed as a first step towards knowledge translation, further 
support visits are needed to embed guideline based care among pharmacists. Gerstein 
(1999) also obtained positive results using scenarios. 
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Two thirds of the pharmacists identified the pen as a useful reminder. Reminders in 
the form of gift incentives have consistently been found to be effective in influencing 
practice in a number of studies (Grol, 1995; Grimshaw, 2005).  
 
Almost all pharmacists (8; 89%) were of the opinion that a certificate would endorse 
their participation in the program. In this study certificates were awarded as an incentive 
to improve response rates for completion of practice scenarios and post-intervention 
questionnaires. This may indicate that pharmacists are likely to participate in surveys 
that acknowledge their participation or possibly offer some incentive. Monetary 
incentives have also been used in other studies to improve survey response rates (Wong, 
2004; Edwards 2005).  
 
Availability of clinical guidelines for the management of chronic diseases does not, 
however, guarantee their use in practice. Most guidelines are written in medical 
terminology which may not be easily translated into practice for pharmacists. 
Guidelines that are adapted and tailored to address the pharmacist’s need would 
facilitate quality care provision. In this study although the folder was specifically 
designed to provide practical, up-to-date, easily accessible information to assist the 
pharmacist in care provision, more strategies that could enable adoption in practice need 
to be sought. For example, focus group discussions with pharmacists and 
pharmaceutical service coordinators could provide a deeper insight into the design of 
pharmaceutical care reminders or tools that would facilitate quality service provision. 
Further, infrastructural and operational changes are needed to enable pharmacists to 
engage directly with patients and interact with nursing and medical staff at the clinics to 
monitor therapy, and fulfill their primary care role (Lindenmeyer, 2006).  
 
In order to determine the effectiveness of this diabetes educational outreach intervention 
on patient health outcomes, a cluster randomized controlled trial (Fairall, 2005) is 
deemed necessary. Alternatively, simulated patients may be used to assess pharmacists’ 
application of key concepts.      
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7.3  Multifacetedness  
In this multifaceted intervention all elements were aimed at influencing the 
pharmacist’s practice pattern. In a multifaceted intervention it is not possible to 
determine which particular element actually promoted greatest receptivity since each 
component of the intervention aimed to promote greater awareness. The folder itself is 
unlikely to have created much impact because studies have shown that printed 
educational materials only are relatively ineffective (Baker, 1999). Wong (2004) found 
that academic detailing plus printed materials demonstrated a trend towards increased 
knowledge retention compared with printed materials only. A multifaceted approach 
using attention-grabbing diagrams that reinforce practical evidence-based information 
is likely to enhance knowledge and possibly with time influence the practice pattern of 
pharmacists.  
 
7.4 Impact of the intervention on pharmacists’ knowledge 
Findings from the pre-intervention study indicated that knowledge deficiencies among 
pharmacists in diabetes management may have affected the quality of care provision. 
However, improvement in pharmacists’ knowledge was evident from the post- 
intervention study and this finding concurs with that in other studies (Leemans, 1998). 
Sczupak (1977) demonstrated that after the pharmacist’s knowledge on diabetes 
management was enhanced through a diabetes mellitus educational intervention, it 
resulted in a more extensive patient-orientated pharmaceutical service that benefited 
the patients. Note that in this study, pharmacists’ knowledge increase was translated 
into improved practice that benefited patients. Schilling (1977) showed that positive 
results were obtained after the pharmacist implemented locally produced guidelines 
among diabetic patients.   
 
Chen (2005) established that improved knowledge, positively influenced some of the 
pharmacists’s attitudes, communication and motivation. However, in the current study 
only a weak link has been established between enhanced knowledge and translation into 
improved counseling.  One pharmacist seemed to be proactive:  
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 “Since the educational program… I advise patients about rotating injection 
sites, I make them follow a pattern … and this is practical since it helps 
them rotate injection sites”. 
Another pharmacist also claimed the program encouraged him/her to talk more 
with patients: 
“The program is interesting and helpful. It encourages you to talk 
more with the diabetic patients”.                          
 
The improvement on pharmacists’ knowledge may be attributed to the fact that the 
pharmacies were established pharmacotherapy learning sites for the final year 
University of the Western Cape pharmacy students’ service-learning programme 
(2003). Since the pharmacists are perceived as service-learning partners, their active 
involvement in student mentoring is essential. Access to evidence based information 
and easy to understand guidelines are needed to promote experiential learning. The 
educational outreach visit may have prompted pharmacists to improve on their 
knowledge and skills as evident from the post–intervention questionnaire survey. 
Further studies are needed to validate this finding at the non-intervention sites.  
 
South African clinical teams conduct random blood glucose and urine tests, and 
measure blood pressure for each visit as part of routine care (Levitt, 1997). Even when 
such test results are noted in the patients’ folder, the question is, do these figures mean 
anything to the pharmacist? While this intervention attempted to engage pharmacists 
more actively in management of diabetes by enhancing their knowledge, it was hoped 
they would also better monitor ambulatory patients from symptoms and monitoring 
parameters such as random blood glucose (RBG), fasting blood glucose (FBG) and 
glycosylated haemoglobin (HbA1c). Medication profile reviews along with 
interpretation of clinical or laboratory data among pharmacists are essential in 
pharmacotherapy (Britton, 1991; Pray, 2003). Therefore, training on clinical guideline 
implementation for pharmacists would equip them with the skills to work alongside 
nurses and doctors in chronic disease management. 
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7.5 Research methods 
The use of mixed methods has provided valuable insight into the pharmacists’ 
knowledge, attitude and practice on diabetes management in the public sector. The 
range and prevalence of barriers to good dispensing practice in a developing country 
against a backdrop of constraints such as high patient load, understaffing and lack of 
educational support has been explored. Further, combining qualitative and quantitative 
(Stange, 1996; Hanson, 2005) methods provided an indepth and credible account on 
acceptability of the intervention under very challenging structural barriers in the public 
sector. Structured reflection may be an alternate approach to identify possible barriers to 
care provision (Freitheim, 2004).  
 
Regular qualitative and quantitative evaluations are needed to check sustainability of  
acquired knowledge and how these actually translate into practice (Wong, 2004). 
Although findings from this study are not generalizable because of the small sample 
(n=9), the range of barriers identified to care provision, the dispensing and counseling 
skills, knowledge and attitudes may be reflective of practice patterns of pharmacists 
working in Western Cape public sector MDHS pharmacies. 
 
By combining research methods, discrepancies in responses can be identified. For 
example results from the post-intervention questionnaire and unobtrusive interviews 
clearly indicated that two-thirds of the pharmacists had believed that their dispensing 
had improved as a result of the intervention but, this was not reflected from observation 
in actual practice, as they adhered to their usual counseling and dispensing styles. Past 
behaviour seemed to directly affect intentions and subsequent behaviour (Szeinbach, 
1998).  Perceived change towards practice improvements is a slow process that requires 
continual support.  Even if care providers are well informed about what they should be 
doing, they often do not perform in accordance with their knowledge and skills 
(Sanazaro, 1983; Kosecoff, 1987; Leemans, 1998).  Although the outreach visit may not 
have resulted in imminent practice change, it brought about more awareness and 
vigilance on good management of diabetes. Continuous on-site educational programs 
are required to translate knowledge into routine practice.     
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A recurring finding from the mixed methods was that pharmacists claimed to not have 
time to advise patients on the importance of controlling blood glucose levels. Other 
studies although they did not use mixed methods have identified lack of time as a major 
barrier to care provision (Armstrong, 1990; Keene, 1994; Mottram, 1995; Moore, 1996; 
Anderson, 1998; Leemans, 1998). A possible reason is that the skills deficiency across 
South African public sector health facilities accounts for a 56 % vacancy rate for 
pharmacists (Pharmaciae, 2006). Consequently, this places a huge burden on currently 
employed staff. The skills deficit certainly poses a grave concern for both academic 
institutions and health-care planners (ibid). The South African public sector remains 
relatively worse off than the private sector in terms of the ability to retain pharmacists. 
According to Söderlund (1998) and van Rensburg (1999), in South Africa more than 70% 
of pharmacists work in the private sector. This could be attributed to better working 
conditions and higher salaries than that offered in the public sector. Lack of dedicated and 
qualified personnel makes it difficult to establish proper drug monitoring services in most 
public health facilities.  
 
One of the aims of the outreach intervention was to address pharmaceutical care 
constraints encountered by pharmacists. The intervention did not attempt to change the 
organizational and / or structural barriers in the public sector MDHS pharmacies, such 
as lack of private consulting rooms which require long term infrastructural changes 
(Grol, 1995).  Until such barriers are addressed pharmacists may not be in a position to 
optimize care provision and would be viewed as ‘mechanical dispensers’. The isolated 
nature of pharmacy practice in the public sector often precludes pharmacists from 
engaging directly with patients on pharmaceutical care plans that are integral to the 
primary health care concept (Emmerton, 2005). The infrastructure to accommodate 
pharmacists to apply their pharmacotherapeutic skills to enable them to interpret 
appropriateness of therapy using clinical monitoring parameters in the privacy of a 
consulting room is deemed necessary for chronic disease management.  
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7.6 Pharmacist’s assistants extended role 
The staff in the pharmacies comprises pharmacists and pharmacist’s assistants (see 
section 4.6 and 6.4).      
 
Although all pharmacists mentioned the problem of lack of time as a factor that 
hindered them from providing pharmaceutical care, qualified post basic pharmacist’s 
assistants (PAs) may be utilized optimally under the supervision of a pharmacist.  Post 
basic pharmacist’s assistants are legally allowed to handle up to schedule 6 drugs in 
terms of their scope of practice according to the Pharmacy Act of 1997. The Act was 
amended in November 2000 to accommodate PAs training and registration. In the 
Western Cape, PAs generally only dispense up to schedule 5. The extended PA role 
could allow pharmacists to re-organise their work schedules to engage fully with 
patients on providing patient-centred care. For example, they could work closely with 
pharmacists to check monitoring parameters [fasting blood glucose (FBG), random 
blood glucose (RBG), glycosylated haemoglobin (HbA1c) levels, triglycerides (TG) and 
total cholesterol levels] to better manage patients for diabetes control (Armstrong, 1990; 
Tietze, 1997).  
7.7 Conclusion and recommendations 
The study clearly underpins several factors that affect pharmacists’ active involvement in 
diabetes management in public sector primary health care facilities. Overall the findings 
of this study imply that: 
• An audit to identify barriers and assess knowledge and practice patterns of public 
sector pharmacists to optimal diabetes care should be conducted  
• Training on monitoring procedures and provision of support programs in chronic 
disease management is crucial in pharmaceutical care 
• Training pharmacists in educational outreach is a viable option for translating 
guideline recommendations into patient-centred care  
• Infrastructural and operational changes (eg. private consulting rooms) should be 
considered to enable pharmacists to achieve patient-orientated care in chronic disease 
management.  
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UNIVERSITY OF THE WESTERN CAPE  
 
 School of Pharmacy 
 Private Bag X17 
                                                 Bellville 7535 
 Ph: 021-9592190 
 Fax: 021-9593407 
 
OBSERVATION STUDY- PHARMACISTS 
ASSESSMENT OF DRUG USE PATTERNS: 
The School of Pharmacy, discipline of Pharmacology, University of Western Cape 
(U.W.C) is undertaking a survey to assess the quality of pharmaceutical services at public 
sector Metropole, District Health Services (MDHS). We are enquiring about barriers, 
views and perceptions concerning service delivery amongst pharmacists.  
 
The aim of the observation study is to assess current dispensing and counseling practices 
of pharmacists.  
 
Information obtained from these surveys is strictly confidential. 
The baseline data on current dispensing patterns will be used to design an improvement 
programme for the pharmaceutical services. 
 
Thank you for taking the time to fill in this questionnaire.  
 
                                                                                                                                                                             
Pharmacist   signature: _________________                        Date :  2004/____/______. 
 
_______________________________________________________________________ 
  
MDHS pharmacy at: 
1 Delft            2 Bishop Lavis          3 Vanguard           4 Athlone           5 Parow 
 
6 Heideveld    7 Hanover Park         8 Elsies River       9 Belhar                         10 Retreat 
 
 
PHARMACIST  BACKGROUND  
 
1.a.  Gender    
    
Male  Female  
                               
 
   b.   Age_______years 
                                                
2. S A Pharmacy council registration # _______________        
 
3. How long have you been working as a pharmacist   _______Years      _______months 
 
Appendix A: checklist for observation study 
Page 152 
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 TABLE 1. FACILITY INDICATORS 
 
INDICATOR GOOD AVERAGE POOR 
Physical 
surroundings: 
           neat 
            tidy 
   
Storage areas: 
      inadequate  
      adequate 
      organised              
disorganized 
   
Labeling and 
storage of 
medicines on shelf  
       organised             
disorganized 
   
Hygiene of surfaces 
used during 
dispensing 
   
 
TABLE 2   REFERENCE BOOKS 
                                               
 Available Edition/ 
year 
 Available but not 
used 
Not available  
i) Copy of  SOP’s   
ii)Essential drug list or  
    Treatment guideline   
iii) Formulary-SAMF 
iii) Martindale 
iv) Daily drug use 
    
 
i) Availability of essential drugs 
                            Yes                   No  
   
 
ii) Names of drugs out of stock  ____________________ 
                                                           ____________________ 
                                                           ____________________ 
                                                           _____________________ 
iii)  “I owe you” note 
  
Given to patient Not given to patient 
 
iv) Availability of tablet counter 
                            Yes                   No  
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TABLE 3 
                                                                 
PHARMACOTHERAPEUTIC ACTIVITY                                
        
  
   
   
    
   
   
   
   
   
   
  
P1
   
   
   
   
   
 
P2
 
P3
  
P4
 
P5
 
P6
 
P7
 
P8
 
 P
9 
P1
0 
 . Establishing contact with patient/ care giver. 
1. Greeting (establishing language used)           
2. Verifying folder number                                 
3. Verifying name of patient 
4. Verifying who medicine is for                      
5. Getting attention of patient  
          
Information, instruction, warnings given to 
patient regarding dispensed drugs. 
Drug details 
1. Clinical indication- (treat what ?)     
2. Generic name 
3. Strengths, 
4. Administrative form 
5. Instruction (when to take, dosage 
Total amount/special instructions (shake…)         
          
Drugs effects (onset and duration of action)      
6. Side effects (describe what to do                    
7. Duration of therapy 
8.  Storage/ safety   
9. Adverse effects /warnings/ cautions 
          
Suitability  
10. Contra- indications                                        
11. Drug Interaction  
12. Convenience                                                   
          
Follow up 
13. Date of  next appointment                              
14. When to return earlier  
          
Communication style  
15. Clear (audibility, pronunciation, and 
understandable                      
16. Structure of conversation (logical).                
17. Allowing patient to express (him/her) 
18. Ensure that patient understands, and asks 
the patient  to repeat  drug information. 
 
         
Non drug measures 
19. Describes rationale 
20. Gives instructions and warnings 
0         
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                                                                UNIVERSITY OF THE WESTERN CAPE  
School of Pharmacy     
Private Bag X17 
Bellville 7535               
Ph: 021-9592190 
                     Fax: 021-9593407                                                                      
     
                                                                
Dear PHARMACIST 
The School of Pharmacy, discipline of Pharmacology, University of Western Cape 
(U.W.C) is undertaking a survey to assess the quality of pharmaceutical services at public 
sector Metropole, District Health Services (MDHS). We are enquiring about barriers, 
views and perceptions about Pharmacists. Information obtained from these surveys is 
strictly confidential. The results of this survey would provide insight into designing an 
improvement program for the pharmaceutical services.  
   
Thank you for taking the time to fill in this questionnaire  
                                                                                                                                                                             
Pharmacist   Signature: _____________                          Date: 2004/ ___  /____ 
  
 
                                                                                    
  
MDHS pharmacy at: 
1 Delft            2 Bishop Lavis          3 Vanguard           4 Athlone                 5 Parow 
 
6 Heideveld    7 Hanover Park         8 Elsies River       9 Belhar                  10 Retreat 
 
PHARMACIST    BACKGROUND  
1.a.  Gender     
 
Male  Female  
             
   b.   Age_______years 
                                                
2.  .S A Pharmacy council registration # _______________ 
3.  How long have you been working as a pharmacist? 
            __________ Years              __________months 
  
Question 1   
PHARMACEUTICAL SERVICES 
 
a) What is the estimated daily average of the number of patients receiving medicines 
from the Pharmacy? Please tick the appropriate box                               
 
Appendix B: pharmacists views of an educational program 
Page 155 
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< 100 
              
100-199            
                                     
  200-299 
            
300-399  
 
400-499 
 
 
 
b) In your experience does the pharmacy have adequate working space to carry out 
dispensing functions:   
                Yes                       No 
  
  
 If No please explain 
…………………………………………………………………………………………
…………………………………………………………………………………………  
c) Do you feel that the out patient window /hatch is a suitable environment for you 
to dispense and counsel patients? 
             Yes                    No  
  
 
 ii) If No explain your difficulties 
………………………………………………………………………………………………
……………………………………………………………………………………………… 
d)   Are there any external sources of interference when you are counseling your   
patients on medication use: e.g.  
 i) Noise:     yes         No        
  
      
  ii) Constant patient queries  
                    Yes     No 
  
 
      
e) Do patients prefer a private counseling area when collecting medication from the 
pharmacy? 
                        Yes                   No  
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Question 2 
 Mention some barriers that prevent you from adhering to good hospital pharmacy 
dispensing and counseling practices 
          a)……………………… 
          b)……………………… 
          c)……………………… 
          d)…………………….. 
          e)……………………… 
 
 
Question 3 
For each of the statements below please choose and tick the box with the correct 
response: 
a) Inaccurate dispensing leads to the patient receiving……… 
                                                                                                         Yes              No 
i) wrong medicines ………………………………………□                 □ 
ii) incorrect strength and/or amount of medicines ………..□                 □ 
iii) incorrect instructions …………………………………..□                 □ 
iv) inadequate instructions on medicine …………………. □                 □ 
v) ambiguous instructions on medicine use……………… □                 □ 
vi) medicines being packaged in an appropriate  
            container (e.g glyceryl trinitrate in a  
            dark/amber glass bottle…………………………………□                 □                                            
                                                                                                                 
b) Incomplete dispensing leads to ………………………… 
                                                                                                          Yes              No 
i) patients lacking understanding of instructions 
            on medicine use ………………………………………….□  □                 
ii) inadequate adherence to medication use…………………□               □ 
iii) non- adherence to medication use………………………..□               □ 
 
 
c) Adequate communication and counseling means that the pharmacist is: 
                                                                                                          Yes             No 
i) aware when additional advice should be given                □               □                
ii) aware of how additional information should be given     □               □ 
iii) knowledgeable about what advice should be given 
            to the patient                                                                     □               □                        
                                                                                                                          
 
 
Question 4 
 
Using the scale 1-10 please rate yourself (satisfactory, good, very good and excellent) 
from the descriptions outlined in the table: Please tick the appropriate column once. 
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 Satisfactory 
1-2-3 
Good 
4-5-6 
Very 
Good 
7-8-9 
 
Excellent 
10 
Your ability   to put to use the 
information you know about rational 
use of drugs… 
    
 Application of  skills and knowledge in 
pharmacology/pharmacotherapy to 
practice is………………… 
    
Your dispensing is 
generally……………………. 
    
 
 
Question 5 
 
PHARMACOTHERAPY TRAINING FOR STUDENTS 
 
 5a) Did you train undergraduate pharmacy students in pharmacotherapy  at this 
pharmacy ? 
                    Yes                     No 
  
 
If No please proceed to question 7 
 If yes   please continue with question 5b 
 
5b)  In your opinion what problems do the  students encounter at your facility during 
training ?Please tick as many as necessary. 
Students seem NOT to   mention: 
                           i) generic drug names ……………… 
                           ii)  side effects of drugs……… 
                           iii) actions or clinical indications of drugs……. 
                           iv) the frequency of use or administration of  the  drugs per day……. 
                           v) the dose of the drug…………………… 
                          vi) special precautions where necessary 
                          vii) directions of use. 
 
 
Question 6 
In the spaces below list the group of drugs and/or name the specific drugs that  
students usually have problems with  in their effort/endevour to give accurate and 
complete information  when dispensing: 
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Pharmacological/Pharmacotherapeutic group or name of drug 
          a)------------------------------                    f)------------------------------ 
          b)------------------------------                    g)------------------------------ 
          c) ------------------------------                    h)------------------------------ 
          d)------------------------------                    I)------------------------------ 
          e)------------------------------                    j)------------------------------ 
 
 
Question 7 
 
RATIONAL    DRUG  USE 
 
a) Are you familiar with the concept of rational drug use  
              Yes                No 
  
 
Have you had any training on rational use of drugs? 
             Yes                    No 
  
 
If yes please specify if the training approach was: 
i) Problem based learning ( PBL) 
     Yes             No    
  
 
        ii)  In-service training 
                    Yes          No 
  
       
 iii) Workshop 
                 Yes            No 
  
       
 iv) Seminar 
                     Yes          No 
  
 
b) Were you satisfied with the type of training you received to be 
                  Poor        Satisfactory Good              excellent 
    
 
 
If yes how do you apply the principles and concepts in your daily practice? 
…………………………………………………………………………………………
……………………………………………………………………………………….. 
d) Are there any tangible results in your practice that could prove application of rational 
drug use? 
……………………………………………………………………………………………… 
 e) What are your views about participating in a training program on rational drug use? 
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………………………………………………………………………………………………
……………………………………………………………………………………………… 
f) i) Have you heard of problem based learning (PBL) 
                  Yes                No 
  
  
  ii) If yes, please explain in simple terms the meaning of PBL ?  
     ………………………………………………………………………………… 
…………………………………………………………………………………………… 
 
 
Question 8 
 
PHARMACOTHERAPY TRAINING FOR PHARMACISTS 
 
1) Based on your experience do you think that patients need to have more information 
about the medicines they are using/taking? 
                                       
                  Yes                No 
  
 
2) Do you feel there is need to improve the quality of dispensing information that you 
give to patients about use of their medicines? 
                 Yes                No 
  
 
 
3) Do you feel that a pharmacotherapy-training programme at the pharmacy would 
enable you to  
               a) Improve your dispensing skills 
                               Yes               No 
  
 
             b) Improve your knowledge about side –affects of drugs 
                           Yes              No 
  
 
 
              c) Alert you to identify drug interactions and contra-indications. 
                          Yes             No 
  
 
              d) Alert you to correct drug dosages easily 
                          Yes                No 
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Question 9 
On a Scale of 1 to 5, please identify which pharmacological group you would like 
pharmacotherapy training in.  Please tick the appropriate box to express your 
perceived needs.  
 
Pharmacological group or category 
H
ig
he
st
 
N
ee
d 
(5
)
H
ig
h 
N
ee
d 
(4
) 
M
ed
iu
m
 
N
ee
d 
L
ow
 
N
ee
d 
(2
)
L
ow
es
t 
N
ee
d 
(1
) 
Antiretroviral drugs      
Antiasthmatic drugs      
Antihistamines      
Antimycobacterials/-Antituberculosis  
drugs 
     
Antidiabetic drugs      
Cardiovascular drugs      
• Cardiac therapy 
• Antihypertensive drugs  
• Diuretics drugs 
• Beta blocking agents 
• Calcium channel blockers 
Drugs Acting on the Central Nervous 
System 
     
• Antiepileptics 
• Antipsychotics/psycholeptics 
• Antidepressants/psychoanalepti
cs 
• Antiparkinsonian agents 
 
Antimicrobial drugs      
• Antibiotics/Antiinfective drugs  
• antifungals 
Chemotherapeutic drugs      
• Cytotoxic drugs(cancer drugs) 
• AntiParasitic drugs 
Oral Contraceptives      
Alimentary Tract and Metabolism 
drugs 
     
• Antiulcer drugs 
• Antispasmodic & 
Anticholinergic drugs 
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Pharmacological group or category 
 
 
 H
ig
he
st
   
N
ee
d 
(5
) 
H
ig
h 
N
ee
d 
(4
) 
M
ed
iu
m
 
N
ee
d 
(3
) 
L
ow
 
N
ee
d 
(2
) 
L
ow
es
t 
N
ee
d 
(1
) 
Ophthalmologic/(eye) drugs 
     
GenitoUrinary System &Sex 
hormones 
     
• Sex hormones and modulators 
of the genital system 
• Oral Contraceptives 
 
Analgesics 
? Opoid 
? Non-opoid 
 
     
Drugs used in Hyperlipidaemic 
conditions 
     
 
 
 
Question 9 
 
a) Do you feel that the pharmacotherapy training should be part of a continuing education 
program for pharmacists?  
                        Yes                No 
  
 
Definitely  Yes maybe       May be     Not at all 
 
 
Question 10 
 
Please comment about anything that concerns you about working in a day hospital 
pharmacy.       
………………………………………………………………………………………….. 
…………………………………………………………………………………………..
………………………………………………………………………………………….. 
………………………………………………………………………………………….. 
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UNIVERSITY OF THE WESTERN CAPE  
 
 School of Pharmacy 
 Private Bag X17 
                                                     Bellville 7535 
 Ph: 021-9592190 
 Fax: 021-9593407 
 
Dear Pharmacist 
The School of Pharmacy, discipline of Pharmacology, University of Western Cape 
(U.W.C) is undertaking a survey to assess the quality of pharmaceutical services   at 
Metropole District Health Services (MDHS). We are enquiring about current approaches 
to diabetes management in primary care facilities. Please note there are no right or 
wrong answers.  Information obtained from these surveys is strictly confidential. 
The results of this survey would provide insight into designing an improvement program 
for the pharmaceutical services. 
  
Thank you for taking time to answer this questionnaire. 
 
Pharmacist   signature: _________________                        Date :  2004/____/______. 
 
 
 
_______________________________________________________________________ 
  
MDHS:  
1 Delft             2 Bishop Lavis            3 Vanguard           4 Dr Abdurahman         5 
Parow   
 
6 Heideveld      7 Hanover Park        8 Elsies River         9 Belhar          10 Retreat   
 
PHARMACIST  
BACKGROUND  
 
1. a.  Gender    
    
Male  Female  
                               
 
   b.   Age  _______years 
                                                
2. S A Pharmacy council registration # _______________        
3. How long have you been working as a pharmacist            __________ Years              
__________months 
 
 
 
Appendix C: Assessment of pharmacists’ knowledge on diabetes management 
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Identifying current practice in diabetes management 
 
A. Guidelines 
Question 1  
Which guidelines do you prefer using when providing care to patients?      
a) National guidelines on the management of diabetes   yes ⁯    no ⁯     
b) Standard treatment guidelines.             yes ⁯    no ⁯ 
    
Question 2 
Are you familiar with the national diabetes guidelines for adults and children ?     
               a) Never heard of it  before              yes ⁯    no ⁯    
               b) Heard of it before  but do not use it to check if prescribed therapy 
    is appropriate                    yes ⁯    no ⁯     
               c) Heard of it and follow it                       yes ⁯    no ⁯  
 
Question 3 
a) In your opinion patients who are more likely to develop diabetes have 
  impaired glucose tolerance (IGT) yes ⁯    no ⁯      
  impaired fasting glycaemia (IFG) yes ⁯    no ⁯                            
 
B. Current role in diabetes management 
Question 4 
a. What are your views regarding your current role in diabetes treatment 
Counseling patients on proper drug use        yes ⁯    no ⁯     
Checking adherence to therapy                     yes ⁯    no ⁯    
Advising on insulin use/administration         yes ⁯    no ⁯    
      
 
 
Question 5 
In your view, is the recommended fasting blood glucose level is … 
                                    <10 mmol/L       yes ⁯    no ⁯      
<16 mmol/L       yes ⁯    no ⁯     
≥20 mmol/L       yes ⁯    no ⁯                 
≥22 mmol/L       yes ⁯    no ⁯                  
 
C. Symptoms 
Question 6 
i. Do you think that patients know what to do when they experience symptoms              
of diabetes? 
                               yes     no     
   
 
ii. In your experience what are the most common symptoms that diabetes 
patients present ?  
    a)…………………………….. 
                        b)……………………………. 
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D. Medication use 
Question 7 
a) Do you think that patients take their medicines as prescribed? 
                                 yes   no           
 
b i) Do you ever ask patients about problems they have  after taking their 
medications?                                                                                  
      yes   no     
      b ii) If yes mention any 1 or 2 problems  they usually  readily tell you 
………………………………………………………………………………………………
……………………………………………………………………………………………… 
b) If a patient is on maximum dose of sulphonylurea, reduce the dose by 50% when   
      introducing bedtime insulin 
                                        yes    no   
 
Question 8 
1. Are patients generally adherent to their medication use? 
       yes    no   
E. Side-effects 
Question 9 
   a)    Have  you  observed patients experiencing side effects resulting from diabetes 
          medication?  
i. oral 
   yes     no    
                        ii. injection 
                                    yes     no    
                        iii. oral and injection 
                                    yes     no    
   
 b)   Have patients reported any side effects resulting from  medication use to you? 
                                    yes     no    
 c)   Do you believe that  hypoglycaemia may be due to the effects of 
       drug therapy? 
                          yes     no    
         
Question 10 
 Do you think that  prescribers  are aware of any drug interactions related to 
diabetes medication? 
                                   yes     no    
 
 
Question 11 
 Have you identified prescription errors in diabetes patients with respect to:        
      a)  over prescribing   yes ⁯         no  ⁯         
      b)  unclear prescribing  yes ⁯         no  ⁯          
      c)     under prescribing  yes ⁯         no  ⁯                                     
 
 
   
 
 
 
 
  166
F. Monitoring  
Question 12 
a) Do you think that patients understand the meaning of different blood glucose    
            levels? 
                                 yes     no     
 
b) Does the recorded  fasting blood sugar levels help you with your prescription 
assessment 
                                   yes     no    
c i)  Does acetylated  haemoglobin 1c (HbA1c) have any importance in your 
     understanding of diabetes?                  
   yes     no     
 
c ii) If you find that a patient’s glycosylated hemoglobin (Hb A1c) levels are beyond 
recommended levels of ≥ 7-8% what action do you take? 
 a)  Let it pass         yes ⁯         no ⁯     
   b)  I do not have time to look at it closely yes ⁯         no ⁯     
            c) Refer to a doctor                          yes ⁯         no ⁯     
  
d) Do you ever refer to the patient’s fasting blood glucose levels to check if 
treatment is appropriate? 
   yes     no     
e) Dipstix  test for proteins in urine is important for diabetes management 
   yes     no    
 
 
f)  The aim of regular follow up in diabetes is to monitor and improve sugar control, 
blood pressure and blood lipids 
                                    yes     no     
 
g)  The ideal lipid profile of a diabetic is … 
   i)  total cholesterol  < 5 mmol/L               yes          no           
   ii) triglyceride        < 1.5 mmol/L             yes          no  
 
h)         The ideal choice of a drug for a patient with predominant hypertriglyceridaemia is 
            bezafibrate yes        no   
i) Fibrates should be used with extreme caution in patients with impaired kidney 
function yes         no            
j) Muscle wasting and abdominal pain are some side effects of bezafibrate 
  yes         no             
         
 
Question 13 
In your practice are you  able to advise the patient on 
a) foot care yes ⁯        no  ⁯     
b) eye care yes ⁯        no  ⁯     
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Question 14 
If you find that a patient’s blood glucose level is very low (< 3.9 mmol/L) or very high  
(≥ 16mmol/L) do you ….. 
          a) Gather more information from the patient on medication use   
yes ⁯       no ⁯  
 b) Refer patient to a doctor     yes ⁯       no ⁯     
       c) Discuss dietary requirements with the patient yes ⁯       no ⁯         
 
 
G. Diabetic  management programme 
Question 15 
Do you think that providing patients with an information leaflet would reinforce 
management of diabetes? 
yes     no     
    i.    if yes, state what information should appear in it 
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………….................... 
 
Question 16 
Tick the appropriate answer 
Do you feel that a  diabetes management  programme should include: 
a) Counselling patients in how to control blood sugar levels 
   yes     no      
 
b) Monitoring blood sugar levels  
  yes     no      
    
 
c) Monitoring long term blood sugar control levels (HbA1c)  
   yes     no      
 
 
d) Monitoring side effects of insulin treatment with patients 
   yes     no    
e)  Monitoring side effects of oral hypoglycaemic agents   
 yes     no      
 
 
 
H. Lifestyle Management 
i) Diet 
Question 17 
a) Do you inquire about dietary recommendations in diabetes management?     
All the time     occasionally                never  ⁯ 
b) Do you think that patients adhere to a recommended dietary programme ? 
 yes     no      
c) Do you advise patients on weight control measures ? 
 yes     no      
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ii) Exercise 
Question 18 
Have you been able to advise patients about the importance of exercise in managing their 
diabetes? 
                                                yes     no    
 
Question 19 
In your view is your current role as a health care provider in diabetes care… 
  Satisfactory    yes ⁯       no ⁯    
 Underutilised    yes ⁯       no ⁯    
 Need to be improved   yes ⁯       no ⁯      
                         Not sure     yes ⁯       no ⁯      
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Practice scenario 1 
Mrs. C. Happy: age 75yrs; weight 60kg; height 166cm; diabetic for 7 years  
Triglycerides 1.77 mmol/L (Recommended must be less than < 1.5 mmol/L) 
Total cholesterol 5.5mmol/L (recommended must be less than < 5mmol /L) 
Fasting blood glucose 3mmol/L (recommended must be between 4 - 7mmol/L) 
She complains of sweating, headache, confusion, impaired vision and is irritable. 
Current treatment: 
Glibenclamide10mg t.d.s x 1/12 
 
Pharmacists were asked the following questions based on the above scenario:  
1. What surprises you about this prescription? (Say anything that comes to 
your mind. 
 
2. Since the patient is irritable and has been waiting for a long time, she 
shouts back to you that, “I am the next patient, I can see that my card is 
ready. I want to go and rest, give me my medicines you know I have been 
taking this medicines for a long time. I will not wait for your pharmacist to 
come back from tea.” What could be the cause for irritability? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix F: scenario 1 
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Practice scenario 2 
Mr .M. Joy: is on hypertension treatment BP 150/95 and is well controlled, he came for 
review but complains of blurred vision and tiredness because he has to get up 3-4 times at 
night to urinate. He has a fasting blood glucose done and reads 10.8mmol/L (normal 4 – 7 
mmol/L). He does not believe he is diabetic, and has come to the hospital to see the 
doctor for a second opinion. Doctor has advised that a different test be done oral glucose 
tolerance test (OGTT) 2 hours post glucose load and is 21.8mmol/L (recommended must 
be less than ≤ 11.1mmol/L). 
 
 1. Doctor asks you for an opinion “is the patient diabetic? If he is diabetic 
what treatment would you recommend? 
 
For the following two questions I asked pharmacists to give possible explanations behind 
all the decisions they made. 
 2.  If you give the patient oral antidiabetic drugs (such as metformin) for the 
           first time what advise will you give?  
 
 3. If the patient receives insulin for the first time what advise will you give? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix G: practice scenario 2 
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Practice scenario 3 
Mr .M. Sad: age 68yrs; weight 76kg; height 166cm; diabetic for 7 years  
Triglycerides 2.77 mmol/L (recommended must be less than < 1.5 mmol/L) 
Total cholesterol 6.5mmol/L (recommended must be less than < 5mmol /L) 
Random glucose 20mmol/L (recommended must be between (11.1 - 15mmol/L) 
HbA1c 12% points (normal must be less than or equal ≤ 7mmol /L) 
Patient has come for monthly supply and will see the doctor after 3 months. 
He complains of thirst and being tired, itchiness and redness on his penis and 
has lost 3 kg in the last 2 weeks. 
 
Current treatment: 
 Metformin 850mg t.d.s  x 1/12 
 Glibenclamide 5mg b.d x 1/12 
 
Pharmacists were asked the following questions based on the above scenario:  
1. What advise would you give? (discuss anything, pharmacological 
and non-pharmacological that comes to your mind, we are thinking 
through this problem together as a team. I am also learning). 
 
2. After 6 months when the patient is on medication, the patient is 
also given acetylsalicylic acid tablets (aspirin): What could happen 
to the antidiabetic treatment when the drugs are given together?  
 
 
 
 
 
 
 
 
 
Appendix H: practice scenario 3 
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UNIVERSITY OF THE WESTERN CAPE  
School of Pharmacy 
 Private Bag X17 
                                                     Bellville 7535 
 Ph: 021-9592190 
Fax: 021-9593407 
  
 
Dear Pharmacist 
The School of Pharmacy, discipline of Pharmacology, University of Western Cape 
(U.W.C) is undertaking a diabetes educational program at Metropole District Health 
Services (MDHS). We are enquiring about the diabetes educational program, that was 
implemented at the pharmacy a few weeks ago. Please note there are  no right or 
wrong answers.  Information obtained from these surveys is strictly confidential. 
The results of this survey would provide insight into designing an improvement program 
for the pharmaceutical services. 
 Thank you for taking time to answer this questionnaire. 
 
 Date :  2005/____/______          
 
_______________________________________________________________________ 
  
MDHS:  
1 Delft            2 Bishop Lavis          3 Vanguard          4 Athlone        5 Parow  
 
PHARMACIST BACKGROUND  
 
Tick the appropriate box 
 
1.a.  Gender    
    
Male  Female  
                               
 
   b.   Indicate your Age range in years 
 
           20 – 29   30 – 39     40 – 49     50 – 59     60 – 69     70 – 79     80 – or more 
  
                                                
2.  How long have you been working as a pharmacist?     ___Years   ___months 
 
3. South African Pharmacy council registration # _______________    
     
4. In which country did you train to be a pharmacist? _______________________ 
                                                                                      _______________________ 
 
Appendix J: post intervention questionnaire 
Page 184 
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Pharmaceutical Services 
 
Tick the correct response 
 
1.    Tick all the options that you consider relevant about the hatch or dispensing 
        window 
a) Too small  yes   no      
         
b) No privacy  yes   no 
 
2.    Tick the options you encounter as external sources of interference when you 
       are counseling your patients on medication use   
          Noise      Constant patient queries       Angry patients Telephone calls 
Tick the correct response 
 
3.     Do patients prefer a private counseling area when collecting medication from the 
         pharmacy?     
 Yes  No  Up to half of the patients More than half of the patients 
 
Barriers 
4.     Tick all the problems and/or barriers that you consider to prevent you from adhering 
         to good hospital pharmacy dispensing and counseling practices. Add more if you  
         feel some have been left out from the list.    
      a) Shortage of staff     b)  Too much work load   c) No privacy 
     
      d) Patients are impatient       e)  Language and communication problems   
  
       f) lack of space   g)  lack of proper equipment 
        
       h) Friends and family members collect medicines for patients who are at home/work  
     
 Other:.......................................................................................................................
 ................................................................................................................................... 
 
Pharmacotherapy educational program for pharmacists 
Please tick the appropriate option 
5.  There is need to improve the quality of dispensing information that I give to 
      patients about use of their medicines?     
 Strongly agree   Agree        Disagree          Strongly disagree 
  
 
Please tick the correct response for questions 6 and 7 
 
 
 
 
 
 
 
 
  186
6.      Do you feel that the diabetes pharmacotherapy educational program at the  
pharmacy helped you in the following areas listed below? Please answer each of 
the questions a,b,c and d    
               a) The program helped me improve my dispensing skills for diabetes  
                    management? 
        Strongly agree   Agree       Disagree        Strongly disagree 
                                                       
 
b) The program helped improve my knowledge about side-effects of  
     drugs used in diabetes management     
 Strongly agree   Agree       Disagree        Strongly disagree   
 
 
       c) The program helped alert me to identify drug interactions and contra- 
            indications in diabetes management          
   Strongly agree   Agree       Disagree        Strongly disagree   
 
d) The program helped alert me to correct drug dosages for diabetes 
     treatment easily      
                        Strongly agree   Agree       Disagree        Strongly disagree       
 
Diabetes care 
Please choose the correct answer 
7.      In your view, what is the recommended fasting blood glucose level range? 
                          a)    4 (≤) and less than or equal to  7 mmol/L          
                           
                          b)  16 (≤) and less than or equal to  20 mmol/L        
  
   c)  22 (≤) and less than or equal to  25 mmol/L        
      
Please choose the most suitable option for questions 8, 9 and 10 
8.   I believe that  hypoglycaemia may be due to the effects of drug 
      therapy such as insulin or the sulphonylurea  e.g glibenclamide?  
       Strongly agree   Agree       Disagree        Strongly disagree  
   
      
9.    In my opinion hypertension accelerates the development of the complications  
         of diabetes such as….  
      a)Diabetic nephropathy         
               Strongly agree   Agree       Disagree        Strongly disagree         
                      
                      b) Diabetic retinopathy 
                              Strongly agree        Agree       Disagree        Strongly disagree 
 
10. After receiving the diabetes educational program are you going to advise patients on  
      the following:      
a)       foot care?  
       Yes   No       I do not have time to do that    
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b)    eye care?         
                                           Yes   No       I do not have time to do that    
          
  c)       glycosylated hemoglobin (HbA1c) levels?  
         Yes   No       I do not have time to do that    
   
  d)       importance of well controlled blood glucose levels?       
         Yes   No       I do not have time to do that    
 
Please choose the appropriate option for statements 11 and 12 
11.   In your practice how many patients are you able to advise on … 
a) foot care? 
1 out of every 2 diabetes patients  
1 out of every 10 diabetes patients  
1 out of every 20 diabetes patients   
All diabetes patients    
None of the diabetes patients   
  
     
             b)        eye care?         
1 out of every 2 diabetes patients  
1 out of every 10 diabetes patients  
1 out of every 20 diabetes patients  
All diabetes patients    
None of the diabetes patients   
                            
 
Please tick the option that is most applicable to you 
 12. After receiving the diabetes educational program I spent more time  
          counseling/advising _________________ .    
      a) Newly diagnosed diabetic patients only       Yes              No 
      b)    Chronic diabetic patients only                      Yes              No 
      c)     All (newly diagnosed and chronic) diabetic patients      
                                                                       Yes              No  
 
Please tick the option that is most applicable to you  
  13.     After receiving the diabetes educational program _________________ . 
        a)   I changed my work routine to spend more time on caring for diabetes 
patients, through more counseling  
                                                                                           Yes              No 
 
       b) I did not change my work routine at all         Yes              No        
        
     Monitoring 
    14.   Please choose one option (a, b, or c) that you consider most appropriate  
 for questions 14 and 15  
  If you find that a patient’s glycosylated hemoglobin (HbA1c) levels is 12% 
which is above the recommended levels,  or less than or equal to (≤) 7-8% 
what action do you take?  
 a) Let it pass 
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                b)  I do not have time to look at it closely      
   
       
             c)    I refer the patient to make enquiries from the doctor                        
    
 
15.    I refer to the patient’s fasting blood glucose levels written on the patient’s folder to 
         check if treatment is appropriate?  
a) In about 1 out of every 10 diabetic folders/charts   
b) In about 1 out of every 30 diabetic folders/charts   
                        c)   In about 1 out of every 50 diabetic folders/charts   
             d)   All the time        
c) Never                   
 
  
Please tick statements that applies to you 
16.    It is important to have monitoring parameters such as fasting blood glucose levels  
         (FBG), random blood glucose levels (RBG), glycosylated haemoglobin levels (HbA1c), 
         triglycerides (TG) and total cholesterol levels, written on patients folders. Concerning  
         their application, which of the following statements best describes your intentions 
         in relation to monitoring patients’ blood glucose and diabetes control? 
          a) I intend to refer to all or some of these levels Agree Disagree          
 
             b) Although these are time consuming and not easy to implement, I intend to  
                 refer to these levels    Agree Disagree 
 
Please use the folder to answer questions 17,18 and 19 
17.    The ideal lipid profile of a diabetic is … 
                    i)  total cholesterol less than (<) 5 mmol/L      
                             Yes                 No            I do not know   
            
        ii) triglycerides less than (<) 1.5 mmol/L                 
                             Yes                 No            I do not know 
18.    The ideal choice of a drug for a patient with predominant hypertriglyceridaemia  
         is  bezafibrate            
              Definitely Yes          Definitely Not            I do not know 
19.    Fibrates e.g bezafibrate should be used with extreme caution in patients with 
         impaired kidney function. 
              Definitely Yes          Definitely Not            I do not know 
 
20.    Muscle waisting and abdominal pain are some side effects of bezafibrate 
             Definitely Yes          Definitely Not            I do not know 
 
Lifestyle Management 
Please tick the option which is MOST applicable to statements 21 and 22  
21.    How many times do you feel you will be able to advise patients on the 
importance of  stopping smoking in managing diabetes?    
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a) All the time       
b) About 1 out of every 10 diabetic patients    
c) About 1 out of every 30 diabetic patients    
d) About 1 out of every 50 diabetic patients    
e)   Never        
   
 
22.          How many times do you feel you will be able to advice patients about the 
               importance of exercise and weight control in managing diabetes?  
e) All the time       
f) About 1 out of every 10 diabetic patients    
g) About 1 out of every 30 diabetic patients    
h) About 1 out of every 50 diabetic patients    
e)   Never        
 
 
Comments 
 23.  Please tick the most applicable option  
        The diabetes pharmacotherapy educational program that we are implementing with  
        you makes dispensing _______________.     
  
  highly interesting      less interesting     boring      It does not make a difference 
 
Educational program     
24.    Please tick all statements that applies, concerning the educational program 
         a)  It increases the work load   Agree Disagree         
                
         b)  Although it increases the work load, it is worth doing  
      Agree Disagree         
          
         c)  It is good practical knowledge that we need to use during our practice 
      Agree Disagree         
          
         d)  It is information that you need to have only if you teach in a university 
              Agree Disagree         
Use of educational material 
25. Please tick the appropriate option  
Which material did you find beneficial at increasing your awareness about diabetes    
when dispensing prescriptions. 
                Folder only        Pen only Both pen and folder       None of them 
 
26. Please tick the option that is most applicable concerning the desk folder for 
      statements a → i    
       a) The desk folder is easy to understand  Agree Disagree         
       b) The desk folder is difficult to understand  Agree Disagree         
      c) The desk folder is a good reference source Agree Disagree         
 d) The desk folder is too much full of information (cluttered) 
        Agree Disagree         
       e) The desk folder is a good reminder  Agree Disagree         
       f) The desk folder helped to improve my knowledge on diabetes management 
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        Agree Disagree         
       g) The desk folder takes too much space  Agree Disagree         
 h) The desk folder helped to improve my confidence on diabetes management 
        Agree Disagree         
 i) The desk folder is easily accessible because it is mounted on the wall 
        Agree Disagree         
 
Please tick the appropriate choice concerning the desk folder 
27.    The illustrations on the desk folder were very useful and considerably improved  
         my understanding and clarity about diabetes 
  Strongly agree     Agree       Disagree        Strongly disagree 
  
Please tick the appropriate option 
28.     I found some information in the folder that I do not agree with because it is wrong.  
       Yes             No        I am not sure   I did not use the folder 
 
Please tick the appropriate option concerning the pen 
29.    The pen serves as a useful reminder. It reminds me there is special information (contents of 
         the desk folder) concerning the management of diabetes that I must discuss with patients 
         when counseling them        
                       Strongly agree     Agree       Disagree        Strongly disagree 
 
Students 
Please choose the statements you agree with, concerning the diabetes educational  
program in relation to facilitation of students learning at the pharmacy 
30.   The educational program will definitely help me when I facilitate student learning 
        at this site 
  Strongly agree     Agree       Disagree        Strongly disagree 
 
 
Opinion on educator  
Please tick all statements that apply 
31.  a) The educator who visited the pharmacy and discussed diabetes management 
principles with me was knowledgeable  
      Strongly agree     Agree       Disagree        Strongly disagree  
       
b) The educator who visited the pharmacy and discussed diabetes management 
principles with me has clarified and reinforced my understanding  
      Strongly agree     Agree       Disagree        Strongly disagree 
 
Educator and the educational material 
For each statements a → e, please tick the appropriate option 
 32.  The components and/or of the diabetes educational program, that could have contributed  
        to improving my understanding of diabetes include _______________. 
       a) Both the educator and educational materials (folder and pen)  
          Agree Disagree        
     
     
a) Only the educational materials(folder and pen)   
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       Agree Disagree         
     
            c)  Only the educator     Agree Disagree         
    
            e)  None of the above     Agree Disagree         
 
                        
Overall view of the educational program   
Please tick the appropriate option   
33. Did you find the educational visit(s) during your routine working hours…  
        useful          did not make a difference  not useful 
 
Perceptions/ feelings about the presentation style of the educational session 
For each statement please tick the option that is most applicable to you 
34.    a) During the discussions I felt free to pose any of my questions or ideas 
                           Agree Disagree         
     
    b) During the discussions I was guided on important concepts and/or 
                             aspects on the management of diabetes 
        Agree Disagree         
           
    c) During the discussions I was encouraged to counsel patients more about  
            diabetes    Agree Disagree         
         
    d) During the discussions I had the feeling I was being dictated how I  
            should act when dispensing and counseling patients on diabetes   
        Agree Disagree  
 
Experiences with the use of the messages/materials in the desk folder 
For each statement (a→f) please tick the option that is most applicable to you 
 35. What are your experiences with the use of the messages/materials in the folder  
      
  a) I did not use the folder Agree Disagree         
 
  b) I know most of the contents about diabetes in the folder and I will apply the
    information when I dispense and counsel patients  
        Agree Disagree  
 
  c) I do not know what is in the folder   
        Agree Disagree         
 
  d) I have no time to apply the information on the folder when dispensing to 
diabetics          Agree Disagree 
          
 
e) I am satisfied with the way I dispense today especially when it comes to 
patient counseling on diabetes treatment          
        Agree Disagree  
 
  f)  I will use the folder from now onwards  
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                Agree Disagree 
         
 
Attendance preference for educational session 
Please tick the appropriate option   
36.     A combined session for the pharmacists and pharmacist’s assistants for the       
          educational program was 
 fine  not fine It did not make a difference 
 
 
Recognition of participation in an educational program 
Please tick the appropriate option  
37.    I need a certificate for having participated in this educational program 
                 Yes  No  It does not make a difference     
 
 
38.   Please tick the appropriate option   
      These short but educative programs on diabetes must be continued with the treatment  
         of other chronic disease conditions 
   
                   Strongly agree     Agree       Disagree        Strongly disagree 
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